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1. Introduction 
 
1.1 Heme Thiolate Proteins 
 Heme thiolate proteins belong to a class of hemeproteins where the heme iron fifth 
ligand is a thiolate group (typically of a Cys residue). These proteins are found in organisms 
from all domains of life and are major catalysts in the oxidative biotransformation of a 
structural diversity of endogenous and exogenous compounds.1, 2   
A distinctive feature of heme-thiolate proteins is a Soret absorption band at around 
450 nm in the CO difference spectrum of reduced forms.3 The class includes the following 
families:  
• Heme chloroperoxidase  
• Nitric oxide synthase  
• P450 enzymes (P450s), also known as cytochromes P450 
Figure 1.  Representation highlighting the sulfur atom / Cys residue of the heme-thiolate porphyrin inside 
the largely hydrophobic enzyme pocket. 
 
 The 3D-structure of a protein can provide valuable insights into its function. Ideally, 
experimental techniques such as X-Ray crystallography, nuclear magnetic resonance (NMR) 
spectroscopy, and electron microscopy are used to determine the 3D-structure of proteins. 
Regrettably, the majority of proteins are currently not open to these techniques as they are 
difficult to crystallize, insufficiently soluble, or too large for NMR studies. One of the best 
alternative methods developed to determine the 3D-structure is the comparative (or 
homology) modeling technique.4 
 
Fe 
S 
Cys 
III
= porphyrin ring 
   = polypeptide chain 
- 
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To date structural models of human P450s were based on known, distantly related, 
bacterial P450s.5 Yet the recent determination of the crystal structure of the more closely 
related rabbit CYP2C56  has improved the reliability of comparative models for human 
P450s.7 Also, the availability of crystal structures of human CYP2C98, 9 and CYP2C810 can 
help in the determination of the structures of the major CYP2 metabolizing forms (CYP2A6, 
2C19, 2D6, and 2E1). Two distinct research groups11-13 have recently independently 
determined the crystal structure of truncated forms of CYP3A4. Cytochrome P4503A4 is 
highly expressed in human liver, it is able to oxidize a large number of structurally diverse 
substrates and contributes extensively to human drug metabolism. 
For the chloroperoxidase from Caldariomyces fumago14,15 and murine iNOS 
oxygenase domain16 the X-Ray structures were determined circa 10 years ago. Surprisingly 
the active site of all these enzymes is extraordinarily simple, with an iron protoporphyrin IX 
buried deep in a hydrophobic, substrate-binding pocket of the protein scaffold.  
Figure 2. Iron(III)-protoporphyrin IX  
FeIII
N
N
N
N
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CO2
Iron(III) protoporphyrin IX
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 Cytochromes P450 are oxidoreductases that activate molecular oxygen (O2) and 
incorporate one of the oxygen atoms into a large variety of biological substrates, with 
concurrent two electron reduction of the other oxygen atom to H2O.  
RH + O2 + 2H+ + 2e¯ → ROH + H2O 
In many, but not all P450 enzymes, and in the biomimetic systems, it is possible to 
circumvent the stepwise activation of molecular oxygen by providing H2O2 or another small 
peroxide as a co-substrate in what is termed the “shunt” oxidation mechanism (Scheme 2). 
However, the catalytic turnover, supported by peroxides, can give product distributions that 
differ from those obtained under normal catalytic conditions17,18 and results in accelerated 
degradation of the prosthetic heme group.19  
 Cytochromes P450, of course, do not function only as monoxygenases but also as 
reductases. For example the CYP101 (cytochrome P450cam) from Pseudomonas putida, 
which naturally catalyses the oxidation of camphor,17 has been shown to catalyze the 
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reductive dehalogenation of haloaliphatic compounds.20,21 And P450nor, found in the 
denitrifying fungus Fusarium oxysporum,22 can reduce NO3- and NO2- to N2O. 
 The P450 structure, biochemistry and molecular biology have been extensively 
reviewed in the last decade.23,24 Such enzymes have been extracted and isolated from 
almost every mammalian tissue (e.g. liver, kidney, lung, intestine and adrenal cortex), as well 
as insects, plants, yeast and bacteria. As monoxygenases they are known to catalyze 
hydroxylations, epoxidations, N-, S- and O-dealkylations, heteroatom oxidations and 
oxidative cleavage of C-C bonds (see Scheme 1).  
Scheme 1.  General Oxidative Metabolic Activity Scheme of diverse Heme Thiolate Proteins 
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 These oxygenation reactions play, for example, an essential role in drug metabolism 
and xenobiotic detoxification, carcinogen activation and steroid and prostaglandin 
biosynthesis.  
 As already mentioned above, for cytochrome P450s to function, they also need a 
source of electrons. The addition of two electrons (reduction) to the heme iron makes the 
difficult chemistry of breaking the oxygen-oxygen bond possible. The electrons are donated 
by another protein that binds to the P450 and passes an electron from a prosthetic group. 
There are two different kinds of electron transfer chains for cytochrome P450s both of which 
depend on the location of the enzyme in the cell.   
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For the P450s found in the mitochondrial inner membrane or for the bacterial P450s, 
the electron transfer chain consists of a three protein system (Type I).25  Ferredoxin (called 
adrenodoxin in the adrenals, but exactly the same gene codes for both proteins) is the 
immediate donor of electrons to the P450s in mitochondria. Ferredoxin has an iron sulfur 
cluster instead of a flavin, however, ferredoxin is reduced by ferredoxin reductase (or 
adrenodoxin reductase in the adrenals) that does contain a flavin. NADPH is the source of 
electrons that flow from ferredoxin reductase to ferredoxin and then to P450.   
Figure 3.  Electron chain for Type I P450s 
(P-FAD)redNADP
+
NADPH
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H2O
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 For microsomal P450s situated in the endoplasmic reticulum (ER) the NADPH- 
cytochrome P450 reductase is again the electron source (Type II).26,27 This reductase is a 
membrane bound protein by an N-terminal tail that crosses the ER membrane once and it 
has two domains each containing one flavin. Two electrons are acquired from NADPH and 
migrate from FAD to FMN, then to the P450 heme iron. In some special cases of the 
microsomal P450s reactions the participation of NADH-cytochrome b5 reductase/cytochrome 
b5 electron transport system was observed.28 
Figure 4. Electron chain for Type II P450s 
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Type III enzymes do not require an exogenous source of electrons, as they already employ 
oxygen-containing substrates.29 Type IV enzymes receive electrons directly from reduced 
pyridine nucleotides, without the intervention of an electron carrier.30 
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1.1.1. Classification of Cytochrome P450  
 The P450 proteins are categorized into families and subfamilies by their sequence 
similarities. Sequences that are greater than 40% identical at the amino acid level belong to 
the same family. Sequences that are greater than 55% identical are in the same subfamily. 
There are now more than 2500 cytochrome P450 sequences known.  
 The nomenclature for the P450 gene superfamily is based on evolutionary 
relationships. CYP is the abbreviation for Cytochrome P450, the first numeral n signifies the 
gene-family, the capital letter for the gene-subfamily and the last numeral m is the gene 
number.31-33  
 
1.1.2 CYP2B1 and CYP2E1  
 
 Typical CYP2B substrates are 7-benzyloxyresorufin, 7-ethoxy-4-
trifluoromethylcoumarin, benzphetamine, and testosterone. An intriguing aspect of many 
P450 enzymes, especially those of family CYP2, involves the differential regio- and 
stereoselectivity among structurally related proteins.34 The phenobarbital inducible rat 
cytochromes P450 2B1 and 2B2 are 98% identical, differing by only 13 amino acids. P450s 
2B1 and 2B2 have similar substrate specificities; however, in most cases P450 2B1 has 
significantly higher catalytic activity than P450 2B2. The critical residues involved in substrate 
binding and catalysis by P450 2B1 have been extensively studied using site-directed 
mutagenesis, susceptibility to inhibition by mechanism-based inactivators, and homology 
modeling based on the crystal structures of bacterial P450s and P450 2C5.35-39  
 
The cytochrome 2E1 was discovered in rabbit liver microsomes and purified and 
characterized  by Koop, Morgan and Tarr.40 CYP2E1 possesses the peculiar characteristic of 
being an ethanol-inducible cytochrome P450. CYP2E1 displays the highest activity of the 
rabbit isozymes in the oxidation of ethanol to acetaldehyde and can also oxidize other 
alcohols, aniline, and several drugs.41 Although this “microsomal ethanol-oxidizing system”42 
may not be a major pathway for alcohol oxidation under most circumstances, the increased 
levels of 2E1 resulting from the diabetic state, fasting, and exposure to ethanol and several 
other diverse agents, is a cause for concern because of resulting toxicities.43 In particular, 
acetaminophen, a widely used antipyretic and analgesic drug, is normally non toxic, but in 
large doses it produces acute hepatic necrosis when converted to its active metabolite. Of a 
series of P450 isozymes examined, 2E1 was one of the most active in producing this 
metabolite.39 
 
Introduction 
 
 
 6 
The mechanism of action of these enzymes has captivated researchers in this area 
for many years. The oxidative metabolic catalytic cycle performed by cytochrome P450 has 
been partially determined and will be examined in the following chapter.   
 
1. 2. The Catalytic Cycle of Cytochrome P450 
  
  A conventional consensus on the mechanism of P450s,44  the rebound mechanism in 
Scheme 2, has been attained from crystallographic and spectroscopic studies of different 
forms of P450cam jointly with mechanistic studies with labeled substrates and substrate 
analogues. Nonetheless, several mechanistic features still remain unresolved. 
 
  The binding of a substrate45 to the low spin ferric (FeIII) resting state 1 causes a 
lowering of the redox potential,46 which makes the transfer of an electron favourable from the 
cytochrome P450 reductase. This is accompanied by a change in the spin state of the heme 
iron at the active site, with a shift of the spin equilibrium from predominantly low-spin to 
almost completely high-spin of the enzyme-substrate complex  2. This spin equilibrium sets 
off the entry into the catalytic cycle. It has also been suggested that the binding of the 
substrate brings about a conformational change in the enzyme which triggers an interaction 
with the redox component. 
 
  The next stage in the cycle is the reduction of the (FeIII)-complex 2 to give the ferrous 
(FeII) substrate complex 3 by an electron from the reductase. Subsequently an oxygen 
molecule binds to form the low spin, diamagnetic (d6, S = 0) intermediate 4. Previous 
spectroscopic techniques alluded to a ferric superoxide (FeIII–O2-•) species as opposed to a 
ferrous species (FeII–O2).47,48 Only recently “time-lapse“ study of the catalytic cycle of 
P450cam using trapping techniques and cryocrystallography by Schlichting provided a high 
resolution structure (1.8 Å) of the dioxygen complex 4.49 
 
  A second mono–electron reduction gives ferric peroxo complex (FeIII–OO-) 5. This has 
been determined to be the rate-determining step of the reaction.50  
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Scheme 2. The consensus mechanism of P450 hydrocarbon hydroxylations 
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 It is difficult to define correctly the next steps of the catalytic cycle (5-9) due to the 
instability of the intermediates formed. Groves et al.44 put forward a rebound mechanism. 
Accordingly the distal oxygen atom of the peroxo complex 5 is protonated to give a 
hydroperoxide complex (FeIII–OOH) 6. A subsequent protonation on the same oxygen atom 
brings about a heterolytic O-O bond cleavage which results in water release and the 
generation of the oxo-ferryl (FeIV) porphyrin radical intermediate Por+. (FeIV=O) 7. This 
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intermediate is equivalent to the high-valent iron-oxo species of peroxidase enzymes, 
commonly known as Compound I.51 Groves suggested that this species 7 Por+. (FeIV=O) 
abstracts a hydrogen atom from the enzyme bound substrate providing a carbon-centered 
radical with a finite lifetime and hydroxo ferryl complex 8. In the subsequent oxygen rebound 
step a transfer of the oxygen atom to the enzyme-bound substrate radical is proposed. This 
results in the formation of the low-spin ferric enzyme-product complex 9. The catalytic cycle 
is closed once the oxidized product dissociates from the active site. 
 
 
1.2.1 The role of axial ligand in heme-based catalysis 
 
As already mentioned in the introduction, the common structural characteristic of 
these enzymes is the heme-thiolate (Fe-S-) coordination in their active sites.17 
 
The strong electron-releasing character of the thiolate ligand has been assumed to 
serve as the “push” effect that enables the heterolytic O-O bond scission to generate the 
activated iron (IV)-oxo species commonly called Compound I.52 Furthermore, the 
electronegative thiolate group should determine the redox potential of the heme in these 
enzymes to accept electrons from their redox partners and to stabilize the electron-deficient 
active species.17 However, the regulation mechanism of these functions by the thiolate ligand 
has not been fully clarified. It has been previously stated that the conserved NH-S hydrogen 
bonds, between the thiolate ligand and the protons from the surrounding polypeptide amides, 
have been assumed to control the functions of the heme thiolate enzymes by neutralizing the 
negative charge on the thiolate.53 Density functional calculations54 have been used to explore 
the nature of this push effect. The calculations confirmed its existence and proved that this 
force is energetically a significant quantity. 
 
 Nevertheless, the push effect of the cysteinate ligand cannot, by itself, carry out the 
cleavage of the O-O bond. In fact it requires a proton source to permit the distal (outer) 
oxygen of the bound peroxide of 5 (FeIII–OOH) to be release as a water molecule. Using 
crystallographic and kinetic isotope studies on the wild-type and D251N mutant of P450cam, 
Sligar proposed a proton shuttle system.55,56 This proton delivery scheme involved two water 
molecules in the active site and two distal site amino acids, Asp251 and Thr252. In this 
proposal Thr252 and Asp251 construct a proton relay network that facilitates, in tandem with 
two other charged residues (Arg186 and Lys178), the networks arrival at the surface solvent  
thus supplying a conduit for protons (Figure 5). This push-pull mechanism, which is also 
   Introduction 
 
 
 9
found in horse radish peroxidase (HRP),57 is sustained by crystal structures seen in the 
“snap-shot “study of Schlichting et al.49 
 
Figure 5. Proton delivery system 
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1.2.2 Electrophilic Oxidative Species in the Catalytic Cycle 
 
In the P450 reaction scheme, two potential oxidants with electrophilic reactivity are 
formed. These are designated the ferric-hydroperoxo species (FeIII–OOH) or Compound 0 
and the high-valency ferryl-oxo π-cation radical Por+. (FeIV=O) or Compound I (6 and 7 in 
Scheme 2). As these intermediates are short-lived in nature, their isolation and 
characterization has proven to be an elusive task. 
 
Hoffman, Sligar and co-workers58-60 have lately used γ-radiation to generate hydrated 
electrons in situ at low temperatures to reduce oxyferrous D251N, T252A, and wild-type 
CYP101. EPR, ENDOR and electronic absorption spectroscopy were then used to directly 
observe the peroxo and hydroperoxo states.58-62 Using the same radiolytic reduction of the 
oxy-ferrous horseradish peroxidase (HRP) at 77 K, Sligar63 observed the formation and 
decay of the putative intermediate hydroperoxo-ferric complex (Cpd0). EPR and UV-visible 
absorption spectra showed that protonation of the primary intermediate of radiolytic 
reduction, the peroxo-ferric complex (FeIII–OO-) 5, to form the hydroperoxo-ferric complex 
(FeIII–OOH) 6 is completed only after annealing at temperatures 150–180 K. This approach has 
sadly not led to direct detection of the elusive P450 Cpd I species, yet its involvement in 
catalysis could be inferred.58 Schlichting et al.49 reported the low-temperature X-ray 
crystallographic characterization of oxyferrous P450 under conditions known to produce 
hydrated electrons. They witnessed a form of the enzyme that was cautiously identified as 
P450 Compound I, even if other species could not be excluded. Kellner have also inferred 
Cpd I existence by using transient electronic spectroscopy and decay kinetics.60  
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 More solid kinetic analysis of Cpd I formation and decay was given by Ishimura, Sligar 
and their co-workers using stop-flow experiments.64, 65 By mixing substrate-free ferric P450 
with m-chloroperoxybenzoic acid, both groups observed a transient derivative with an 
absorption spectrum that showed a good similarity to that of C. fumago chloroperoxidase 
Compound I. 
 
Further evidence for the participation of a second electrophilic oxidant in P450-
catalysed reactions has come from studies of substrate oxygenations by P450 active-site 
mutants with impaired hydroxylase activity (see chapter 1.3.2.).44, 66-69   
 
1. 3. P450 Oxidation Mechanism 
 
1.3.1. From the Rebound Theory to the Two Oxidant Theory 
 
 The rebound mechanism formulated in the original studies of Groves44 (see chapter 
1.2) has gained support by the results from a variety of experiments favoring the existence of 
a discrete radical intermediate.70-79 
 
One example is the strong kinetic intramolecular isotopic effects (kH/kD> 11) observed 
for the first time by Hjelmeland70 and by Groves71 respectively for benzylic and aliphatic 
hydroxylation performed by P450s. The lack of a carbocation rearrangement and the 
extremely low acidity of typical aliphatic C-H bonds suggested a two step radical mechanism. 
Additional proof of the existence of a radical intermediate was attained when stereochemical 
scrambling, for example, in cytochrome P450-2B4 hydroxylation of the exo-d4 norbornane 
was detected71 (Figure 6). 
 
Figure 6.  Stereochemical scrambling in the P450 hydroxylation of exo-d4 norbornane 
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This scrambling phenomenon was also observed by Sligar et al. in the camphor 
hydroxylation with P450cam (CYP101), which had the ability to extract either an exo or endo 
hydrogen but delivered the oxygen solely to produce the exo-hydroxy isomer (Figure 7).72  
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Figure 7. Stereochemical scrambling in P450 camphor hydroxylation  
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  In another publication Groves, in the P450-2B4 hydroxylation of (3,3,6,6-d4) 
cyclohexene, reported an allylic rearrangement of the hexene double bond.74 This allylic shift 
was attributed to a hydrogen atom abstraction from the allylic site and a subsequent 
geminate, cage recombination of the incipient allylic free radical (Figure 8). 
 
Figure 8. Allylic rearrangement in the P450 hydroxylation of (3,3,6,6-d4) cyclohexene. 
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Nevertheless, Woggon et al.80 alleged that this allylic rearrangement was faster than 
the trapping by the hydroxyl radical delivered by the PorFeIV-OH 8 (see Scheme 2) due to the 
cyclic nature of the substrate. In support of this statement they performed an allylic enzymatic 
oxidation of an open system. P450Cath–catalyzed hydroxylation of both enantiomers of 
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geraniol, which is chiral by virtue of isotopic substitution on the terminal methyl group (see 
Figure 8b), showed a very high level of regio- and stereospecificity, indicating that the radical 
intermediate was short-lived. 
 
Figure 8b. P450Cath-catalyzed hydroxylation of chiral geraniol. 
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White et al. determined that the S and R enantiomers of (1-d1) ethylbenzene were 
hydroxylated by P-450LM2 with very high regioselectivity at the benzylic position and that a 
moderate preference (4:1) was exhibited for pro-S hydrogen removal.75 White noticed also 
that an appreciable fraction (25-40%) of the hydroxylation events involved crossover of 
stereochemistry between the hydrogen-abstraction and oxygen-delivery steps (Figure 9). 
This observation required that a tri-coordinate benzylic carbon atom had to have been a 
discrete intermediate.  
 
Figure 8. Regioselectivity in the P450 hydroxylation of S and R enantiomers of (1-d1) ethylbenzene. 
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Dinnocenzo and Jones et al.76, 77 provided more indirect evidence for this rebound 
mechanism using KIE measurements. They found that for several aryl methanes the KIE’s of 
P450 hydroxylation equate to those of an equivalent hydrogen abstraction reaction by tertial 
butoxyl radical. Both processes necessitate isostructural transition states. All these results 
suggested that an intermediate species, most probably a radical, was formed in the 
hydroxylation reaction. 
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To verify the existence of the hydrocarbon radical intermediate and explore its lifetime 
“radical clock” experiments were undertaken. The pioneering experiments were performed 
with a radical clock consisting of a cyclopropyl ring bonded to the carbon that is proposed to 
become a radical centre during the course of the reaction. The three-membered rings have 
an inherent strain which causes such cyclopropyl carbinyl radicals to quickly and essentially 
irreversibly rearrange81 to the corresponding homoallylic radical. The ratio of products derived 
from the cyclopropyl carbinyl radical versus the homoallylic radical is thus determined by their 
relative magnitudes of the rate constants for radical quenching (kt = kOH, Figure 10) and 
rearrangement (kr = krearr, Figure 10). 
 
Figure 10.  Measurement of kOH of a cyclopropyl radical clock  
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Since the rate of rearrangement can be independently measured, the ratio of 
unrearranged to rearranged product allows the determination of both the rate of radical 
quenching (oxygen rebound) and the lifetime of the radical intermediate. Initial experiments 
with a variety of substrates containing relatively simple cyclopropyl rings (kr = 1-4 × 108 s-1 at 
37°) yielded only unrearranged product.78, 79, 82 Thus, either a radical intermediate was not 
present or its rebound rate was much faster than that of the rearrangement. 
 
Bicyclo[2.1.0]pentane (Figure 11) was then subjected to P450-catalyzed 
hydroxylation by Ortiz de Montellano and Sterns83 since this hydrocarbon would yield a 
radical which was known from studies by Jamieson et al to rearrange (kr = 2.4x109 s-1) more 
rapidly than cyclopropylmethyl radical.84   
 
Figure11.  P450-catalyzed hydroxylation of Bicyclo [2.1.0] pentane 
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Due to the extra strain of the system the rearrangement rate is faster than the 
recombination rate and the P450 oxidation reaction produced rearranged and unrearranged 
products that allowed a rebound rate of 1.4x1010s-1 to be calculated.85 Similar oxidation 
experiments performed much later with norcarane and spiro[2, 4]octane gave comparable 
values to that above in the range of 1010s-1. In this case the oxidation of norcarane and 
spiro[2, 4]octane with P450cam (CYP101), P450BM3 (CYP102), CYP2B1 and CYP2E186 
afforded products indicative of a radical intermediate with a lifetime ranging from 16 to 52 ps. 
 
For fully probing the rebound mechanism more sophisticated probes were devised. 
Phenyl substituted cyclopropyl probes produced cyclopropyl carbinyl radicals which were 
found to rearrange at a rate up to 1000 times faster than the parent probes seen above.87 
The two ultrafast probes used in these experiments, trans- 1-methyl-2-phenylcyclopropane 
10 and 1-methyl-2,2-diphenyl-lcyclopropane 11 (Figure 12), gave alcohol products ratios 
which yielded unexpected high values for kOH ca. 1.5 X 1012 s-1 and ca. 7 X 1012 s-1, 
respectively.88  
 
Figure 12. Ultrafast radical clock probes trans- 1-methyl-2-phenylcyclopropane and 1-methyl-2,2-diphenyl-
cyclopropane. 
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With the phenyl-substituted cyclopropylcarbinyl radicals corresponding to 10 and 11, 
Atkinson and Ingold believed that there was a likelihood that the enzyme enforced 
conformations where the π-electron system of the phenyl ring(s) could not overlap fully with 
the bond which breaks in the cyclopropane ring, and thus induce a “slowing down“ of the 
ring-opening. This possibility had been considered by Liu et al. (1993) in their study of the 
oxidations of 10 and 11 by methane monooxygenase from Methylococcus capsulatus 
(Bath).89 This explanation was in full agreement with the experimental results obtained with  
bycyclo[2.1.0]pentane, where Ortiz de Montellano83 witnessed limited mobility also for this 
smaller substrate. Nevertheless this rationalization of high kOH values based on the steric 
constrains in the enzyme pocket was dismissed by the subsequent Atkinson experiment 
performed with both enantiomers of 10. Regardless of the fact that two enantiomers should 
give different results due to their different diastereomeric complexes with the enzyme, both 
gave, upon microsomal P450 hydroxylation, quite similar results in terms of their overall 
reactivity, the observed KIEs, and, most importantly, the product distributions.90  
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Newcomb believed that a definitive answer to the high kOH values could be found 
employing an ultrafast clock 12 (kr = 3x1011s-1)91 (Figure 13) having an accelerating substituent that 
was conformationally locked with respect to the cyclopropane ring.92 This probe was unlikely to be 
subjected to steric constraint. Surprisingly, the rebound constant calculated from the distribution of 
the rearranged and unrearranged alcohols had the value 1.4 x 1013 s-1 which was on the order of a 
vibrational rate constant and not of a chemical rate constant (Figure 13). The generally accepted 
upper limit lifetime of a radical intermediate in the transition state theory is 170fs. 
 
Figure 13. Ultrafast radical clock probe with kr = 3x1011s-1 
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 At this stage Newcomb felt it necessary to carry out a systematic study on the 
hydroxylation of ten probes (Figure 14) by P450 2B1 and 2B4  in order to verify if a linear 
correlation with a slope of 1 existed in a log-log plot of the ratio of rearranged to 
unrearranged alcohol product versus the radical rearrangement rate constant.93  
 
Figure 14.  P450 hydroxylations of ten key probes 
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The lack of a consistent trend in the set of “quantitative” data94 together with the 
results of kinetic isotope studies95 and the outcomes of experiments performed with P450-
mutants on the same set of probes by Coon (see next paragraph), lead Newcomb to 
conclude that the overall mechanistic picture was incomplete. Newcomb cast doubts about 
the general accepted hydrogen abstraction-rebound mechanism44 and suggested that an 
unidentified process might be occurring in competition with or as a part of the hydroxylation 
sequence. Because a radical and a cationic intermediate would suffer the same skeletal 
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reorganization in each probe for which rearranged products were found, the possibility of a 
side reaction involving a cation could not be excluded. 
 
His attempted solution was to use hypersensitive radical probe substrates that could 
distinguish between radical and carbocation intermediates on the basis of the identity of the 
rearranged products (Scheme 3). Production of a radical at the methyl group in this probe 
gives highly regioselective cleavage, favoring the benzylic radical product (>50:1), and 
production of a cation at the methyl position results in ring opening towards the alkoxy group 
to the limit of detection (>1000:1).96-98 
 
 Oxidation of trans,trans-2-methoxy-3-phenylmethylcyclopropane 21 with six 
cytochrome P450 isozymes gave cation derived rearrangement products, disproving the 
assumption that such rearrangements arose exclusively from radical species. Variable 
partitioning between the radical and carbocation mechanisms thus was concluded to explain 
the wide range of measured kOH values.99  
 
From the small amounts of radical rearrangement products generated from the 
hypersensitive probes, the radical lifetimes in the P450-catalyzed reactions could be 
calculated to range from 70 to 200 fs98,99 which are again too short for true radical 
intermediates, but rather correspond to the decomposition rate of a transition state. The 
occurrence of cationic intermediates necessitated another mechanistic model (Scheme 3).  
 
Scheme 3. The carbocation model proposed in fast radical clock experiments 
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In this regard, the most plausible premise was insertion of OH+ into a C-H bond to generate 
protonated alcohol species that could undergo solvolysis-type reactions to yield cationic 
rearrangement products.94,99 This route required heterolytic O-O bond fission of the 
hydroperoxo-iron state (Compound 0) of P450 (Scheme 3b) to insert OH+.98,99 The new 
mechanism as shown in Scheme 3, was therefore based on a “two oxidant” paradigm 
whereby both oxo-ferryl-(FeIV) Cpd I and its precursor hydroperoxo-(FeIII) Cpd O are good 
electrophiles and can respectively react through a radical and a cationic mechanism 
(Scheme 3b). Variable partitioning between the radical and carbocation mechanisms thus 
was concluded to explain the wide range of measured kOH values. 
 
Scheme 3b.  Involvement of Compound 0 in the catalytic cycle 
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However, density functional analysis of mechanisms involved in ethylene epoxidation 
by a Fe(III)–OOH model disclosed barriers for the model pathways, detailed by Shaik,  of 37-53 
kcal/mol.100 This was taken to indicate that hydroperoxo-iron (Cpd 0), as such, could not be the 
ultimate oxidant, in line with its significant basicity and poor electron-accepting capabilities.100   
 
Furthermore this hydroxylation reaction effected by hydroperoxo iron species 
(Compound 0) was not a viable alternative since Loew calculated that protonation of the 
distal oxygen in the reduced ferrous dioxygen unit [Fe-O-O]2- triggers Fe-O bond 
weakening101 and Kamachi determined that the subsequent conversion of the protonated 
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PorFeIII-OOH2+ to Por+.FeIV=O (CpdI) involves a barrierless reaction pathway with a 
significant energy release of 50 kcal/mol.102   
 
It is noteworthy that the percentage of cationic rearrangement products observed in 
these experiments does not correspond to the stability of the cation involved. One example of 
this is seen in a series of probes,66 with either a hydrogen or para-trifluoromethyl substituent 
on the phenyl and an ethyl, propyl, or isopropyl group replacing the methyl on the 
cyclopropane ring (Figure 14). Even though ring opened products were again observed the 
overall results were contradictory. In fact the cation stabilizing groups resulted in less rather 
than more rearrangement, the opposite  to what would be expected should a protonated 
alcohol have been the initial oxidation product.66 Unfortunately this result does not sustain the 
production of a protonated alcohol, which should ionize and rearrange more readily with 
increasing stability of the carbocation, and thus these findings weigh heavily against the 
participation of an FeIII–OOH species.66 
 
The alternative Ortiz de Montellano’s proposal86,103 of a carbocation formation through 
a monoelectronic oxidation of the radical intermediate requires that this oxidation reaction 
proceeds at higher rates than usual radical rearrangement.104 
 
Scheme 3c. Proposed monoelectron oxidation of cyclopropylcarbinyl radical 
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Unfortunately there are no experimental data that could prove or disprove this 
proposition. Factors which could influence the rate of electron transfer include the relative 
proximity of the electron donor and acceptor and the redox potential difference between 
them. At this point it was clear that there was no general consensus on the oxidative power 
of the Fe-OOH intermediate claimed by Newcomb to be the second electrophylic species 
acting in the P450 hydroxylation mechanism. 
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1.3.2 Evidence from experiments with genetically engineered P450 enzymes 
 
  A contribution to this debate came from studies with mutated P450s.The crystal 
structures of bacterial CYPs 101,102 and 108 contain a highly conserved active-site 
threonine within H-bonding distance to the peroxo-iron unit.17 Of particular interest, 
attenuated camphor and laurate hydroxylation was observed, when T252/268 in the CYP101 
and CYP102 polypeptide, respectively, were replaced with alanine.68,105 In the opinion of 
Sligar and Ishimura the production of less than 0.1% of hydroxycamphor implied that this 
mutant makes a minimal amount of oxo-ferryl Por+.Fe=O (CpdI). 
 
Nevertheless, the T252A variant was found to accept electrons from NADH and 
reduce dioxygen to H2O2105 via the intermediacy of hydroperoxo-iron.92 Mutation was 
considered to disrupt a key step in H+ delivery, presumably introduction of the second proton 
to hamper O-O bond dissociation.58 Therefore, P450 mutants devoid of the active-site 
threonine were regarded as ideal means for testing the direct involvement of hydroperoxo-
iron (Cpd0) in epoxidations. Sligar, in a series of oxidation reactions, showed that T252A, a 
form of the enzyme that produces none or very little of the hydroxylated product with the 
normal substrate, 1R-camphor, is however, capable of catalyzing the epoxidation of olefins. 
Indeed, a drastic increase in the ratio of epoxide to hydroxy products derived respectively 
from two camphor analogues (5-methylenecamphor and 5-norbornen-2-one) and 1R-
camphor during catalysis by the T252A congener of CYP101 could be demonstrated in 
comparison to the wild type parent by Sligar et al.64 (Figure 15) 
 
Figure 15.  Epoxidation of two camphor analogue by the T252A congener of CYP101 
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These two alkenes, however, were epoxidised by the mutant T252A at a rate only 15-
20% compared to that of the wild-type CYP101. In summary, while it seems that the 
hydroperoxoferric P450 intermediate Cpd 0 is capable of epoxidising alkenes, the Cpd I state 
is still probably the major catalyst for alkene epoxidation in the wild-type enzyme.  
 
Similar findings were made with truncated CYP2E1 lacking the active-site threonine. 
Vaz et al. showed that the 2E1 mutant T303A mediated the metabolism of cyclohexene, cis-
but-2-ene and trans- but-2-ene at an increased ratio of epoxidation to allylic hydroxylation.106 
On the other hand, when CYP2B4 T302A was employed on the same substrates the results 
were different. A reduction of the rates of both allylic hydroxylation and epoxidation was 
registered. The failure to observe similar changes with the CYP2B4 mutant to those seen 
with CYP2E1 was disappointing, but could be rationalized assuming that the mutation causes 
changes in the active site and not only eliminates the hydrogen bond that is used to promote 
O–O bond cleavage. 
 
Jones et al. assessed the participation of an alternative electrophilic intermediate in 
heteroatom oxygenation by employing the T268A mutant of CYP102. The engineered 
enzyme fostered sulfoxidation of p-(N,N-dimethylamino)thioanisole relative to N-dealkylation 
of the substituted amine function (Figure 16).107 Nevertheless this research was inconclusive 
since, even if the KIE data and products distribution seemed to demonstrate the involvement 
of two separate oxidants, it was impossible to determine which reaction was catalyzed by 
which specific oxidant. 
 
Figure 16. Sulfoxidation vs N-dealkylation of p-(N,N-dimethylamino)thioanisole. 
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A mutant of truncated CYP2B4 with exchange of alanine for threonine at position 302 
turned out to have decreased ability to catalyze NADPH-dependent N-oxide formation from 
N,N-dimethylaniline, questioning an obligatory hydroperoxo-iron-promoted mechanism.108 
However, when the measurements were conducted with iodosylbenzene in place of 
NADPH/O2 to directly generate the favored Por+.FeIV=O entity (CpdI),109 the enzyme variant 
still mediated N-oxygenation of the tertiary arylamine at a rate less than half that of the wild-
type-catalyzed reaction107 so that reasonable interpretation of the data seemed difficult. 
 
Using the same wild-type and engineered P450s pairs, the potential involvement of 
Fe(III)-OOH in hydroxylation reactions was inferred from mutant-induced changes in 
regioselectivity during the oxidation of cyclopropyl probes (previously mentioned) designed to 
give different rearrangement products with radical and cationic intermediates.66 95 97, 110 The 
results of these investigations provided evidence supporting the existence of a second (or 
altered) oxidant in the mutant enzyme and the formation of (carbo)cationic species as minor, 
non critical intermediates in certain oxidations.  
 
Both Coon and Newcomb results suggested that the oxidizing species produced 
when the distal threonine is mutated to an alanine in CYP2E1, but probably not in CYP2B4, 
may vary to some extent from that formed in the intact enzyme. What these results did not 
discover was whether or not this species is in fact the PorFeIII–OOH intermediate. The 
authors also acknowledge the possibility that the reported results of the mutation could be 
due to physico-chemical changes, which affect the reactivity of the ferryl species. Thus there 
is no concrete indication that the ferric hydroperoxy species is an oxidant in C–H 
hydroxylations by P450 enzymes. 
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1.3.3 A theoretical approach of monooxygenation mechanisms by P450 enzymes. 
 
Density functional theory (DFT) together with quantum mechanical/ molecular 
mechanics) calculations (QM/MM) are capable of supplying chemists with a tool that can 
provide, at least qualitatively, reliable and detailed descriptions of bioinorganic reaction 
mechanisms.111 Indeed, Shaik’s DFT calculations73, 112  have attempted to offer a simple 
resolution of the mechanistic dilemma, posed by studies of C-H P450-hydroxylation,94 in terms 
of a two-state reactivity (TSR) of Cpd I alone; namely, one reagent with two different pathways.  
 
Prior to a detailed description of these two different pathways, it is necessary to 
elucidate how Shaik et al. describe, by the use of DFT and of the QM/MM calculations, all 
known model and enzymatic Cpd I species as tri-radicaloid.73, 86, 95, 98, 107, 110, 112, 113 Scheme 4 
shows the key orbitals of Cpd I: five d-block orbitals, labeled as δ x2-y2, σ*xy, σ*z2, π*xz, and 
π*yz, and one porphyrin sulfur mixed orbital, labeled as a2u.  
 
Scheme 4. Key orbitals of Cpd I of P450. Origin of the degenerate state of CpdI (2,4A2u) 
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Of the d orbitals, only the δ orbital is pure nonbonding, while the rest have antibonding 
interactions with the ligands.99 94 The species Cpd I possesses three odd electrons in the π* 
and a2u orbitals. The coupling between the electron in a2u and the π* triplet is very weak, 
since the π* and a2u orbitals are virtually disjointed. As a result the ferromagnetic state, with 
all spins up, and the antiferromagnetic state, where the electron in a2u possesses an opposite 
spin to those in π*, are close in energy. DFT calculations show the close proximity of the two 
states.72 Clearly, therefore, Cpd I has a virtually degenerate ground state 2,4A2u and is 
accordingly a two-spin--state oxidant. Hereafter, the two states are referred to as the high-
spin (HS) and low spin (LS) states. 
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In the light of the TSR theory, Shaik has re-examined the experimental results 
obtained by various research groups relative to the diverse P450-oxidative reactions as 
epoxidation, heteroatom oxidation, (N,S,O)-dealkylation and C-H hydroxylation. In the 
specific case of a C-H bond hydroxylation of an alkane (Alk-H), the energy profile along the 
reaction coordinates resulted in the following (Scheme 5): 
 
Scheme 5. Energy profile for C-H hydroxylation of Alk-H by Cpd I of P450. 
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A two-spin state mechanism is outlined above with HS and LS pathways that begin from 
the degenerate states 2,4A2u of Cpd I (the 2, 4 superscripts relate to the doublet, 
antiferromagnetic, and quartet, ferromagnetic, spin states of Cpd I). During the C-H bond 
activation phase both reaction profiles stay in close proximity up to the iron-hydroxo radical 
species (4,2CI). At the point where the alkyl radical is released from the weak OH...Alk interaction 
to take up a rebound position (4,2Creb), the two states split. Two scenarios can then occur:112 
 
1. The rebound on the LS surface is barrierless and thereby the LS route is 
characteristic of a concerted mechanism. Along this pathway leading to the 
formation of the LS ferric-alcohol complex (2P) no radical intermediate is formed. 
 
2. The HS route, leading to the HS ferric-alcohol complex (4P) is stepwise with 
discrete lifetimes for the radical intermediates.  
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The interplay of a concerted (LS) and a stepwise process (HS), spin crossover, produces 
the “illusion” of two different oxidants and is, in Shaik’s view, the cause of the controversy over 
the exact nature of the oxidant species involved in the P450 hydroxylation.73, 112  
 
This two state scenario has a direct impact on how radical lifetimes are determined. In 
the radical clock experiments this separation of states sees the radical in the HS state having 
sufficient time to rearrange. Conversely the radical in the LS state, with a lifetime 
approaching zero, will collapse to give the ferric-alcohol product. The rearranged product 
thus formed originates only from the HS state while the unrearranged product is due to both 
LS and HS states with the largest contribution coming from the LS.114 Therefore, the radical 
lifetime, which is quantified from the ratio [U/R], (Scheme 6) is not a “legitimate” lifetime, 
since it also reflects the relative yields of the HS and LS processes. As a consequence, since 
the LS surface in C-H hydroxylation lies below the HS, the quantity [U/R] will yield apparent 
lifetimes that are shorter than the real ones. 
 
An important indication emerging from these theoretical studies demonstrates that, not 
only is Cpd I a chameleon species (with its two spin state nature) but, it is also a chameleon 
oxidant that tunes its reactivity and selectivity patterns in response to the protein environment 
in which it is accommodated and in dependence of the substrate.115-118  
 
 TSR73, 119 describes a two-state rebound mechanism, which on one hand supports the 
KIE evidence indicative of a hydrogen abstraction-like transition state in the bond activation 
and on the other hand reveals how a two-state rebound step can lead to apparently 
controversial lifetimes. This occurs if one starts from the assumption that the [U/R] quantity is 
a result of a single radical intermediate that is rapidly partitioned between instant rebound 
and rearrangement followed by rebound, as in Scheme 6.  
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Scheme 6. One radical intermediate which divides between instant rebound and rearrangement 
followed by rebound to produce both U and R products. 
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In order to confirm the effectiveness and legitimacy of this complex theoretical-
computational creation, Shaik tried to rationalize a set of “quantitative” results obtained in 
Newcomb’s laboratories in experiments performed with the substrates a-e and P450 
enzymes (Scheme 7) (see chapter 1.3.1, Figure 14). 
 
Scheme 7. A mechanistic scheme for determining the apparent lifetime (τ app) of a radical intermediate, 
using the ratio of rearranged (R) to unrearranged (U) alcohol products derived from P450 oxidation of the 
probes a-e.94 
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The ratio (U/R) in the above table, obtained in Newcomb’s enzymatic experiments, 
lead to the calculation of rebound rate constants that exceed the decomposition rate for a 
transition state and showed no correlation to each other. These data brought Newcomb and 
Toy 94 to put forward their two oxidant theory. 
 
The TSR scenario, with rearrangement occurring only on the HS manifold, could give 
order to the experimental data. An examination of the rebound barrier for the HS manifold 73, 
112 led to the estimation that as the radical becomes a better electron donor (lower ionization 
potential, IP, or oxidation potential), so should the rebound barrier decrease until it would 
completely cease to exist. Therefore the first two probes a and b should produce large 
quantities of the rearranged product. On the other hand probe e, which produces the radical 
with the lowest IP, exhibits virtually no rearrangement (<1%). DFT calculations120 confirmed 
that indeed b should produce a considerable amount of rearranged product, estimated as 
20–30% based on the relative HS and LS barriers, while e, which also reacts by TSR, should 
yield no rearranged products, since its LS and HS pathways are both effectively concerted. It 
can be concluded from this that Shaik’s TSR theory could predict accurately the product ratio 
(U/R).  
 
Another example how the TSR theory can find a rationale behind the kinetic isotope 
effect (KIE) is shown below. Shaik again reinterpreted the findings of Newcomb et al.95 that 
the two alcohols U-b, and R-b (Figure 17) exhibit different sensitivities to isotopic substitution 
of the scissile C-H bond in the substrate, trans-2-phenyl-methylcyclopropane b, such that the 
reaction is characterized by the product isotope effect (PIE) that is significantly different from 
unity, namely PIE(U-b/ R-b) > 1.  
 
Figure 17. Kinetic isotopic studies 
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This finding proposes that U-b and R-b cannot be formed from a single intermediate 
that partitions into U-b, and R-b; the finding requires two different mechanisms, and the 
applicability of TSR was again put to the test. 
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In the TSR model the U-b alcohol is produced mainly on the LS manifold and the R-b 
on the HS route. Since the HS and LS hydrogen-abstraction transition states (4,2TSH) in 
Scheme 5 are not theoretically equal the subsequent kinetic isotope effects (KIE) will 
unavoidably be distinct. This then equates to KIELS≠KIEHS. From this an intrinsic product 
isotope effect (PIEint)120 for the rearranged (R) and unrearranged (U) products, can then be 
described by the following equation (Eq.1): 
  
PIEint  = PIETS =  (UH/UD) / (RH/RD) =  (KIELS/KIEHS)  (Eq.1) 
 
It is quite tricky to compare theoretical KIE values to experimentally determined ones, 
since the latter may be masked and may not reflect the intrinsic KIE values.76, 121, 122 
Nevertheless, Jones et al.121 demonstrated that, in this specific case, the PIE observed 
(PIEobs) coincided with the PIEint. This allowed Shaik to directly compare the DFT calculated 
PIE values with the Newcomb’s experimental PIE values and a perfect match could be 
revealed. 
 
 Both the examples above show how the TSR theory accommodates some of 
Newcomb’s experimental results. Shaik’s calculations accommodate nearly all the outcomes 
of various oxidations performed by P450 enzymes/ mimics and it is thus a unifying theory 
that could potentially resolve any final debate in this area. A large number of chemists 
believe that his calculations carry a lot of weight to rationalize the results coming from a 
plethora of different reactions.  
 
The TSR theory is also a good starting point for developing an interpretation of the 
experimental results of this thesis work described in the following chapters.  
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1.3.4. The Exact Nature of the Transition State 
 
 It is necessary, when discussing the activity of the enzyme cytochrome P450 to take 
into account the true definition or modern day consensus as to what classifies a “transition 
state” or “reaction intermediate”. As it is impossible to categorically define what exact species 
are formed in the latter part of the catalytic cycle, an insight could be provided by examining 
what constitutes a “transition state” as defined by Newcomb. He argues that since the 
measured rate constants kOH for radical trapping are on the order of vibrational rate constants 
and not chemical rate constants,92 thus the radical lifetimes approach those of a transitional 
state, about 100-170 fs at ambient temperature.  
  
 Recent advancements in physical chemistry have brought a new insight into reactive 
intermediates by the use of compact ultra-fast laser pulse techniques.123-125 As the technique 
becomes widely used a wealth of findings are emerging. Zewail has produced a 
breakthrough by taking femto-second snapshots of reactions with exposure time measured in 
femtoseconds.126 This has revolutionized the understanding of how reactions proceed and 
redefined what chemical intermediates can be properly identified. From Zewail ‘s study of 
Norrish type-II reactions (Scheme 18) with this revolutionary technique a first glimpse of 
carbon-hydrogen homolytic cleavage at a femtosecond scale was observed.127 128-131 
 
Figure 18. Norrish type II reaction 
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The time scale for the ultrafast hydrogen atom transfer (70 ± 90 fs) and diradical 
closure and cleavage (400 ±700 fs) are obtained from the time evolution of the mass gated 
species. The observed vastly different reaction times indicate the non concerted nature of the 
two steps. This is of vital importance as it redefines how species with finite lifetimes as short 
as 70 fs can be categorized as reaction intermediates and not simply “transition states” as 
previously imagined. In this context it is necessary to reevaluate Newcomb’s need to 
introduce a new oxidant.66, 93 This new definition of an intermediate with such short lifetimes 
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makes it necessary to raise the question how it is possible to reconcile the experimental 
results of Newcomb with the calculations of Shaik.  
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2. Description of the problem and Aim of this Work. 
 
 As already mentioned in chapter 1.3.3 opposing conclusions were reached from the 
experimental findings of Newcomb (with his two oxidant theory)66, 98, 110 and the calculations 
of Shaik (he postulates a one oxidant theory).113 Shaik questions Newcomb’s interpretation 
whether or not the observed short “radical lifetimes” invalidate the existence of radical 
intermediates.  
 
  Yet it was felt necessary to re-examine the experimental work of Newcomb in detail 
to determine how, exactly, he evaluated the lifetimes of the radical formed during the course 
of his experiments. If alkane hydroxylation is indeed initiated by hydrogen abstraction then 
the lifetimes of carbon radical can only be calculated indirectly by first deducing the rate at 
which the radical can be hydroxylated. This rate constant of the oxidation step can, in turn, 
only be calculated by knowing two specific measurements; firstly the ratio of rearranged 
(ROH) and un-rearranged (UOH) products formed and, secondly, the rate constants of the 
radical rearrangements. (see Eq.2 and Eq.3) 
 
Life time (fs) = 1/kOH   (Eq.2)          and                 kOH = kr  x [UOH]/[ROH]  (Eq.3) 
 
 From Eq.2 it is obvious that the rate of hydroxylation is directly proportional to the rate 
of rearrangement and, herein, is found a fundamental problem with how Newcomb evaluates 
and projects his results. It is apparent that any misinterpretation of the kr values could have a 
fundamental impact on the rate of hydroxylation and conversely the lifetime of the radical 
species formed. It is only since accurate values of rate constants for hydrogen atom transfer 
became available that it has been possible to show an indirect method for measuring 
rearrangement rate constants in archetypal fast radical reaction, i.e. the cyclopropylcarbinyl 
radical ring opening. These experiments, conducted by Ingold,132 Newcomb and others133-137 
have provided a powerful and convenient method for measuring the rate constants of these 
rearrangements at intermediate and warm temperatures.  
 
It would be reasonable to propose that a substantial change in the environment where 
the radical formation takes place would have considerable influence on the rate of 
rearrangement. This “effect” has already been noted in several examples where some “fast” 
radical clocks have yielded less rearrangement than slower clocks.88, 91, 93 Shaik’s DFT 
calculations have attempted to account for such confusing results by again demonstrating 
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the “chameleon” like character of Cpd I, with its HS and LS states, but his theoretical 
calculations only offered a qualitative explanation of the short lifetimes observed by 
Newcomb.  
 
These new radical clock experiments, reported in this thesis and based on novel 
porphyrin mimics, have certain advantages:  
 
1. The experimental work on P450 mimics is important because, in these new 
experiments oxidation rates (kOH) can be calculated for reactions performed under 
similar conditions used to determine kr rates in previous trapping experiments. 
 
2.  The novel experiments have the advantage of producing radical species in a 
simple environment without the influence of outside factors. This is in contrast to 
previous P450 experiments with microsomes or purified isozymes, which gave kOH 
values influenced by substrate-protein interactions.   
 
The next chapter outlines the reasoning behind the porphyrin mimic synthesis as well 
as its design and also discusses the implications of the results of the new radical clock 
experiments.   
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3. Porphyrin and Probe Synthesis. 
 
3. 1. Towards the Synthesis of a First Porphyrin Model  
 
 Studies using synthetic metalloporphyrins as models for P450 have afforded 
important insights into the nature of the enzymatic reactions. Their use to mimic metallo-
enzyme has long been shown to be an effective strategy in elucidating the sophisticated 
mechanisms of biological processes.138 Experiments with synthetic P450 enzyme models are 
still today contributing to the understanding of the mechanism of the P450 action and 
providing information on the possible structure and electronic nature of iron porphyrin 
intermediates of the catalytic cycle. 
 
When designing a porphyrin synthesis two fundamental characteristics of the model 
should be taken into account: stability and reactivity. The stability of the porphyrin 
chromophore is especially important in the presence of powerful oxidants. In order to have 
robust porphyrins and simultaneously control the spin- and oxidation state of the iron many 
research groups employ face sheltered and/or electron deficient iron porphyrins     
(Figure19).139-143 The structural-electronic aspects that modulate the reactivity of the 
porphyrin are not well defined. Certain rules, though, are applicable irrespective of the 
porphyrin involved. The catalytic efficiency and the reactivity of the porphyrin can, for 
example, be enhanced by introducing halogens on the aryl groups of meso-
tetraarylporphyrins and on the β-pyrrolic positions of the macrocycle ring144-146 139, 140    
(Figure 19). 
 
Figure 19. Examples of metalloporphyrins  
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Any good active site analogues of P450s should aim to reproduce as much as 
possible the structural features found in the enzyme itself. A good design of a structural 
mimic has to take into account the characteristic coordination of the sulfur to the central iron 
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of the heme-thiolate protein. Examples of synthesized porphyrins which follow this reasoning 
are given below (Figure 20). 
 
Figure 20. Metalloporphyrin analogues of P450 active site. 
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In both porphyrin models described in the next chapters the cysteine like coordination 
found in the natural enzyme is reproduced by the thiolate or thiophenolate groups 
coordinated to the iron. Furthermore, in the second model, the introduction of 
electronwithdrawing groups increases the activity of the porphyrin mimic. In the following 
paragraph the methodology used for the synthesis of two novel porphyrins is described. 
 
3.2 Synthesis of porphyrins 38 and 39 - first models for mimicking the prosthetic 
porphyrin IX active site of P450. 
 
 The target compound 38147 is a face-protected iron(III) diphenyl porphyrin carrying a 
thiophenolate ligand attached to a bridge tightly spanning the porphyrin plane such that the 
sulfur is forced into coordinating to the iron, and its decomplexation from the iron is 
prevented for steric reasons.148 The substrate binding site is protected against porphyrin–
porphyrin interactions by means of two pivalylamido groups (“picket-fences”)149 that also 
provide H-bonding to ligands coordinating to the iron. The complex compound 38 was 
prepared keeping in account established procedures. 147, 148, 150 151 
 
 A retrosynthetic analysis of the iron(III)-porphyrin  38 (Scheme 8) leads to three main 
building blocks: the dipyrromethane derivative 30, the 2,6-substituted benzaldehyde 27 and 
the protected thiophenyl bridge 42.  
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Scheme 8.  Retrosynthetic analysis of methylcarbamoyl iron porphyrin model 38. 
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The salicylaldehyde derivative 27 was synthesized in two steps by performing a prior 
protection of the aniline and a subsequent formylation directed in the 2-position by the 
methoxy (R = Me) and carbamate groups (Scheme 9).152 
 
Scheme 9. Synthesis of salicylaldehyde derivative 27 
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The second fragment for the porphyrin condensation was the dipyrromethane 30. It 
was synthesized from diester 28 which was already on stock in our group. Saponification of 
the diester 28153 and subsequent decarboxylation of the resulting diacid 29 yielded α-
unsubstituted, air and light sensitive dipyrromethane 30 which was immediately used in the 
next step (Scheme 10). 
 
Scheme 10. Synthesis of dipyrromethane 30 
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Classical MacDonald [2+2]-type porphyrin condensation153 of dipyrromethane 30 and 
benzaldehyde 27 under acid catalysis with p-toluenesulfonic acid gave the porphyrinogen 
compound with the characteristic UV-vis band at 486 nm. The reduced chlorin form of the 
porphyrin was subsequently oxidased with DDQ providing a mixture of two atropisomers, αα-
31 and αβ-31, in ~ 35% yield that is perfectly in agreement with the values reported in 
literature for this kind of reaction.154, 155 This mixture was then treated with trifluoroacetic acid 
to remove the N-protecting groups in a quantitative way. The rationale behind the use of a N-
Boc protected benzaldehyde (27) at the MacDonald condensation stage is based on the 
know-how, acquired earlier in our research group, with experiments where the direct [2+2] 
addition of the N-Piv benzaldehyde and the dipyrromethane derivative gave considerable 
lower yields (see Mu Linjing, Report 2001). 
 
Scheme 11. From the MacDonald condensation to the atropoisomers separation 
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 The synthesis proceeded with the protection of the amino function of αα-32 and αβ-
32 with the pivaloyl group. For obvious polarity reasons the separation of the two 
atropoisomer (αα and αβ) by flash chromatography was attempted at this stage rather than 
in the following step, after the cleavage of methyl ethers. The atropisomers of this porphyrin, 
due to steric overcrowding between the substituents at the β-pyrrole and 2‘- and 6‘-positions 
of the phenyl rings, are configurationally stable during manipulation or purification. Since the 
atropisomers cannot interconvert at high temperatures used in the bridging step, it 
necessitated the use of pure αα-isomer cleanly to avoid formation of side products during the 
coupling step with sulfur bridge 42.  
 
 The purification on silica gel yielded αα-33 in 44% as the more polar fraction and αβ-33 
in 29% as the less polar compound. The ratio of the two atropoisomers αα /αβ ~ 6:4 was 
slightly in favor of the desired product αα-33 with an overall yield of 25% for both αα and αβ 
from benzaldehyde 27. The correct assignment of the atropisomers of 34, product obtained 
from the cleavage of the methylether, was based not only on NMR investigations but also on 
the analysis of the products of the reaction of the supposed αα-34 with 1, 11-dibromoundecane 
in the presence of Cs2CO3 in hot DMF under high-dilution conditions (Scheme 12). 
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Scheme 12. Chemical derivatisation of bisphenol porphyrin αα-34 for atropisomer assignment. 
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 The 1H-NMR spectrum of 35 displayed high-field shifted signals for the methylene 
groups of the undecanylene chain due to the ring current of the porphyrin and proved the 
atropoisomers identification to be right. 
 
The synthesis was continued with the αα-atropisomer of 33 and cleavage of the 
methyl ethers was carried out with anhydrous aluminum chloride in a solvent mixture of 
CH2Cl2 and EtSH to give αα- 34. 
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Scheme 13. Cleavage of the methyl ether and synthetic route to bridged bis-(methyl carbamoyl)- 
porphyrin 36. 
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This gave bisphenol porphyrin αα-34 in good yield (Scheme 12 and 13). The more 
commonly used de-methylation method with BBr3 at -78°C was not employed due to the 
unwanted removal of pivaloyl N-protecting groups and the low efficiency of phenol formation. 
The activated and protected thiophenylene 42 was then slowly added to the αα-34 under 
high-dilution conditions in hot DMF in the presence of Cs2CO3. The dimesylate 42 used in the 
bridging was synthesised from the corresponding diol 41 which was obtained via the 
hydroboration reaction of diallylthiophenol carbamate 40148 that was on stock in our group 
(Scheme 13). 
 
Cleavage of the thiocarbamate protecting group of 36 liberated the thiophenol 
function and subsequent iron insertion using FeBr2 in the presence of 2,6-lutidine as base in 
refluxing toluene completed the synthesis of bis (methyl carbamoyl ) model 38. 
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Scheme 14. Completion of the synthesis of the porphyrin 38. 
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 Upon iron insertion the Soret band in the UV/vis blue-shifts from 413 nm for 37 to 404 
nm for iron (III) compound 38. Furthermore, the correct mass of the isolated iron(III) 
porphyrin model compound 38 was confirmed by ESI-MS and MALDI-TOF-MS. It is essential 
to carry out the deprotection reaction of 38 and the iron insertion under strict exclusion of 
dioxygen as it is known from previous work in our group that the sulfur of the thiophenolate is 
prone to oxidation to give the phenylenesulfonate compound [T.R.Leifels, Synthese von 
Modellverbindungen–PhD Dissertation-Uniiversität Basel 2001]. In practice, the deprotection 
reaction of 36, the work up and the purification of 37 was done under argon with degassed 
solvents and reagents. The iron insertion and all further reactions with the iron(III) porphyrin 
38 were performed in a glove box with an inert atmosphere, degassed solvents and 
reagents.  
  
The cw-EPR spectrum of 38 in dry toluene at low temperature showed g-values (8.30, 
5.29, 3.10, 2.05 and 2.00) characteristic of pure high-spin iron(III) porphyrins with a strong 
rhombic distortion (Figure 21).  
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Figure 21.cw-EPR spectrum of 38 in toluene 
 
 
It has already been observed that porphyrin 38 is an adequate P450148 and CPO147 
mimic respectively in epoxidation reactions (i.e. of cis-stilbene 43 and in the chlorination 
reaction of monochlorodimedone (MCD) 44 (Scheme 15). 
 
The halogenation of MCD performed using 1.5% mol of porphyrin 38, together with 
the transfer-catalyst benzyltriethylammonium hypochlorite as the chlorine source and the 
AcOH as proton supply, gave the dichlorodimedone in 75% yield and a turnover equal to 45. 
The epoxidation of cis-stilbene was carried out with iodosylbenzene (PhIO) as an oxygen-
donor and 1.1% mol of porphyrin 38 as catalyst and it proceeded in almost quantitative 
manner. 
 
Scheme 15. Epoxidation of stilbene 43 and chlorination of MCD 44. 
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A major problem with porphyrin 38 is its lack of stability during aerobic reaction conditions 
which makes its handling quite problematic and time consuming. Despite considerable steric 
congestion at the thiolate ligand in complexe 38, oxidants used for the ‘shunt pathway’ such 
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as PhIO, PhF5IO, and H2O2 and in particular O2 oxidize the thiolate slowly via -SO–, -SO2– to 
SO3– creating an undesired mixture of porphyrin oxidants during reactions In order to avoid 
this problem, the model compound 39 was considered as an alternative to the thiolate ligand 
(Figure 22). Although it was initially difficult to visualize how the new sulfonate ligand could 
replace the thiolate ligand and still genuinely mimic the naturally occurring enzyme, this new 
sulfonate iron(III) porphyrin 39 has some important features of note. 
 
Figure 22. Iron(III) porphyrin 39. 
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The synthesis of the sulfonate iron porphyrin [Fe-SO3(H)] was prompted from data 
relating to unusual characteristics of the local environment of the proximal Cys-ligand in the 
P450s. As clearly represented in the illustration below, extracted from a paper of Poulus53 (Figure 
23), the thiolate ligand of the P450 is at the positive N-terminal end of a helix and accepts three 
hydrogen bonds, one of which has the optimal orientation,  from peptide NH groups.  
 
Figure 23. (H-bonding) - Schematic diagram showing the H-bonding interactions between the proximal 
heme thiolate ligand in P450. 
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The conservation of these H-bonds in structurally unrelated thiolate-iron proteins like 
chloroperoxidase CPO14 and nitrogenase156 emphasizes the importance of these 
interactions. Thus, in thiolate iron proteins, the sulfur atom is surrounded by an 
electropositive environment, exactly the opposite to what is found for the His ligand in 
peroxidases and globins. This hydrogen network appears necessary to decrease the 
negative charge on the thiolate ligand in P450/CPO and increase the negative charge on the 
His in peroxidases. One can speculate that this is required to increase the redox potential of 
heme-thiolate proteins and decrease the redox potential in peroxidases relative to the non-H-
bonded situation.  
 
 Our porphyrin model is somehow able to mimic the H-bonding of the thiolate to the 
amino acid residues of the protein backbone, since the negative charge is not merely located 
on the sulfur atom, but it is delocalized over the three oxygen atoms. The inverted umbrella 
shape of the sulfonate group functions as the hydrogen-bonds set (Figure 24).157 
 
Figure 24. Umbrella-Sulfonate-porphyrin model 
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 Additionally, even though no systematic studies with this sulfonate type compound 39 
have been previously conducted in our group148 a theoretical DFT study of its reactivity was 
initiated in collaboration with the laboratory of Prof. Shaik. The results of these DFT 
calculations were surprising and, as elucidated in Figure 25, the comparison between the 
reactivity of the first (SH) model 38 with that of the SO3-type 39 suggested a very strong 
equivalence.  
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Figure 25. Energy profile of propene oxidations by Cpd I (in black) versus Cpd I - SO3 (in red)- obtained 
with DFT calculation.157 
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From the examination of the energy profile diagram above, representing the conclusions 
of these theoretical studies, the existence of a solid analogy between the activities of the two 
porphyrins 38 and 39 is rather evident. By comparing the hydroxylation coordinates of the 
CpdI-SO3 and Cpd l-SH profiles a difference is observed particularly at the rebound stage. In 
the Cpd l-SH profiles the low spin surface is barrierless which contrasts sharply to the Cpdl-
SO3 profile where both HS and LS states approximate each other. This is important for the 
following reasons: 
  
a) The concerted LS manifold seen in the Cpd l-SH profile will alter the lifetime of the 
only transition state (HS) giving the false perception of a very short lifetime. 
 
b) In the second profile (CpdI-SO3) two defined transition states are observed which offer 
a truer reflection of the actual lifetime since both the LS and HS states approximate 
each other. In this scenario the “observed lifetime” has a higher probability of being the 
“actual lifetime” making this Cpdl-SO3 a better porphyrin probe. 
  
In addition, the synthetic model shows a small preference for C-H hydroxylation over 
C=C epoxidation, while the natural species has an opposite slight preference.  
 
The DFT calculations supported a proposal that one of the oxygens from the SO3- 
ligand coordinates to the iron instead of the S-. This is shown in Figure 25b  where  the iron-
oxo porphyrin species 39DFT which acts as a model for 39, is described in two different 
coordination modes, one with an Fe-O bond between the heme and the RSO3– ligand 39DFT-A, 
and the other with an Fe-S bond 39DFT-B. The second option (model B) is unfavorable, the Fe-S 
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bond is too long and the species is positioned at an energy level 19-31 kcal/mol higher than the 
corresponding Fe-O bond (mode A). In addition, frequency calculations have demonstrated 
that 39DFT-B (B) are not stable minima but are in fact saddle points for the exchange of three 
different Fe-O bonds.  
 
Figure 25b.  Porphyrin Models  39DFT-A  and 39DFT-B  obtained by DFT calculations.157 
 
  Thus calculations have shown that the new sulfonate porphyrin possesses an 
equivalent reactivity to its thiolate precursor even though the nature of the 5th ligand is very 
different -the “hard” oxygen of the Fe-O-SO2 ligation in this case replaces the “soft” sulfur of 
the Fe-S (thiolate) ligation. It should be noted that Shaik calculated both energy profiles and 
bond distances only with an optimized Cpd I SO3 species. Thus, although these DFT 
calculations proposed a certain structure and reactivity of the new porphyrin mimic, it was 
hoped that both UV, EPR analysis and eventually X-Ray analysis would properly define the 
structure of 39. The attainment of the X-Ray structure was particularly important as it would 
help identify the nature of the Fe-SO3 ligation and the actual bond distances in the porphyrin 
resting state.  
 
 At this point, therefore, it was necessary to find a good procedure for obtaining 
compound 39. Several attempts in oxidizing the thiolate functional group of the porphyrin with 
or without iron already inserted (37 and 38 respectively) have been made. Reaction 
conditions like TBHP or m-CPBA in dichloromethane, H2O2 together with a micro-emulsion of 
Na2MoO4 and sodium dodecylsulfate in BuOH158 gave low yields and numerous side 
products. KMnO4 and 18-crown-6 ether in benzene or KMnO4 alone in acetone was found to 
be the most efficient system even if the yield was very modest at 25%. Finally it was found 
that the cleavage of the thiocarbamate protecting group of 36 using aerobic conditions was 
the shorter and most effective way to produce compound 39. The solution of 36 in dioxane 
was bubbled with O2 before the addition of KOMe and the reaction mixture was then left 
refluxing for 30 hours in an atmosphere enriched in molecular oxygen. With this procedure 
“Cpd I” Fe-O-SO2 DFT Model A “Cpd I” Fe-SO3 DFT Model  B 
Distance Fe=O  1.62Å
Distance Fe-O(SO2) 2.05Å
Distance Fe=O  1.62Å
Distance Fe-S(O3) 3.75Å
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there is no need to isolate the thiolate porphyrin and the overall yield of compound 37-SO3 
was between 35-40 %. Upon iron insertion, the porphyrin 39 was then obtained. 
 
Scheme 16.Completion synthesis ironsulfonate porphyrin 39 
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A considerable difference was observed between the UV-vis spectrum of thiolate 
iron-porphyrin 38 and the sulfonate iron porphyrin 39. The Soret band of 38 has a λmax = 404 
nm and 39 presented, on the other hand, a split Soret band with maxima at λmax = 389 and 
414 nm (Figure 26). 
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Figure 26. UV-visible spectrum of 38 in chloroform and 39 in methanol 
 
 
 
 
 
The cw-wave EPR spectrum of porphyrin 39 is axial distorted with g-values 
characteristic of a high spin FeIII system (toluene, 94K, g-factor: 5.6) (Figure 27). 
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Figure 27 cw-wave EPR spectrum of porphyrin 39 in toluene 
 
On finishing the original synthesis the new porphyrin mimic 39 was utilized for finding 
the correct conditions for substrate oxidation and subsequent analysis. As already mentioned 
in the previous experimental work we attempted to examine the definition of radical lifetimes 
of the intermediate predicted by the rebound mechanism. The compounds chosen as 
substrates for C-H hydroxylation were the cyclopropyl radical clocks used extensively for this 
purpose.137,87,159 The ultimate objective of this work was to examine the behavior of the trans-
methyl-phenyl cyclopropane 10 (Figure 28) in the so called shunt pathway (see Shunt 
pathway in section 1.2), involving our porphyrin mimic and a suitable oxygen donor. Yet, as a 
primary non activated C-H bond is very prohibitive to oxidation, the correct conditions needed 
to successfully perform this reaction had to be found using a similar but more activated 
cyclopropane derivative. Trans-benzyl-phenyl cyclopropane 45 (Figure 28) was designed as 
the required substrate analogue since the C-H benzylic position of the ethyl benzene was 
reported by Groves160 to be easily hydroxylated in a reaction employing a metallo porphyrin 
catalyst and oxygen donors. 
 
Figure 28. Substrates use in the oxidation performed with metallo porphyrin and oxygen donor 
10 45  
  
 
 
 
Poprhyrin and Probe Synthesis 
 
 
 48 
3. 3. Optimization of reaction conditions for radical clock experiments 
 
 Since the overall yield of the oxidation products of 10 was expected to be low, it was 
necessary that the reaction conditions were maximized. This required optimal solvent, time, 
oxidizing reagent, and temperature to be found along with a suitable porphyrin/ substrate 
ratio. The decision of which oxidant to use was based on its ability to produce an 
unambiguous oxidative species. In order to avoid the formation of a synthetic Cpd 0 (Figure 
29) all peroxide oxidants were excluded.161, 162 Iodosyl benzene was chosen since, as a 
mono oxygen donor, it can give the synthetic analogue of Cpd I but not the hydroperoxide 
form (equivalent to Cpd 0).163 164, 165   
 
Figure 29. Comparison between single oxygen atom donors and peroxides 
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This oxidant had the added bonus, in that its degradation product, iodobenzene, has 
a very low retention time during GC analysis and therefore, does not interfere with the 
alcohol product signals. This preference for PhIO then limited the solvent selection, used in 
the oxidation reaction as iodosyl benzene is known to be partially soluble only in CH2Cl2.166 
This oxygen transfer reagent has been, for several years, incorrectly adjudged to be soluble 
in MeOH. In fact the high solubility of iodosylbenzene in methanol is due to a solvolysis 
reaction that forms iodobenzene dimethoxide, PhI(OMe)2.166 Dry CH2Cl2 on the other hand is 
an ideal solvent for these radical clock experiments as it could reproduce a similar 
environment to that experienced by the probe inside the hydrophobic surroundings of the 
enzymatic pocket. The temperature range in which the reaction could be carried out was 
quite restricted. At low temperatures (around 0°C) PhIO was found to precipitate out of 
solution. All the oxidation reactions were eventually carried out at 20°C, in CH2Cl2 using 1 
equivalent of PhIO. An assessment of the ratio of porphyrin mimic to substrate was also 
important. Various trial reactions were conducted using 1-10% porphyrin to detect how this 
ratio affected the quantity of product formed. There was found to be no increase in the 
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quantity of products produced using an amount greater than 2.5% porphyrin mimic. The 
actual duration of the oxidation reaction was also short - typically it was found that there was 
no increase in yield after a 30 minute time period.   
 
 
3.4 Synthesis of porphyrins 55 - novel model for mimicking the prosthetic porphyrin IX 
active site of P450. 
 
During the course of these trial experiments a second porphyrin mimic was synthesized. The 
reasoning behind this decision were 
 
• A new porphyrin with all meso positions locked was thought to be a more stable 
alternative to 39. The stability of the porphyrin could also be improved by 
incorporating EWD groups that reduce the electron density on the porphyrin 
ring.167-169  
  
• The overall length and yield of the original synthesis were prohibitive to producing 
the quantities of porphyrin required to conduct several oxidation reactions. The 
choice of a C2 symmetry porphyrin core was deemed a better alternative and had 
the bonus of avoiding the time consuming separation of the atropisomer 
intermediates formed after the MacDonald condensation (see Paragraph 3.2.). 
 
• As another member of the research group was attempting the synthesis of an 
analogous porphyrin it was thought valuable to produce a similar species for 
comparative analysis.  
 
The synthesis of this novel porphyrin was then undertaken. A retrosynthetic analysis 
of the iron (III)-porphyrin 55 leads to three main building blocks: the dipyrromethane 
derivative 49, the commercially available 2-methoxybenzaldehyde 46 and the protected 
thiophenyl bridge 42 (Scheme 17). 
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Scheme 17. Retrosynthetic analysis of the novel iron (III) porphyrin model 55. 
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 5-Substituted dipyrromethanes are important precursors for the synthesis of meso-
substituted porphyrins.155, 170 The method for obtaining the dipyrromethane 49 is a one-flask 
synthesis in which the aldehyde is dissolved in a 80-fold excess of pyrrole 48 with a catalytic 
amount of the acid (0.1 equiv. of TFA) at room temperature in the absence of any other 
solvent.170 The reaction is performed in the dark and it goes to completion after only five 
minutes. The crude solution was a complex mixture of six compounds. The desired 49 
compound was the main product with two of the side products almost certainly were the N-
confused 5-phenyldipyrromethane 50a, and 5,10-diphenyltripyrrane 50b as suggested 
previously by Lindsey (Scheme 18).171  
 
Scheme 18. Synthesis of 5-Substituted dipyrromethane 49. 
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 This synthetic procedure followed by flash chromatography purification and 
subsequent crystallization provided a yield of pure 5-(2,6-dichlorophenyl)dipyrromethane of 
around 30%, that it was in full agreement with the literature values.171 
 
The synthesis of the A2B2-porphyrin was completed using the optimized conditions 
reported by Lindsey et al.171 The condensation is performed in dilute solution at room 
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temperature. The 49 and 2-methoxybenzaldehyde 46, in ratio 1:1, have a concentration 
around 10 mM in CH2Cl2. TFA was used as the acid of choice, rather than BF3.Et2O, since 
the degree of scrambling with the latter increases dramatically. The porphyrinogen species 
formed with a UV absorption at 485 nm is then oxidized with DDQ to give the pure porphyrin 
51 characterized by a Soret band at 418 nm in 30% yield. 
 
The cleavage of the methyl ethers was carried out following the commonly used de-
methylation method with BBr3 at -78°C. The reaction course was followed by ESI-MS in order 
to verify when the transformation of 51 into the bisphenol porphyrin 52 was accomplished. 
The synthesis continued with the bridging of 52 with activated and protected thiophenylene 
42 under high-dilution conditions in hot DMF in the presence of Cs2CO3 to give porphyrin 53. 
(Scheme 19). 
 
Scheme 19. Synthetic route to the porphyrin 55 
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Finally the cleavage of the thiocarbamate protecting group of 53 in aerobic conditions 
produced compound 54 with an overall yield around 35%. Subsequent iron insertion using 
FeBr2 in the presence of 2,6-lutidine as base in refluxing toluene completed the synthesis of 
model 55 (Scheme 19). 
 
The UV-visible spectrum of 55 presents a Soret band at λmax = 416 nm. 
 
Figure 30. UV-vis spectrum of 55 (in CH3Cl) 
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The EPR analysis of compound 55 displayed a high spin axial distorted spectrum, 
indicative of a slightly strained system with the iron protruding out of plain towards the fifth 
ligand and typical of a oxygen- iron coordination (Figure 31).172 
 
Figure 31. cw-wave spectrum of porphyrin 55 in toluene 
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Cyclovoltammetry revealed a distinctive feature of these Fe-SO3-type porphyrins. The 
results showed the porphyrin mimic redox potential E0 is comparable to that of heme thiolate 
proteins. In fact, as is shown in Figure 32, measurements done by Meyer using porphyrin 55 
and a second porphyrin 55b, illustrated below, provided values  of E0(55) = -280 mV and  
E0(55b) = -340 mV respectively, that correspond, for example to the P450 cam E0 = -290 
mV.173 
 
 It is noteworthy that previous cyclovoltammetry experiments conducted with Fe-SH 
porphyrins, synthesized in our research group, gave redox potentials of ≈ -600 mV. In this 
context the anodic shift can be rationalized in terms of a negative charge which is no longer 
localized on the sulphur atom, as in the Fe-SH mimic, but is redistributed in the S03 conical 
volume.  
 
 
 
 
 
 
Poprhyrin and Probe Synthesis 
 
 
 54 
 
 
 Figure 32. Cyclovoltammogram of porphyrin 55 (0.6 mM ) in 0.1M LiClO4 solution in DMF with 
ferrocene as internal standard.173 
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The X-ray structure of 55 (Figure 33) confirmed the accuracy of the synthetic design 
and more importantly reinforced the hypothesis that one of the oxygen atoms, and not the 
sulfur atom, of the SO3- group, was coordinated to the central iron.  
 
Figure 33. ORTEP representation of model compound 55 (the solvent THF is coordinated to the Fe as 
sixth ligand). 
 
 
The X-Ray also provided more information relating to the bond distances of the fifth 
ligand in the porphyrin resting state. A comparison can be made between the Fe-S bond 
distance of the P450cam (2.2Å)174 and the Fe-O bond distance (1.96Å) of 55.  Unfortunately, 
at this present time, no DFT characterization of the resting state model is available which 
would have established the reliability of Shaik’s calculations. It should be taken into 
consideration that a structural equivalence of the DFT model to the mimic is not always a 
prerequisite to the prediction of how the porphyrin behaves. Even if the mimic 55 has been 
synthesized in order to perform typical heme thiolate protein reactions it is interesting, from 
the structural point of view, to see that the Fe-O bond distance of 55 is similar to the Fe-OTyr 
(1.85Å)175 bond distance of human catalase, an enzyme which typically catalyses the 
disproportion reaction of H2O2 into H2O and O2 in biological systems. 
 
The coordination of one of the three oxygen atoms to the iron rather than the sulfur 
itself, seemed to undermine the hypothesis that the model 55 could, to some extent, mimic 
the Fe-SCys bond situation, within its hydrogen bond network. In spite of the structure of 55 
not being true to the native enzyme system, the proximity of the redox potential of 55 and 
55b to the P450 redox potential, coupled with the reactivity predictions coming from the DFT 
calculations, led us to believe that this research was worth continuing with and had the 
potential to produce some interesting results. 
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3.5 Synthesis of the cyclopropyl derivatives – slow and fast radical clocks. 
 
 As already mentioned in the section 3.2., the molecules selected as substrates for the 
oxidation reactions catalyzed by the porphyrin model 55 were the 2-arylsubstituted 
cyclopropyl derivatives 10 and 45. The analytical method chosen for the qualitative and 
quantitative analysis of the products generated during the oxidative reaction was gas 
chromatography analysis performed with a GC-FID instrument. Extensive analysis were 
initially undertaken using both normal and reverse phase HPLC but both proved inadequate 
due to the irreproducibility of the results and the lack of sensitivity. GC-MS analysis was also 
attempted to analyze the products formed but it again proved unsuitable due to a lack of 
sensitivity of the in-house machine. It should be noted that other research groups have 
successfully analyzed the products from these radical clock reactions with “finely tuned” GC-
MS machines. Once the starting substrates were purified to a very high degree (typical purity 
>99.9%) GC-FID proved to be the only method suitable for quantitatively analyzing products 
with yields less than 1%. Before the radical clock experiments with subsequent GC analysis 
could be performed it was necessary to synthesize not only the substrates 10 and 45 but 
also standard compounds corresponding to the expected products of the oxidation. 
 
 The α-ketone-cyclopropane 57 was synthesized starting from the commercially 
available trans-chalcone 56 (Scheme 21).  
 
Scheme 20. Synthetic route of substrate 45 and its oxidation products. 
O
OH
O O
O
OH
NaH, Me3SOI 
DMSO
H2NNH2, KOH
diethylene glycol
NaBH4, MeOH
OH
1. 2,3-dihydrofuran,CH2Cl2,-20°C
2. MeSO3H,CH2Cl2,-20°C -> 0°C
3. PhMgCl (THF) -20°C ->18°C
4. H3PO4, 0°C  NaBH4,MeOH
45
56 57 58
59 60 61  
 Poprhyrin and Probe Synthesis 
 
 
57 
 
The ketone intermediate 57 was formed by the reaction of chalcone 56 with 
oxosulfonium ylide whose reactivity was studied for the first time by Corey and 
Chaykovsky.176 In this case, the ylide itself was formed by the reaction of 
trimethyloxosulfonium iodide with a strong hydride base. The ylide has a nucleophilic 
character and transfers the methylene to the C=C double bond in a stereoselective manner 
through a 1,4-Michael addition to the α,β -unsaturated ketone.177 178 The obtained 1, 2 –trans 
–di-substituted α-ketone-cyclopropane 57, was then transformed into the corresponding 
alcohols by a simple reduction with NaBH4. These two diasteroisomers were not only easily 
differentiated by TLC and 1H-NMR, but more importantly also by gas-chromatography. The 
substrate 45 was obtained by complete reduction of the carbonyl group of 57 using a Wolff-
Kischner reduction. The synthetic strategy adopted for the synthesis of the (E)-1, 4-diphenyl-
3-buten-1-one 61 utilized the methodology of ketone synthesis from acid via acyl hemiacetal 
reported by Rapoport.179 Thus, the protection of the acid as 2-tetrahydrofuranyl ester 
followed by the addition of the phenyl magnesium bromide and acid work-up afforded the 
desired unsaturated β, γ – unsaturated ketone. Simple reduction gave the compound 61. 
 
The synthesis of the second substrate, the trans-2-methylphenylcyclopropane 10, 
started from the commercially available trans-2-phenylcyclopropanecarboxylic acid 62 
(Scheme 21). The starting material was transformed into the correspondent alcohol 63 by 
simple reduction with LiAlH4. The trans-(2-phenylcyclopropyl)methanol 63 was then 
converted to the mesylate. This was then subsequently reduced to the desired compound 10 
using LiEt3BH. 
 
Scheme 21. Synthetic route for the substrate 10 and the standards for the predict products. 
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The allylic alcohol 66, that is the expected oxidation product of the ring-opened 
radical, was obtained by simple Grignard reaction between benzaldehyde 64 and 
allylmagnesium chloride 65. Another product detected during Newcomb’s enzymatic 
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experiments with the substrate 10 was trans-2-(p-hydroxyphenyl)methylcyclopropane 72.95 
Therefore it was also advisable to synthesize a standard for this phenolic derivative. This 
was required even if there was no proof that the porphyrin mimic system could perform an 
aromatic hydroxylation (Scheme 22). 
 
Scheme 22. Synthetic route for the phenolic derivative 72. 
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Reaction of p-vinylanisole 67 with ethyl diazoacetate180 68 gave a mixture of ethyl cis- 
and trans-2-p-(methoxyphenyl)cyclopropanecarboxylates 69, which was separated by 
column chromatography and crystallization. The trans isomer, identified by NMR 
spectroscopy, was reduced with LiAIH4 to the alcohol 70. The product 70 was then converted 
to its mesylate that, without being isolated, was directly reduced in the same pot with LiEt3BH 
at -78°. To prevent polymerization necessitated the need to work as such low temperatures. 
Finally the resulting trans-2-p-(methoxyphenyl)-methylcyclopropane was demethylated with 
NaSEt in DMF to give the desired product 72. 
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4. Radical Clock Experiments and Discussion 
 
4.1. Radical Clock Experiments 
 
The radical clock experiments were conducted in order to initially examine the 
suitability of the porphyrin mimic as a tool for substrate hydroxylation and, if successful, 
engage a debate about the exact nature of the catalytic pathway mechanism. Therefore it 
was proposed to use the porphyrin mimic 55 firstly in a systematic study of a “slow” radical 
clock 45 and subsequently in an examination of a “fast” radical clock 10. As already 
mentioned in chapter 2 the value of this experiment was that, given the krear values, kOH 
values can be deduced from the ratio of rearranged and unrearranged alcohols formed.   
 
4.1.1 Slow Radical Clock Experiments 
 
The first set of these experiments were performed with substrate 45. Since this 
substrate has been categorized as a “slow” radical clock (krear= 3.6 X108 sec-1) it was not 
expected to give an insight into the kinetic mechanism of the hydroxylation.88 What it could 
provide, on the other hand, was initial confirmation that the porphyrin mimic itself could 
perform the hydroxylation of substrates similar to those found in Newcomb’s enzyme 
experiments. If the initial experiments were successful it was hoped to perform more detailed 
experiments with substrates defined as “fast” radical clocks. 
 
The reaction was typically performed in anaerobic conditions at 20°C in CH2Cl2 using 
2.5% of porphyrin mimic and 1 eq. of PhIO (Scheme 23). All substrates used during these 
experiments had an analytical purity of 99.9% by GC analysis. The purity of each substrate 
was examined prior to the start of each experiment to ensure no artifacts were present. 
Using analytical techniques described in the experimental chapter the crude reaction mixture 
was then analyzed with a GC-FID technique. The results of the oxidation R1 of substrate 45 
are shown in Table 1. It is important to note that the distribution of products formed during 
this reaction was not as expected. As it is known that this substrate is a slow radical clock 
predisposed to a fast hydroxylation rate the presence of rearranged alcohol 61 and the 
ketone 57 in the GC analysis came as a surprise.  
Radical Clock Expeiments and Discussion 
 
 
 60 
 
Scheme 23. Hydroxylation performed with porphyrin 55 in catalytic amount. 
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Table 1.  
Reaction 57* 58-dia-1* 58-dia-2* 61* 
R1 226.7 505.0 242.6 11.7 
R2 1.1 4.8 3.2 0.1 
R3 186.5 488 238.9 12.4 
R4 232.5 551.6 269 11.1 
GC-retention time 20.7min. 22.7min. 22.9min. 23.6min. 
* 1 unit corresponds to 0.013 µmol / mL (CH2Cl2) 
 
The overall yield was moderate but the products formed were easily distinguishable from 
each other using standard gradients (Table1). The major products formed were the 
unrearranged diastereoisomer alcohols 58. The minor product formed was the corresponding 
rearranged allylic alcohol 61 and the ketone 57. In order to eliminate the possibility of other 
alternative routes to the products formed, subsequent blank reactions were performed. The 
logic behind these control experiments was the following.  
 
The blank reaction R2 was performed to control the effect of PhIO without the contribution of 
porphyrin catalyst. (Scheme 24) 
 
 Scheme 24. Blank reaction R2. 
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 The control experiments R2, shown in Table1, proved that PhIO, on its own, produces 
a background reaction which corresponds to ≈1 % of the overall yield seen in R1. The results 
from the R2 reaction prove how vital the porphyrin is in this oxidation process and 
demonstrates that this porphyrin mimic can act in a catalytic manner. 
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 R3 and R4 blank experiments, conversely, were necessary to demonstrate whether it 
was possible to rearrange the alcohol 58, formed from direct hydroxylation of 45 before the 
opening of the cyclopropyl ring, into the allylic alcohol 61. (Scheme 25) 
 
Scheme 25. Control reactions R3 and R4 
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The reactions R3 and R4 were performed using the unrearranged alcohol 58 as the 
starting substrate.  Here, the actual amount of starting substrate, 58, used in R3 and R4 was 
equal to the quantity of unrearranged alcohol 58 that was produced during the R1 reaction. If 
both the rearranged alcohol 61 and ketone 57 are exclusively derived from the unrearranged 
starting alcohol 58, then the yields of products formed in R3 and R4 should be consistent 
with those observed in R1. The results showed that the quantity of 61 and 57 observed in R1 
were entirely derived from the action of PhIO on 58 (Scheme 26). 
 
Scheme 26. Action of the PhIO on the alcohol 58 
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In summary, the formation of the ketone 57 is understandable as it is the product of a 
direct oxidation of alcohol 58. The presence of the rearranged alcohol, on the other hand, is 
more difficult to rationalize. One plausible hypothesis about the mechanism of formation of 
the allylic alcohol 61 starting from the alcohol 58 is a probable action of the PhIO as an 
electrophile on the newly formed hydroxyl functional group of 61. 
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In conclusion the proof that 61 and 57 are products of a side reaction makes it 
possible to state that the rebound rate for this specific substrate is greater than the rate of 
rearrangement krear = 3.6 X108. 
 
After a detailed literature research it was discovered that 45 has not been used as a 
substrate in enzymatic oxidations. Therefore for completeness a decision was made to verify 
that the metabolites produced in such a process are actually the products obtained in R1. 
The enzymes that have been employed for this purpose are the liver microsomes, 2B1 and 
2E1. The protocol used for this experiment is detailed in the experimental section. The 2E1 
proved to be inactive but the liver microsomes and 2B1 enzyme gave only the unrearranged 
alcohol 58 as metabolites (Scheme 27). 
 
Scheme 27. Enzymatic incubation with liver microsomes or 2B1 
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This is a further confirmation that the hydroxylation takes place before the substrate 
can undergo the ring opening rearrangement. It also demonstrates, for the first time, that a 
porphyrin model is a suitable mimic for P450 action on radical clocks. 
 
4.1.2. Fast Radical Clock Experiments 
 
It was logical at this time to continue the investigation by examining the hydroxylation 
of a substrate belonging to the class of fast radical clocks. For these new experiments it was 
practical to choose a substrate that, from previous DFT calculations and P450 experiments, 
had already triggered the debate on the existence of a second oxidative intermediate. For 
this purpose trans-methylphenyl cyclopropane 10 was the substrate of choice. This particular 
substrate was used extensively in Newcomb’s enzymatic radical clock experiments to put 
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forward the proposal for a second oxidant. Here, the C-H hydroxylation was expected to be 
much more difficult. The energy required for the dissociation of a primary C-H bond is 
significantly higher than that required for the cleavage of a benzylic C-H seen with substrate 
45. Furthermore since the rearrangement rate constant for this substrate is up to three orders 
greater than that of the previous example (krear = 1.8 X 1011 sec-1, 20°C) it was expected that 
the results from these experiments would contribute to a greater understanding of the 
hydroxylation rate and consequently of the nature of the oxidative intermediate(s). 
 
Similar conditions to those shown previously were employed to perform the porphyrin 
mimic catalysis. Again all reactions were performed in CH2Cl2 under anaerobic conditions 
using PhIO as the oxygen source and 2.5% mol. of porphyrin 55 as a catalyst. The results of 
the catalysis were evaluated using GC-FID and are shown in the following Scheme 28. 
 
Scheme 28. Hydroxylation of substrate 10 catalyzed by porphyrin 55 
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Table 2. 
Reaction 66* 63* 72* 
R5 1 9 22 
Retention time 10.37 min. 13.02 min. 14.91 min. 
* 1 unit corresponds to 0.003 µmol / mL (CH2Cl2) 
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This type of hydroxylation is very difficult to perform and in spite of the fact that it 
gave, as expected, a reduced yield, this experiment should be considered a success. More 
importantly the three distinctive products observed in the GC analysis correspond to the 
metabolites that Newcomb detected in his enzymatic experiments employing the same 
substrate.95 It is first necessary to detail which exact reaction mechanism produces these 
products formed and therefore blank experiments were undertaken to eliminate any 
uncertainty about their formation. The first blank experiment R6 was performed to control the 
oxidative power of PhIO without the contribution of porphyrin catalyst.   
 
Scheme 29. Control reaction R6. 
 
1 eq. PhIO / CH2Cl2
10
(R6)none of the three products are detected
 
 The substrate 10 was not subject to oxidation with PhIO and no products were 
observed. This demonstrated the essential role played by the porphyrin 55 in the 
hydroxylation reaction. Even in these more difficult oxidation reactions the porphyrin mimic 
possesses a reactivity similar to that of the parent enzyme.   
 
The following blank experiments R7 and R8 were performed to investigate the 
possibility of the alcohol 63, formed from direct hydroxylation of 10, to rearrange into the 
alcohol 66 (Scheme 30). 
 
Scheme 30. Control reactions R7 and R8. 
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Although these blank experiments seem similar to the previous example with 
substrate 58 one important difference is noted. In the hydroxylation of substrate 10 the 
overall yield was extremely low with poor yields of the unrearranged alcohol 63. This 
necessitated that the quantity of alcohol 63, used as a starting material in the subsequent 
blank reactions R7 and R8, was not equivalent to the quantity of alcohol 63 produced in the 
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reaction R5. Because of this it was necessary to use a 25 fold excess of this alcohol 63 in 
experiments R7 and R8 in order to have product quantities above the detection limit of the 
GC machine. It consequently turned out that the results of R7 and R8 demonstrated that the 
iodosylbenzene was unable to transform the alcohol 63 into the corresponding rearranged 
allylic alcohol 66 on its own or in combination with the porphyrin. 
 
Once the control experiments were completed it was then possible to unambiguously 
analyze the radical clock experiment R5 in detail. The relative amount of the three 
compounds was biased in favor of the phenol derivative 72. The aromatic hydroxylation is an 
unexpected product from this catalysis. Using porphyrins as a catalytic source only a few 
examples of this type of aromatic oxidation have been published in the literature.181 The 
production of phenol competes with the oxidations at the cyclopropyl carbinyl position, but 
has no significance with respect to the mechanistic analysis. 
 
The GC analysis showed that the unrearranged and rearranged alcohols had an 
average ratio of 9:1 (Table 2). The formation of the rearranged alcohol (ROH) demonstrates 
that the reaction does not only proceed via a concerted oxygen atom insertion into the alkyl 
C-H bond. 
 
Scheme 31. Hydroxylation of substrate 10 catalyzed by porphyrin 55 
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The ratio of alcohols formed was important in the estimation of the hydroxylation rate 
(kOH) given that the rearrangement rate (krear) of the fast radical clock is already known. This 
ratio, when inserted into the equation Eq.3 (see Chapter 12), produced a value for the 
rebound rate of kOH = 1.6 X 1012sec-1. This value translated in terms of the lifetime of the 
radical intermediate corresponding to 10, is equal to 625 fs (Scheme 31). Although this result 
on its own is very noteworthy it is interesting to see how this lifetime relates to lifetimes 
derived from other radical clock experiments using identical substrates, experimental 
conditions and appropriate rearrangement rate values. A comparison with the “lifetimes” 
obtained from Ingold and Newcomb’s enzymatic experiments with the trans-methyphenyl 
cyclopropane 10 is quite striking90, 93 (Table 3). 
 
Table 3. Comparison of the UOH/ROH ratio obtained in our metalloporphyrin experiment and in the 
enzymatic experiment performed by Ingold and Newcomb. 
 
OH
OH
UOH ROH  
 
Reaction UOH/ROH krearr, temp 
Calculated 
Lifetimes (Eq 3) 
*Metalloporphyrin 9:1 1.8x1011, 20°C 625fs 
      **Enzyme 4:1 4.1x1011, 37°C ~666fs 
 
*Porphyrin 55.  
**Phenobarbital induced rat liver microsomal enzymes 
 
The table shows the values of the calculated lifetimes (derived from Eq 1) of the 
intermediates formed during the course of the reaction. It clearly illustrates that the 
metalloporphyrin yielded an intermediate with a lifetime identical, within experimental error, to 
the corresponding value calculated from the above product distribution (Table 3) in the P450 
enzymatic hydroxylation of 10. More importantly, for a detailed interpretation of these new 
results, the newly calculated lifetime greatly exceeds 170 fs, the generally accepted “lifetime” 
of a transition state.45, 126 Additionally, the anaerobic conditions and the use of the PhIO as an 
oxygen surrogate in the porphyrin catalyzed oxidation rule out the possibility that a peroxo- 
and/or hydroperoxo iron (III)-porphyrin complex could form. As it was already pointed out in 
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chapter one, the iodosyl benzene as a mono-oxygen donor can only generate the synthetic 
equivalent of Compound I and not a synthetic species corresponding to the Compound 0 or 
its protonated form. This automatically excludes any interpretation of these results in terms of 
a two oxidant theory, which has been the source of so much controversy.  
 
4.1.3. Proposed Mechanism 
 
This new synthetic porphyrin is clearly a good mimic of the parent enzyme due to the 
calculated lifetimes of the intermediates formed but since the overall legitimacy of these radical 
clock experiments have been questioned, perhaps it is necessary to interpret these new results 
in relation to new DFT calculations concerning trans-methylphenyl cyclopropane 10. 
 
In a recent paper120, 182 Shaik shows that the scenario of a two state (High Spin and 
Low Spin states: Chapter 1.3) rebound mechanism accommodates much of the experimental 
data. In this paper he outlines that there is little difference in the calculated high spin (HS) 
and low spin (LS) energy levels of the transition states and intermediates during the course 
of the oxidation. One exception to the rule is noted in the two divergent routes that key 
intermediate 73 (common to both HS and LS routes) can undergo during the reaction 
process. Shaik has computed that one transformation of 73 into the rebound product 63, by 
concerted “O” insertion into the C-H bond, occurs in an LS route that has essentially no 
energetic barrier. Yet conversely by starting from 73 the alternative HS route, to give to the 
rebound product 63 via a H• abstraction, encounters a transition state (Scheme 32). 
 
Scheme 32. Activation rebound energy on the HS route  
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O
C
H
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•
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S
O
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HS: -41.5 kcal LS:-45.1 kcal  
 
 This route is energetically unfavorable and lies 2 kcal above that of the intermediate 
73. From these calculated energy profiles it can be assumed that there is a preference in 
favor of one of the two possible routes for the formation of 63.  
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Yet when the routes leading to the ROH product are examined a different scenario 
becomes apparent. The same communal intermediate 73 needs only to overcome a minute 
energy barrier of 0.2 kcal in order to transform itself into an open chain radical. This 
rearranged intermediate is later trapped in a “rebound” step to yield the cofactor bound 
product 66. Although the overall picture seems complicated, the following Figure 34 attempts 
to shows graphically our interpretation of the reaction routes leading to both UOH and ROH 
products.183 
 
Figure 34. Energetic profile of the proposed mechanism for this thesis work.183 
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This graphic is applicable to both the metalloporphyrin and enzyme model and uses 
the oxo-ferryl species (Cpd I) as a starting point for subsequent HS and LS routes. It uses 
Shaik’s published relative energies of all the states and also takes into consideration that 
their HS and LS forms are not distinctly separated.120  
 
Thus the first transition state TSC-H is formed upon activation of the substrate complex 
CpdI-10. This transition state is itself changed into the already referred to key intermediate IC-H. 
As the reaction progresses to this point it is impossible to distinguish between the energy 
levels of the HS and LS forms of both TSC-H and IC-H and therefore no distinction is made at 
this stage between the LS and HS routes. The way in which the oxygen atom approaches 
the primary C-H bond is a point of contention. Groves,86, 184 for example, proposes that the 
position of the incipient carbon radical, during the proton (H•) abstraction by the active 
oxygen is different from the position of the already formed carbon radical during the 
subsequent C-O bond formation (Scheme 33). The extent of the radical rearrangement could 
be greatly influenced by the “tightness” of the radical cage and the combination of steric and 
electronic factors experienced by the incipient radical with the cage. 
  
Scheme 33.  Molecular trajectory of the radical carbon  
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Our view on how IC-H is formed is quite different.183 We predict a “side-on” approach of 
the oxygen atom to the C-H bond rather that a linear H-abstraction as shown above since 
this would permit a mutually inclusive “O” insertion together with a .H abstraction (this HS 
route is improbable in this instance due to high activation energy) (Scheme 34). 
 
A stretching is quite probable in the C-H of the methyl group which consequently creates 
a spin density at CH2 with one of the cyclopropyl C-C bonds already compromised. The IC-H thus 
formed is predisposed to either a rearrangement or a direct hydroxylation. 
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Scheme 34. “Side-on” approach – mutually inclusive “O” insertion and H. abstraction 
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The activation energies needed by the HS and LS routes to complete their passage 
determines which contribution, if any, each separate route will have on the products formed. 
Since the HS rebound route has an activation energy of ~2 kcal in comparison to the 
rearrangement route (∆H# = 0.2 kcal) the HS rebound route is thus excluded as a possible 
pathway in the formation of 63-bound. The ratio of UOH and ROH products formed corroborates 
these calculated energies since, if in fact the 63-bound includes a contribution from the HS 
pathway, then 66-bound would also have a HS input up to 10 fold greater. Thus, for the HS 
pathway, a bias towards the formation of this rearranged species 66-bound would be observed 
resulting in a different distribution of oxidized products. With a ratio of 9:1 observed in favor of 63-
bound this is clearly not the case. The opposite is observed in the LS route to form 63-bound. 
This route is effectively barrierless and has to compete with the combined HS and LS 
rearrangement routes which travel a joint pathway of low activation energies via intermediate 
IC-H and transition state TSC-H to yield the rearranged species 66-bound 
 
The complex scenario above, with its dependence on the interplay of activation energies and 
type of intermediate (IC-H) formed, is different  to Shaik’s120 interpretation of how the TSR theory 
contributes to the formation of products. It is estimated that the observed product ratio may be 
due to a variation of ∆H# = 1-2 kcal in the two routes which form 63 and 66 respectively, 
bearing in mind that the rearrangement of a cyclopropyl methyl radical has an activation energy 
of about 1kcal in solution. In other words, since the high-spin and the low-spin form of the 
crucial intermediate IC–H are equal in energy the observed product distribution 63/66 = 9:1 does 
not reflect the yield of HS-IC–H  over LS- IC–H as stated by Shaik  but is rather a matter of the 
respective activation energies of the forward reactions. For this theory to be workable it is 
crucial that the intermediate species IC-H is not looked at in terms of a isolated radical but more 
in terms of a cluster containing a CH2-group carrying spin density coupled to the spin system of 
the …H…O-FeIII porphyrin radical cation. An exact determination of the true “nature” of the 
intermediate species IC-H should eventually show how correct this theory is. 
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5.  Future Directions 
 
 A logical continuation of this work is to examine how this applied theory relates to 
similar probes used in other radical clock experiments (Scheme 35).  
 
Sheme 35. Radical probes used in the experiments by Ortiz de Montellano and Groves. 
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The life times observed for the alkyl radical intermediates of compounds A-D were in 
the range of 20-80 ps. Although, with our present understanding of molecular processes, it is 
not yet possible to rationalize the different physico-chemical parameters involved in the 
rebound mechanism some observations can still be put forward. Firstly all the carbon centers 
involved in the C-O bond formation are secondary carbons. Hence this will effect the 
environment of the radical cluster containing a CHR-group, its stability and ability to 
transform from an intermediate into a potential product. Secondly and specifically for the 
more rigid probes C and D, the effective C-H bond strength will depend on the 
stereoelectronics of the interaction of the C-H with the neighboring cyclopropyl groups. For 
the probe A and B the long fatty acid chain may interact with residues not necessarily 
surrounding the porphyrinic active site. This would then hinder the substrates approach to 
the active oxidative species. Certainly the strength of the C-H bond together with the 
activation energies needed to transform the intermediates IC-H are crucial in determining the 
measured life time. 
 
This is the first type of radical clock experiments using porphyrin mimics as a catalyst 
so it is evident more work is needed in this area to provide a more robust contribution to the 
rebound mechanism debate. It would be prudent to continue this research using other probes 
(Scheme 36). 
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Scheme 36. Radical clocks proposed for further experiments. 
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A similar experiment would be to use the analogue radical clock of 10, I, with the 
para-position blocked by a substituent (i.e. CF3). The second radical clock II could also be an 
interesting probe to verify if a metalloporphyrin system also gives the products that, in 
Newcomb’s opinion, should be produced by a cationic pathway from P450 catalysis.  Finally 
the third radical clock probe III would be an ideal substrate for working on the outer limit of 
what is generally accepted as transition states. In fact, it is this exact substrate, with its 
rebound constant estimated to be in the range 1013 that strongly provides evidence which 
undermines the existence of a radical intermediate. 
 
 More experimental and theoretical work needs to be conducted to define what extent 
the nature of the 5th ligand has in influencing the oxidative behavior of the porphyrin. Overall 
it is quite surprising that such a divergent (from nature) O-SO2 ligand could indeed mimic the 
parent heme-thiolate enzyme to such a high degree. It is known that the oxidative character 
of the porphyrin can be affected by the nature of axial ligands harnessed by the heme iron, 
which can tune the electronic structure of the Cpd I species adequately for its own purpose in 
conjunction with amino acids surrounding the heme sites. In order to understand homologies 
and differences between the thiolate and sulfonate type porphyrins it could be interesting to 
conduct a more detailed systematic studies, with the aid of various spectroscopic techniques 
(EPR, UV-vis, NMR, Mössbauer, resonance Raman), of porphyrins which have the same 5th 
ligand (either SH or SO3) but with diverse backbones. Furthermore, for porphyrins not prone 
to oxidation, it would also be appealing to test the ability of SO3 porphyrins to catalyze the 
dismutation of hydrogen peroxide. 
Future Directions  
 
 
73 
 
 
6. Summary 
 
 In summary, the porphyrin mimics designed and synthesized during the course of this 
thesis were successfully used as catalytic oxidants in radical clock experiments. Despite the 
contrasting nature of the SO3 fifth ligand of the porphyrin mimic to the native cysteine ligand, 
found in the P450 enzyme, the results from subsequent catalytic oxidations showed a very 
good degree of similarity. These experiments, performed in organic solution, using a novel 
P450 Cpd-I model and specifically chosen probes, with the exclusion of any substrate protein 
interactions, have produced lifetimes (~625 fs) of the intermediate IC-H which are analogous to 
the lifetimes observed in enzymatic hydroxylations. It was proposed that this intermediate is 
not a free radical but instead a cluster containing a CH2 group carrying spin density joined to 
the spin system of the …H…O-Fe(III) porphyrin radical cation. The two routes to the final 
oxidized products, originating from this intermediate IC-H, are divergent, the unrearranged 
alcohol is formed via a concerted route whereas the rearranged product is produced from 
either a high-spin or low spin pathway.   
 
In conclusion the porphyrin mimic catalytic experiments performed and outlined above make a 
contribution towards understanding exactly how the P450 catalytic cycle works. 
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7. Experimental Part 
 
7. 1. General Remarks 
 
7. 1. 1. Solvents and Reagents 
 
Reagents were used as received from Fluka AG (Buchs, Switzerland), Merck AG 
(Darmstadt, Germany) and Aldrich (Buchs, Switzerland) unless otherwise stated. Chemicals 
of the quality purum, purum p. a. or >98% were used without further purification. 2,6-lutidine 
for iron insertions was purchased from Aldrich, dried over solid KOH, distilled from BaO and 
degassed in high-vacuum by four freeze-pump-thaw cycles. 
Solvents for chromatography and extractions were distilled prior to use. Dry 
dichloromethane (CH2Cl2) was distilled from CaH2, Et2O and THF from Na/benzophenone, 
MeOH from Mg, DMF dried over solid KOH and distilled from BaO, dioxane and toluene 
distilled from Na. All freshly dried solvents were stored over activated molecular sieves. 
Further solvents used for reactions corresponded to the quality puriss p. a., abs., over 
Molecular Sieves from Fluka AG. HPLC-grade solvents were purchased and used for 
analytical RP-HPLC. Degassed solvents for reactions under oxygen-free condition (e.g. in 
the glove box) were obtained by at least four freeze-pump-thaw cycles. 
For an inert atmosphere Argon 56 (< 4 ppm other gases) from Carbagas AG (Lenzburg, 
Switzerland) was used. 
 
7. 1. 2. Materials & Instruments 
 
Solvents were removed with a Büchi (Switzerland) rotary evaporator (Waterbath 461, 
Rotavapor RE 111 and Vacuum Controller 168) and a MZ 2C membrane pump 
(Vacuubrand). For cooling a mixture of EtOH and water was kept at 4° with a UKW 300 
thermostat (Vacuubrand).  
For weighing compounds and reagents Mettler (Switzerland) balances P1200 (> 1 g) , 
AE163 (< 1 g), and AX205 (< 100 mg) were used. 
A high-vacuum pump D5E from Trivac (Köln, Germany) was used for drying compounds 
and reagents.  
Slow addition of reagents to a reaction mixture was achieved with a Precidor 5003 syringe 
pump (Informs HT, Switzerland). 
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For all non-aqueous reactions glassware were flame dried either under vacuum or argon 
overpressure, and the atmosphere was exchanged by three cycles of evacuating and 
flushing with argon.  
Iron insertions and all other reactions with iron porphyrins were carried out in a Labmaster 
130 glove box (MBRAUN). The levels of dioxygen (< 2 ppm) and water (< 0.1 ppm) were 
measured with a combined H2O/O2-analyser (MBRAUN). All solvents and reagents used in the 
glove box were dried and degassed in high-vacuum. 
melting points (mp) were determined on a Büchi 510 apparatus and are uncorrected. For 
the porphyrins, the melting points are > 250° and were not determined.  
 
7. 1. 3. Chromatographic Methods 
 
Analytical thin layer chromatography (TLC) was performed on 0.25 mm precoated 
glass plates (5×10 cm, silica gel 60 F254, Merck AG, Darmstadt, Germany) or on 0.2 mm 
precoated plastic plates (5×10 cm, ALUGRAM® aluminum oxide N/UV254, Macherey-Nagel, 
Germany). Compounds were detected at 254 nm (UV) or at 366 nm (fluorescence). 
Description: TLC (solvent): Rf.  
 
Preparative thin layer chromatography was conducted on 0.25 mm precoated glass 
plates (20×20 cm, silica gel 60 F254, Merck AG, Darmstadt, Germany).  
 
For normal phase column chromatography silica gel 60 from Merck (0.043-0.06 mm, 
230-400 mesh) or aluminum oxide 90 from Merck (standardized (activity II-III), 0.063-0.2 mm, 
70-230 mesh) were used and for eluting the compounds pressure (0.3–0.5 bar N2) was 
applied (flash chromatography). 
 
Analytical reversed phase HPLC (RP-HPLC) was performed on LiChrospher® 100 RP-
18 silica gel from Merck (5 µm particle size, 4×250 mm column) with nanopure water and 
HPLC-grade MeOH or acetonitrile. HPLC-System: Merck Hitachi LaChrom system with 
interface D-7000, pump L-7000, UV-detector L-7400, autosampler L-7200, column oven 
L-7300, column changer LabSource 6 Port Valve 7066 and on-line solvent degasser L-7612.  
 
Gas chromatography (GC/MS) was performed on a Hewlett Packard 5890 series II using 
a 25 m dimethyl silane column coupled with a Hewlett Packard 5971 series mass selective 
detector  
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Gas Chromotography (GC-FID) was performed on Finningan Focus using a 15 m 
Supelcowax column. 
 
7. 1. 4. Spectroscopic Methods 
 
Ultra violet – visible absorption spectra (UV/Vis) were recorded on a Hewlett-Packard 
8452A Diode Array spectrophotometer and a Agilent 8453 Diode Array spectrophotometer 
using optical 110-OS Hellma cuvettes (10 mm light path). Description: UV/Vis (solvent): 
wavelength of maxima (λmax) in nm (relative extinction coefficient in %). sh = shoulder. 
 
1H-Nuclear magnetic resonance spectroscopy (1H-NMR) was performed using either a 
Bruker DPX-NMR (400 MHz), Bruker DRX-500 (500 MHz) or a Bruker DRX-600 (600 MHz) 
spectrometer. Solvents for NMR were obtained from Dr. Glaser AG (Basel, Switzerland) and 
Cambridge Isotope Laboratories (Andover, MA, USA). CDCl3 was filtered through basic 
alumina prior to use. If not otherwise stated all spectra were recorded at room temperature. If 
necessary for the interpretation correlated spectra like COSY, TOCSY, NOESY and ROESY 
were recorded also. Description: 1H-NMR (frequency, solvent): δH in ppm relative to residual 
solvent peaks (peak multiplicity: s = singlet, d = doublet, t = triplet, q = quartet, quin = quintet, 
sext = sextet, m = multiplet, br = broad; coupling constants J in Hertz). 
 
13C-Nuclear magnetic resonance spectra (13C-NMR) were 1H-decoupled and recorded 
on a Bruker DPX-NMR (100 MHz), Bruker DRX-500 (125 MHz) and Varian Gemini 300 (75 
MHz) spectrometer. For the assignment of carbons APT, DEPT, HETCOR, HMQC and 
HMBC experiments were carried out if essential.  
Porphyrin models atom numbering for NMR assignment: 
 
NH
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HN
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O
O
NH
HN
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O
SH
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2''
3''
4''
5''
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PyCH3
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NH
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Cl
Cl
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b c
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O
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Description: 13C-NMR (frequency, solvent): δC in ppm relative to residual solvent peaks 
(multiplicity: s = singlet (C), d = doublet (CH), t = triplet (CH2), q = quartet (CH3)). 
Electron impact mass spectra (EI-MS) and fast atom bombardment mass spectra 
(FAB-MS) were measured by Dr. H. Nadig on a Varian double focussing VG-70-250 
spectrometer in the mass spectrometry laboratory of the institute. As matrix for FAB-MS 
nitrobenzyl alcohol was used and, if necessary KCl added. Electron spray ionisation mass 
spectra (ESI-MS) were recorded on a Finnigan Mat LCQ-700 or a Bruker Esquire 3000plus. 
For matrix-assisted laser desorption/ionisation mass spectra in conjunction with time of 
flight mass analysis (MALDI-TOF-MS) a Perseptive Biosystems Vestec Mass Spectrometry 
Products Voyager™ Elite Biospectrometry™ Research Station was used. Porphyrin samples 
were prepared as follows: either 1-2 µl of a diluted solution of porphyrin in dichloromethane 
was mixed with 1 µl of a 0.1M matrix solution of 2,5-dihydroxybenzoic acid in 
MeCN/H2O/EtOH 50:45:5, placed on a 100-wells sample plate and left standing or the diluted 
porphyrin solution was placed directly on the sample plate and measured without matrix 
(LDI-MS). Description: MS (solvent): mass peaks in m/z (relative intensity in %). Peaks with 
an intensity of less than 5% were not considered.   
 
Continuous wave electron paramagnetic resonance spectroscopy (cw-EPR) was 
carried out using a Bruker ESP-300 X-band (νmicrowave = 9.485 GHz) spectrometer equipped 
with a T102 cell and a ER4111VT liquid nitrogen cryostat to assure low temperature during 
measurement. Sample concentration was typically 5mM and spectra were measured with a 
microwave power of 20 mW, modulation frequency of 100 kHz, and a modulation amplitude 
of 5.2 G. Samples were measured in dry and degassed toluene and/or 2-methyl-
tetrahydrofurane (2-MTHF) which was purchased from Fluka (purum) and distilled in high-
vacuum over a small Vigreux column. Caution ! 2-MTHF slowly decomposed upon heating 
and therefore destillation should be carried out under reduced pressure at room temperature. 
In additon 2-MTHF should not be dried by distilling from Na because this results in a solvent 
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which is extremely basic (pH ∼ 10). If this basic 2-MTHF is used for measuring iron porphyrin 
samples it can lead to low-spin signals (sometimes quantitatively) and accordingly to wrong 
interpretations! 2-MTHF mostly gave exactly the same spectra but sometimes with better 
resolution. Description: cw-EPR (solvent, temperature): g-values.  
 
7. 2. Syntheses 
 
7. 2. 1. Cyclopropyl Derivatives and Related Synthetic Studies 
 
rac-Phenyl-(trans-2-phenylcyclopropyl-methanone (57). 
 
O O
NaH, Me3SOI 
DMSO
56 57  
Solid NaH (60% in oil, 231 mg, 5.77 mmol, 1.2 equiv.) was placed in a 3-necked flask, 
washed with n-hexane, and fully pumped to dryness. Trimethyloxosulfonium iodide (1270 
mg, 5.77 mmol, 1.2 equiv.) was added, and DMSO (10 mL) was added dropwise to the solid 
mixture through an addition funnel. After hydrogen evolution, the milky solution turned clear 
and was stirred for 15 min. trans-Chalcone 56 (1 g, 4.81 mmol, 1 equiv.) was added. The 
mixture was stirred for 20 h, and the reaction was quenched with water. The mixture was 
extracted with ether, and the organic layers were dried, rotovapped, and chromatographed 
(silica gel hexane/diethylether 10:1) to give 57(773 mg, 72%) as a white solid. 
 
TLC (hexane/diethyl ether 8:1): Rf = 0.30. 
UV/Vis (CH2Cl2): 246 (100), 223(70). 
1H-NMR (400 MHz, CDCl3): 8.01-7.98 (m, 2H,arylH); 7.59-7.56 (m, 1H, arylH); 7.49-7.43 
(m, 2H, arylH); 7.35-7.29 (m, 2H, arylH); 7.25-7.22 (m, 1H, arylH); 7.21-7.17 (m, 2H, arylH); 
2.91 (ddd, J = 8.72 ,5.32 ,4.04 ,1H , cyclopropH), 2.70 (ddd, J = 9.71, 6.56, 4.04, 1H, 
cyclopropH); 1.95-1.91 (m, 1H, cyclopropH); 1.58-1.54 (m, 1H, cyclopropH). 
13C-NMR (100 MHz, CDCl3): 140.90 (Cquat.); 138.13 (Cquat.); 133.32 (arylCH); 128.97 
(arylCH.); 128.52 (arylCH.); 127.01 (arylCH); 126.63 (arylCH); 30.43 (cyclopropCH); 29.71 
(cyclopropCH); 19.66 (cyclopropCH2). 
EI-MS (70 eV, 50°): 222.0 (32, M+), 297 (5), 105 (100), 77(33), 51(6). 
EA calc. for C16H14O (222.10). 
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rac-trans-1-benzyl-2-phenyl-cyclopropane (45) 
 
 
O
2HNNH2, KOH
diethylene glycol
57 45  
 
1.2 g of phenyl-(trans-2-phenylcyclopropyl-methanone 57 (1 equiv., 5.40 mmol) was 
dissolved in 5.5 mL of diethylenglycol and 540 mg of 2HNNH2 (525 µL, 12 equiv., 10.80 
mmol) and 705 mg (2 equiv., 10.80 mmol) of KOH 86% were added. The yellowish solution 
was heated at 120°C (oil bath) for 1 hour. Then other 540 mg of 2HNNH2 and 705 mg of KOH 
86% were added and the reaction mixture was heated at 140°C for further 6 hours. After the 
orange solution was cooled at room temperature, treated with 5 ml of saturated aqueous 
NH4Cl and extracted with three portions of hexane. The combined organic phases were 
washed with distilled water and dried over Na2SO4. The crude was purified by a first flash 
chromatography (silica gel, hexane/diethyl ether 8:1) and a second one (alox, hexane + 5% 
diethyl ether). Each fraction was checked by GC-FID analysis. The final product obtained 
were 79 mg (60%) of a colourless viscous oil.    
 
TLC (hexane/diethyl etehr 4:1): Rf = 0.45. 
1H-NMR (400 MHz, CDCl3): 7.31-7.18 (m, 7H, arylH); 7.15-7.10 (m, 1H, arylH); 7.06-7.03 
(m, 2H, arylH); 2.84-2.66 ( m, 2H, CH2Ph); 1.82-1.75 (m, 1H, cyclopropH, PhCH2CH);1.41-
1.30 (m, 1H, cyclopropH, PhCH) ; 1.02-0.90 (m, 2H, cyclopropCH2). 
EI-MS (70eV, RT): 208.1(7); 117.1 (100); 104.1 (25); 91.0 (20); 65.0 (5). 
EA calc. for C16H16 (208.13). 
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α-[2-phenylcyclopropyl]- benzene methanol (58) 
 
O
NaBH4, MeOH
57 58
OH
 
 
150 mg (1 equiv., 0.67 mmol) of Phenyl-(trans-2-phenylcyclopropyl-methanone 57 was 
dissolved in 3.5 ml of MeOH and the solution as cooled at 0°C in an ice bath. 1.10 mmol) 
was added and the reaction mixture was stirred for 1.5 hours at 0°C and for further 1.5 hours 
at room temperature. Then, the solution was cooled in an ice bath and quenched with 2.0 ml 
of saturated aqueous NH4Cl. The mixture was then extracted with diethyl ether. The 
combined organic layers were then washed twice with 5 mL of water, brine and finally dried 
over Na2SO4. The crude material was purified by two subsequent flash chromatographies 
(silica gel, hexane/ ethyl acetate 2:1). A white solid (130 mg, 86%) was obtained as a mixture 
of enantiomers of two diastereoisomers with a ratio of 1.4. The purity of each fraction was 
determined by GC-FID analysis. 
 
TLC (hexane/ethyl acetate 1:1): Rf  = 0.41 and Rf  = 0.50 
1H-NMR (400 MHz, CDCl3, less polar diastereoisomer): 7.46-7.24 (m, 7H, arylH); 7.17-
7.13 (m, 1H, arylH); 7. 10-7.08 (m, 2H, arylH); 4.32 (d, J = 7.84, 1H, PhCHOH); 2.11-2.07 (m, 
1H, cyclopropH); 1.93 (br s, 1H, OH); 1.60-1.53 (m, 1H, cyclopropH); 1.11-1.05 (m, 1H, 
cyclopropH); 1.01-0.96 (m, 1H, cyclopropH). 
1H-NMR (400 MHz, CDCl3, more polar diastereoisomer): 7.42-7.38 (m, 2H, arylH); 7.37-
7.19 (m, 5H, arylH); 7.17-7.08 (m, 1H, arylH); 7.02-6.99 (m, 2H, arylH); 4.38 (d, J = 7.32, 1H, 
PhCHOH); 2.02-1.98 m, 1H, cyclopropH); 1.96 (br s , 1H, OH); 1.58-1.50 (m, 1H, 
cyclopropH); 1.21-1.17 (m, 1H, cyclopropH); 1.07-1.04 (m, 1H, cyclopropH). 
13C-NMR (100 MHz, CDCl3, less polar diastereoisomer): 143.80 (Cquat.); 142.72 (Cquat.); 
128.92 (arylCH); 128.79 (arylCH.); 128.16 (arylCH); 126.48 (arylCH); 126.31(arylCH); 126.11 
(arylCH); 77.95 (CHOH); 31.11 (cyclopropCH); 22.31 (cyclopropCH); 13.96 (cyclopropCH2). 
13C-NMR (100 MHz, CDCl3, more polar diastereoisomer): 143.90 (Cquat.); 142.44(Cquat.); 
128.91 (arylCH); 128.72 (arylCH.); 128.11 (arylCH); 126.47 (arylCH); 126.42 (arylCH.); 
126.10 (arylCH); 77.24 (CHOH); 31.11 (cyclorpopCH); 21.42 (cyclorpopCH); 14.03 
(cyclorpopCH2). 
EI-MS (70eV, RT): 206.1 (3, [M+ -18]); 120 (100); 107.0 (17); 91.0 (24); 79.0 (17.84); 51.0 
(4). 
GC-MS: 224 (1, M+); 118( 98); 107 (100); 79 (60); 51(6). 
EA calc. for C16H16O (224.12).  
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(E)-1, 4-diphenyl-3-buten-1-one (60) 
 
OH
O
OTHF
O O
2,3-dihydrofurane, CH2 Cl2, -20°C
MeSO3H, CH2Cl2, -20°C to O°C
PhMgCl(THF),-20°C to 18°C
H3PO4, 0°C
59 59-THF 60
 
To a solution of trans-styryl acetic acid 59 (2.0 g, 12.33 mmol, 1 equiv.) in dichloromethane 
(48 mL) at -20°C was added 2,3-dihydrofuran (0.98 mL, 12.91 mmol, 1.05 equiv.) followed by 
methane sulfonic acid (1.6 mL, 24.80 mmol, 2 X 10-3 equiv.) dissolved in a solution of 
dichloromethane (0.16 mL). The mixture was allowed to warm to 0°C over 4 h and then 
recooled to -20°C. To this mixture was then added dropwise phenylmagnesium bromide 
(12.33 mL, 12.33 mmol, 1 M in THF, 1 equiv.) over 5 min. Stirring was continued for an 
additional 30 min, and then the solution was allowed to warm to ambient temperature over 18 
h. The mixture was then cooled to 0°C and added dropwise to a solution of H3PO4 (16 mL, 
1.0 M) at 0°C. The mixture was then allowed to warm to ambient temperature, diluted with 
water (12.3 mL) and dichloromethane (78 mL). The solution was then poured into a 
separatory funnel and the organic layer was removed. The aqueous phase was washed with 
dichloromethane (3 × 12 mL). The organic phases were combined and shaken with a solution 
of H3PO4 (14.7 mL, 0.25 M) for 5 minutes and separated again from the aqueous layer. Since 
the THF ester was still present (TLC control) in the dichloromethane solution, the latter was 
stirred overnight at room temperature together with methane sulfonic acid and methanol (few 
drops of Moshe in 1.2 mL of MeOH) in order to hydrolyze it. The reaction mixture was then 
washed with aqueous NaHCO3 (3 X 20 mL, 1/1 H2O/saturated aqueous NaHCO3) and brine 
(25 mL). It was then dried over Na2SO4 and evaporated (up to 40°). Dilution and evaporation 
with hexanes (2 X 60 mL) yielded the crude ketone as an oil. The flash chromatography 
purification (silica gel, hexane / ethyl acetate 7:1) provided 1.10 mg (41%) of pure ketone 60 
as a white soft solid.  
 
TLC (hexane/AcOEt 5:1): Rf = 0.46. 
mp: 88-90 °C. 
1H-NMR (400 MHz, CDCl3): 8.04-7.98 (m, 2H, arylH); 7.60-7.57 (m, 1H, arylH); 7.51-7.46 
(m, 2H, arylH); 7.40-7.35 (m, 1H, arylH); 7.33-7.27 (m, 2H, arylH); 7.25-7.20 (m, 1H, arylH); 
6.56 (d, J = 16.2, 1H, alkene-H, PhCH); 6.48 (dt, J = 16.0; 6.32, 1H, alkene-H, 
PhCHCH);3.92 (dd, J = 6.32; 0.76, 2H, alkane-H, CH2C(O)Ph). 
ESI-MS (MeOH): 245.0 [M+Na+] ; 223.0 [M+1]+. 
EI-MS (70 eV, 50°): 222 (5, M+), 220(6), 105(100), 77 (27), 51 (5).  
EA calc. for C16H14O (222.10). 
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rac-α-[(2E)-3-phenyl-2-propenyl]-benzenemethanol (61) 
 
OHO
NaBH4, MeOH
60 61  
To a yellow solution of the ketone 60 (33.1 mg, 0.13 mmol, 1 equiv.) in MeOH (0.8 mL) at 0 
°C the NaBH4 (10.0 mg, 0.26mmol, 1.95 equiv.) was added. After the addition of the reducing 
agent the solution became colourless. The solution was stirred at room temperature for 5 
hours. The reaction mixture was then quenched with a saturated aqueous NH4Cl (1 mL) and 
then extracted with diethyl ether (5 mL). The organic layer was then washed with water (2 X 
2mL) and brine (3 mL) and dried over Na2SO4. The crude was purified by flash 
chromatography (hexane/ethyl acetate 5:1) and 14.6 mg (48%) of a pure white solid 61 was 
obtained.  
  
TLC (hexane/AcOEt 5:1): Rf = 0.08. 
1H-NMR (400 MHz, CDCl3): 7.41-7.26 (m, 9H, arylH); 7.23-7.19 (m, 1H, arylH); 6.51(d, J = 
15.8, 1H, PhCHCHCH2); 6.21(dt, J = 15.8, 7.6, 1H, PhCHCHCH2); 4.82(dd, J= 7.32, 
7.32CHOH), 2.71-2.63(m, 2H, CH2CHOH). 
EI-MS (70eV, 50°): 316 (21, [M+1]+); 315 (100, M+); 313 (6); 255 (6); 254 (11); 125 (5); 77 
(7); 58 (19). 
EA calc. for C16H16O:(224.12). 
 
 
trans-(2-phenylcyclopropyl)methanol (63) 
 
OHOH
O
LiAlH4
62 63  
To a solution of 2 g (12.33 mmol, 1 equiv.) of trans-2-phenyl cyclopropane carboxylic acid in 
diethyl ether (67 mL), 24.66 mL of a solution 1M of LiAlH4 in Et2O ( 24.66 mmol, 2 equiv.) 
was added and the reaction mixture was refluxed for 12 hours. Then it was treated 
sequentially with water (1.0 mL), 15% aqueous NaOH (1.0 mL) and water (6.0 mL). Then the 
ethereal solution was filtered off through a fritted funnel and dried over Na2SO4 and 
concentrated in vacuum. The obtained residue was distilled with the kugelröhr apparatus 
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(1.0E-1 mbar, 150°) providing 1.25 g of colorless viscous oil. The purity was tested by GC-
FID and just the factions 99.7% pure were collected together and used for the control 
experiments. 
 
TLC (hexane/AcOEt 1:1): Rf = 0.60 
bp: 152°,30Torr 
1H-NMR (400 MHz, CDCl3): 7.28-7.23(m, 2H, arylH); 7.16 (tt, J = 7.32,1.24,1H , para-
arylH); 7.08-7.04(m, 2H, arylH); 3.63 (d, J = 6.8, 1H, CH2OH); 3.61 (d, J = 6.8, 1H, CH2OH); 
1.83 (dt, J = 8.6, 4.8, 1H, PhCH); 1.50-1.42 (m, 1H, cyclopropH); 0.99-0.91 (m, 2H, 
cyclopropH). 
13C-NMR (100 MHz, CDCl3):143.07(Cquat);128.81(arylCH);126.29(arylCH);126.08(arylCH); 
66.71(arylCH);25.68(cyclopropCH);21.76(cyclopropCH); 14.39(cycloproCH). 
GC-MS: 148 (20, M+); 117(100); 115(64); 104(35); 91(37). 
EA calc. for C10H12O : (148.09). 
 
trans-(2-phenylmethyl)cyclopropane (10) 
 
OH LiAlH4
63 10  
 
To a solution of 578 mg (3.90 mmol, 1 equiv.) of trans-(2-phenyl cyclopropyl)-methanol 63 in 
dichloromethane (21 mL), 923 µL of triethylamine (6.63 mmol, 1.7 equiv.) and 364 µL of 
benzenesulfonyl chloride (4.68 mmol, 1.2 equiv.) were added at -10°C. The reaction mixture 
was stirred for 1 hour at -5°C and then transferred into a chilled separatory funnel and 
extracted with the following chilled solutions: water, 10% aqueous HCl, saturated aqueous 
NaHCO3 and saturated aqueous NaCl. The solution was dried over Na2SO4 while standing at 
0°C in an ice bath, filtered through a fritted funnel previously chilled up and then concentrated 
in vacuum at low temperature (around 5°C). Chilled THF (3.5 mL) was added and the solvent 
was again removed under reduce pressure at 5°C. The residue was dissolved in chilled THF 
(7 mL), treated with 8.5 mL of a solution 1M LiBEt3H in THF and stirred at 0°C for 5 hours 
and for further 12 hours at ambient temperature. The reaction mixture was quenched by drop 
wise addition of aqueous 3M NaOH (5 mL) and slow addition of 30% H2O2 (5 mL), refluxed 
for 1 hour, cooled down and then separated. The aqueous layer was extracted three times 
with hexane. The combined organic phases were washed with saturated aqueous NaCl, 
dried over Na2SO4 and concentrated under reduce pressure.  The yellowish oil was distilled 
with the kugelrörh apparatus (4.5E-2 mbar, 80°C) and a colourless oil was obtained. The 
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latter was further purified by flash chromatography (silica gel, hexane).The purity of the 
compound 10 was determined by GC-FID analysisand only the fraction 99.9% pure were 
used as substrate in the porphyrin catalyzed oxidation. 
 
TLC (hexane): Rf = 0.55. 
1H-NMR (400 MHz, CDCl3): 7.30-7.25 (m, 2H, arylH); 7.19-7.15 (m, 1H, arylH); 7.09-7.06 
(m ,2H, arylH); 1.64-1.59 (m ,1H, cyclopropH, PhCH); 1.23 (d, J = 6.08, 3h, CH3); 1.14-1.06 ( 
m, 1H, cyclopropH); 0.95-0.91 (m, 1H, cyclopropH); 0.81-0.76 (m, 1H, cyclopropH). 
13C-NMR (100 MHz, CDCl3): 144.48 (Cquat); 125.94 (arylCH); 125.86 (arylCH); 24.73 
(arylCH); 19.51 (arylCH); 18.41 (arylCH); 18.03 (arylCH). 
GS-MS: 132 (43, M+); 131(15); 117 (100); 115 (42); 91 (30). 
EA calc. for C10H12 : (132.09). 
 
1-phenyl-3-buten-1-ol (66) 
 
OH
H
O
MgCl Et2O+
64 65 66  
 
1 g of benzaldehyde 64 ( 0.96 mL, 9.42 mmol, 1.0 equiv.)  was dissolved in diethyl ether (2.5 
mL) and the transparent solution was cooled at 0°C (ice bath). Then 7.1 mL of a solution 2M 
of allylmagnesium chloride in THF 65 (14.13 mmol, 1.5 equiv.) was added and the solution 
that turned orange was stirred for 2 hours. The reactionmixture was then quenched with 
aqueous saturated NH4Cl (5 mL).  The aqueous phase was extracted with Et2O (2 X 8 mL) 
and the combined organic layers were then washed with water (10 mL) and dried over 
Na2SO4. The solvent was removed under reduce pressure. The obtained 1.3 g of crude 
product 66 (92%) did not need any purification 
 
TLC (hexane/EtOAc 1:1): Rf = 0.7 
1H-NMR (400 MHz, CDCl3): 7.37-7.26(m, 5H, arylH); 5.87-5.76 (m ,1H , alkeneH, 
CH2=CHCH2); 5.20-5.13 (m, 2H, alkeneH,  CH2=CHCH2); 4.76-4.72 (m, 1H, benzylicH 
PhCHOH); 2.58-2.46 (m, 2H, alkaneH, PhCH(OH)CH2). 
13C-NMR (100 MHz, CDCl3): 144.41(Cquat); 134.99 (arylCH); 128.82 (arylCH); 128.82 
(arylCH); 127.94 (arylCH); 126.35 (CH=CH2); 118.60 (CH2=CH); 73.82 (CHOH); 44.18 
(CH2CH=CH2). 
GC-MS: 148(5,M+);107(100), 91(5); 79(55); 77(30). 
EA calc. for C10H12O : (148.09). 
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Ethyl trans-2-(4-methoxyphenyl)-cyclopropane-carboxylate (69) 
 
O
O
O
O
O
OEtN2+
67 68 69
benzene
 
 
To a mixture of 4.98 g of p-vinylanisole 67 (5 mL, 37.18 mmol, 1 equiv.) in benzene (15 mL) 
with 0.5 g of CuSO4 (2.7 mmol, 7.5%mol equiv.) at 75°C was added dropwise over 2 hours 
8.48 g of ethyl diazoacetate 68 (7.7 mL, 2 equiv.). After an additional 3 hours reflux (90°C), 
the mixture was allowed to stand for 12 hours at room temperature. Water (23 mL) was 
added, and benzene was removed by azeotropic distillation at normal pressure (68°C). 
Diethyl acetate (20 mL) was added to the orange residue, and the resulting solution was 
extracted with water ,aqueous saturated NaCl and dried over Na2SO4. Concentration at 
reduced pressure gave a residue containing starting material and cis- and trans- 
cyclopropane carboxylic acid esters which was partially purified by flash chromatography 
(silica gel, hexane/ethyl acetate 10:1). A fraction enriched in the trans ester was obtained. 
Crystallization (ethyl acetate/ hexane) gave 5.42g (33%) of ethyl trans-2-(p-methoxyphenyl)-
cyclopropanecarboxylate 69. 
TLC (hexane/ ethyl acetate 10:1): Rf (trans) = 0.43; Rf (cis) = 0.38 
mp (trans):80-82 °C  
1H-NMR (400 MHz, CDCl3) (trans-isomer): 7.03 (d, J = 9, 2H, arylH); 6.82 (d, J = 9, 2H, 
arylH); 4.16 (q, J =7.1, 2H, OCH2CH3); 3.78 (s, 3H, OCH3); 2.48 (ddd, J = 9.2,6.6, 4.2, 1H, 
cyclopropH); 1.81 (ddd, J = 8.7,5.4, 4.2, 1H , cyclopropH); 1.55 (ddd, J = 9.6, 5.1, 4.2 1H, 
cyclopropH),1.27 (t, J = 7.1, 3H, OCH2CH3), 1.26-1.22 (m, 1H,  cyclopropH)  
1H-NMR (400 MHz, CDCl3) (cis-isomer):: 7.18 (d, J = 8.1, 2H, arylH); 6.80 (d, J = 8.1, 2H, 
arylH); 3.89 (q, J = 7.2, 2H, OCH2CH3); 3.78 (s, 3H, OCH3); 2.52 (m, 1H, cyclopropH); 2.03 
(ddd, J =  9.3, 7.8, 5.7, 1H, cyclopropH);1.64 (m, 1H, cyclopropH), 1.29 (ddd, J = 9.3, 8.1, 
5.4, 1H, cyclopropH), 1.01 (t, J = 7.2, 3H, OCH2CH3).  
13C-NMR (100 MHz, CDCl3) (trans-isomer): 173.9 (C=O), 158.7 (COCH3), 132.4 (Cquat), 
127.7(arylCH), 114.2 (arylCH), 61.0 (CH2CH3), 55.7(OCH3), 26.1(cyclopropCH), 24.2 
(cycloproCH), 17.1(cycloproCH), 14.6(CH2CH3). 
13C-NMR (100 MHz, CDCl3) (cis-isomer): 171.4 (C=O), 158.6 (COCH3), 130.6(Cquat), 
129.1(arylCH), 113.6(arylCH), 60.5(CH2CH3), 55.5(OCH3), 25.2 (cyclopropCH), 22.0  
(cycloproCH), 14.4 (cycloproCH), 11.6 (CH2CH3). 
EI-MS (70ev, 50°): 220 (43, M+); 191(19); 175(19); 147( 1000); 115( 12); 91(13). 
EA calc. for C13H16O3 (220.11). 
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trans-2-(4-methoxyphenyl) - cyclopropanemethanol (70) 
 
O
O
O
69
O
OH
70
LiAlH4 in Et2O
 
 
675.8 mg of the ester 69 (3.07 mmol, 1 equiv.) was dissolved in diethyl ether (12 mL) and 
reflued with 5.9 mL  of  1M  LiAlH4 in Et2O (5.83 mmol, 1.9 equiv.) for 12 hours. Then the 
solution was cooled and treated sequentially with water (0.3 mL), 15% aqueous NaOH (0.3 
mL) and water (1.0 mL). Then the ethereal solution was filtered off through a fritted funnel 
and dried over Na2SO4 and concentrated in vacuum. The obtained colourless oil (536.4 g, 
80%) was used without further purification for the synthesis of the compound 70. 
 
TLC (hexane/ ethyl acetate 1.1): Rf = 0.21 
1H-NMR (400 MHz, CDCl3): 7.01-6.98 (m, 2H, arylH); 6.82-6.79 (m, 2H, arylH); 3.77 (s, 
3H, OCH3); 3.65-3.61 (m, 2H, CH2OH); 1.81-1.76 (m, 1H, cyclopropH, p-OMePhCH); 1.46 
(br s, 1H, OH); 1.43-1.34 (m, 1H, cyclopropH); 0.91-0.84 (m, 2H, cyclopropH, CH2). 
13C-NMR (100 MHz, CDCl3): 158.17 (Cquat); 134.73 (Cquat); 127.40 (arylCH2); 114.23 
(arylCH2); 67.10 (CH2OH); 55.73 (OCH3); 25.17 (cyclopropH); 20.98 (cyclopropH); 13.68 
(cyclopropCH2). 
EA calc. for C11H14O2: (172.10) 
 
 
 
trans-1-methyl-2-(4-methoxyphenyl)-cyclopropane (71) 
 
O
OH
70
O
71
1. LiAlH4/ Et2O
2. MsCl, THF, -30°
3. LiBEt3H, THF, -70°
 
 
A solution of 105 mg trans-2-(4-methoxyphenyl)-cyclopropanemethanol 70 (0.59 mmol, 1 
equiv.) in THF (5.5 mL) under Argon atmosphere was cooled to -30°C. To this was added 
sequentially via syringe 164 µL of triethylamine (1.18 mmol, 2 equiv.) and 55 µL of 
methansulfonyl chloride (0.71 mmol, 1.2 equiv.). The mixture was stirred at -30°C for 30 
minutes and then cooled to -78°C. Then 2.4 mL of a solution of LiBEt3H (2.36 mmol, 1M in 
THF, 4 equiv.) was added via syringe. The reaction mixture was allowed to warm slowly to 
room temperature, it was stirred for 13 hours and finally quenched by the addition of 30% 
H2O2 (1 mL) and 15% aqueous NaOH (1 mL). The resulting mixture was heated at reflux for 
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1 hour and then cooled to room temperature. The organic layer was separated, and the 
aqueous layer was extracted with ether (3 X 10 mL). The combined organic phase was 
washed with brine (20 mL), dried over Na2SO4, filtered and concentrated in vacuum at 0°C. 
The crude product was opalescent oil that was purified by flash chromatography (silica gel, 
hexane) to give 83.15 mg (87%) of transparent oil 71. 
 
TLC (hexane/ ethyl acetate 10:1): Rf = 0.3 
1H-NMR (400 MHz, CDCl3): 6.95-6.91 (m, 2H, arylH); 6.78-6.74 (m, 2H, arylH); 3.74 (s, 
3H, OCH3); 1.51-1.46 (dt, J = 8.3, 4.8, 1H, cyclopropH); 1.13 (d, J =6.1, 3H, CH3); 0.95-0.90 
(m, 1H, cyclopropH); 0.76 (dt, J = 8.6, 4.8, 1H, cyclopropH); 0.64 (dt, J = 8.6, 4.8, 1H, 
cyclopropH). 
EA calc. for C11H14O: (162.10) 
 
 
 
trans-2-(4-hydroxyphenyl)-methylcyclopropane (72) 
 
O HO
71 72
NaSEt / DMF
 
 
To a solution of 52.5 mg of NaSEt (0.62 mmol, 2.5 equiv.) in 1.5 mL of freshly distilled 
dimethylformamide 40 mg of trans-1-methyl-2-(4-methoxyphenyl)-cyclopropane 71 (0.25 
mmol, 1 equiv.) dissolved in 1 mL of DMF was added. The mixture was heated at reflux 
(150°C) for 3 hours and then allowed to stand at room temperature for 12 hours. The yellow 
mixture was extracted with diethyl ether and the combined ethereal extract was washed with 
a 3M aqueous HCl solution, brine and dried over Na2SO4. Distillation of the solvent at reduce 
pressure gave 31.5 mg (85%) of crude 72. 
 
TLC (hexane/ACOEt  3:1): Rf = 0.1 
1H-NMR (400 MHz, CDCl3): 6.93-6.90 (m, 2H, arylH); 6.73-6.70 (m, 2H, arylH); 1.59 (br s, 
1H, OH); 1.53-1.48 (m, 1H, cyclopropH, p-(OH)PhCH); 1.16 (d, J =5.8, 3H, CH3); 1.00-0.92 
(m, 1H, cyclopropH); 0.80-0.76 (m, 1H, cyclopropH); 0.68-0.63 (m, 1H, cyclopropH). 
GC-MS : 148 (53, M+); 133(100); 105(33), 91(10). 
EA calc. for C10H12O : (148.09). 
 
 
 
 
Experimental Part 
    
 89
7. 2.2. Pivaloyl Porphyrins 
 
tert- Butyl- N-(3-methoxyphenyl)carbamate (26) 
 
NH2
OMe
Boc2O
NHBoc
OMe
25 26  
 
 
To a solution of 2.5 ml of m-anisidine 25 (1 equiv., 22.3 mmol) in 50 ml of THF was added 
7.8 g (1.6 equiv., 35.6 mmol) of di-tert butyl carbonate and the resulting solution was stirred 
overnight at room temperature. The solvent was removed by evaporation under reduced 
pressure and the obtained crude brown oil was distilled bulb-to-bulb (150° at 0.08 mbar) to 
yield 6.0 g (quant.) of the desired product 26 as yellowish oil. 
 
1H-NMR (400 MHz, CDCl3): 7.19 (t, J = 9.4, 1H, arylH-5); 7.10 (s, 1H, arylH-2); 7.09 (d, J = 
10.5, 1H, arylH-6); 6.65 (br, s, 1H, NH); 6.52 (d, J = 9.8, 1H, arylH-4); 3.80 (s, 3H, OCH3); 
1.53 (s, 9H, t-Bu). 
EI-MS (70eV): 223 (16, M+); 167 (83); 150 (17); 149 (27); 123 (54); 106 (8); 94 (13); 93 
(11); 59 (39); 57 (100); 41 (33).  
 
tert- Butyl- N-(2-formyl-3-methoxyphenyl)carbamate (27) 
 
 
 
 
4 g (1 equiv., 17.9 mmol) of tert-Butyl N-(3-methoxyphenyl)-carbamate 26 was dissolved in 
20 ml of dry Et2O and cooled to –30°C (dry ice/i-PrOH). To this solution 26.72 ml (2.2 equiv., 
39.4 mmol) of a 1.5M solution of t-BuLi (in hexane) was added dropwise and the temperature 
was kept below –15°C. When the addition was terminated the solution was stirred for 3.5 h at 
–10°C. Then the reaction mixture was cooled to –76°C and 2.86 ml (2 equiv., 37.1 mmol) of 
DMF in 5 ml of dry Et2O was added dropwise. Afterwards it was warmed to room temperature 
and stirring was continued overnight. The reaction was then quenched with brine and 
extracted three times with Et2O. The organic layers were separated, washed with water, dried 
over Na2SO4 and concentrated in vacuo. The viscous yellow oil was distilled bulb-to-bulb 
NH2
OMe
Boc2O
NHBoc
OMe
CHO
26 27
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(180°C, 0.1 mbar) which gave 4.0 g (88%) of the title compound 27 as light yellow oil which 
solidified on storing at 4°C. 
 
TLC (hexane/ethyl acetate 5:1): Rf = 0.41 
1H-NMR (300 MHz, CDCl3): 10.96 (br, s, 1H, NH); 10.45 (s, 1H, CHO); 8.10 (d, J = 10.1, 
1H, arylH-5); 7.40 (t, J = 9.8, 1H, arylH-4); 6.53 (d, J = 9.8, 1H, arylH-3); 3.90 (s, 3H, OCH3); 
1.45 (s, 9H, t-Bu). 
EI-MS (70eV): 251 (15, M+); 195 (24); 178 (29); 167 (16); 151 (47); 123 (15); 122 (43); 93 
(16); 57 (100); 41 (26). 
 
 
3,3‘-Dibutyl-4,4‘-dimethyl-2,2‘-dipyrrylmethane-5,5‘-dicarboxylic acid (29) 
NH HN
EtOOC COOEt
NaOH
NH HN
HOOC COOH
28 29  
 
In 155 mL of EtOH were suspended 10.0 g (1 equiv., 23.2 mmol) of diethyl 3,3‘-dibutyl-4,4‘-
dimethyl-2,2‘-dipyrrylmethane-5,5‘-dicarboxylate 28 and after heating a clear solution was 
obtained. Then 4.6 g (5 equiv., 116 mmol) of NaOH dissolved in 50 ml of water was added 
and the reaction mixture was stirred at reflux for 4 h. After cooling down unreacted starting 
material was removed from the mixture by two consecutive extractions with CH2Cl2. The 
aqueous phase was acidified with 1M HCl until pH ∼ 5. The acid 29 precipitated as 
colourless, soft solid which was take out from the aqueous phase performing for three times 
an extraction with Et2O. The organic layers were dried over Na2SO4 and concentrated in 
vacuo. In this way 8.5 g (97%) of crude acid 29 as a pale pink powder was obtained and was 
used without further purification in the following step.  
 
1H-NMR (400 MHz, CDCl3): 11.62 (br, s, 2H, COOH); 11.07 (br, s, 2H, NH); 3.77 (s, 2H, 
PyCH2Py); 2.27 (t, J = 7.1, 4H, PyCH2); 2.14 (s, 6H, PyCH3); 1.15-1.33 (m, 8H, PyCH2CH2 
and Py(CH2)2CH2); 0.88 (t, J = 7.1, Py(CH2)3CH3).  
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3,3’-Dibutyl-4,4’-dimethyl-2,2’-dipyrrylmethane (30) 
 
NH HN
HOOC COOH
H2N(CH2)2OH
NH HN
29 30  
A solution of 8 g (1 equiv., 21.3 mmol) of crude diacid 29 in 100 ml of freshly distilled 
ethanolamine was stirred in the dark at 120°C for 50 min. After CO2 formation was over the 
hot reaction mixture was poured into ice-water and the crude product precipitated 
immediately as pink solid. The crude product was extracted three times with Et2O, the 
organic layers were dried over Na2SO4 and all volatiles were removed under reduced 
pressure. The crude product was purified by column chromatography (silica gel, CH2Cl2, 
argon, in the dark) followed by recrystallisation from degassed hexane which yielded 3.87 g 
(63%) of dipyrrylmethane 30 as pale pink needles. This compound is extremely sensitive to 
light and air, especially if in solution, and should be used immediately for the next step. 
 
TLC (CH2Cl2): Rf = 0.78. 
1H-NMR (400 MHz, CDCl3): 7.38 (br, s, 2H, NH); 6.73 (s, 2H, pyrrylH-5, pyrrylH-5‘); 3.81 
(s, 2H, PyCH2Py); 2.41 (t, J = 7.1, 4H, PyCH2); 2.04 (s, 6H, PyCH3); 1.28-1.50 (m, 8H, 
PyCH2CH2 and Py(CH2)2CH2); 0.94 (t, J = 7.1, 6H, Py(CH2)3CH3). 
 
 
αα/αβ-10,20-Bis[6-(tert-butoxycarbonyl)-amino-2-methoxyphenyl]-3,7,13,17-tetrabutyl-
2,8,12,18-tetramethylporphyrin (αα/αβ-31) 
NH
N
HN
N
OMe
OMe
NH
HN
NH HN
30
NHBoc
OMe
CHO
27
+
αα/αβ-31
1.p-TsOH
2.DDQ
O
O
O O
 
 
In 300 ml of MeCN 3.5 g (13.9 mmol, 1 equiv.) of tert-butyl N-(2-formyl-3-methoxyphenyl) 
carbamate 27 was dissolved and the solution so obtained was degassed by bubbling with 
argon for 20 min. Then 4.0 g (13.9 mmol, 1 equiv.) of 3,3‘-dibutyl-4,4‘-dimethyl-2,2‘-
dipyrrylmethane 30 was added with a spatula in the dark under argon atmosphere. The 
reaction mixture was bubbled again with argon for another 20 min. Subsequently 264 mg (1.4 
mmol, 0.1 equiv.) of p-toluenesulfonic acid was added and the solution turned immediately 
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dark-brown. The reaction mixture was left stirring in the dark overnight at room temperature. 
In order to oxidize the formed greenish porphyrinogens, formed during the Mac Donald 
condensation, 6.31 g (27.8mmol, 2 equiv.) of DDQ dissolved in THF (0.4M) was added. The 
black mixture was stirred at room temperature and completion of the oxidation was followed 
with UV/Vis (in CH2Cl2 + 1% Et3N) by the disappearance of the porphyrinogen absorption at 
486 nm and the appearance of the porphyrin Soret absorption at 410 nm. After 1.5 h all the 
volatiles were removed in vacuo which gave 16 g of crude product which was dissolved in 
CH2Cl2 and filtered through aluminum oxide, using. Fractions were controlled by TLC (silica 
gel, hexane/ethyl acetate 2:1 + 1% Et3N) and MALDI-TOF-MS and those displaying mass 
peaks at m/z 1033 (M+), 933 ([M-Boc]+) and 833 ([M-2Boc]+) were combined. The 5.10 g of 
crude porphyrin mixture αα/αβ-31 obtained after removal of the solvent in vacuo was used 
without further purification for the next step. 
 
TLC (hexane/ EtOAc + 1% NEt3): Rf =0.59   Rf =0.64  
MALDI-TOF-MS :1033 (M+), 933 ([M-Boc]+) and 833 ([M-2Boc]+) 
 
 
αα/αβ-10,20-Bis(6-amino-2-methoxyphenyl)-3,7,13,17-tetrabutyl-2,8,12,18-tetramethyl-
porphyrin (αα/αβ-32) 
NH
N
HN
N
OMe
OMe
BocHN
BocHN
NH
N
HN
N
OMe
OMe
NH2
H2N
TFA
αα/αβ-31 αα/αβ-32  
To a solution of 2.0 g (1 equiv., 1.93 mmol) of the atropisomeric mixture αα/αβ-31 
dissolved in 180 ml of CH2Cl2 13 ml (82 equiv., 160 mmol) of trifluoroacetic acid in 30 ml of 
CH2Cl2 was added slowly by the use of dropping funnel at room temperature under vigouros 
stirring. The coulor of the solution turned from red-purple to greenish purple. This reaction 
mixture was then stirred for 6 h at room temperature and subsequently it was cooled in an ice 
bath and quenched with 180 ml of saturated aqueous NaHCO3. After phase separation the 
organic layer was washed again with 120 ml of saturated aqueous NaHCO3. The combined 
aqueous phases were extracted twice with CH2Cl2 until colourless. The combined organic 
phases were finally washed with water (180 ml) and brine (120 ml), dried over Na2SO4 and 
the volatiles were removed under reduced pressure. The crude product was purified by flash 
chromatography (silica gel, hexane/ethyl acetate 5:1 + 1% Et3N) which yielded 1.42 g (88%) 
of a 6:4-mixture of αα-32 and αβ-32, respectively (estimated from 1H-NMR) as purple, 
metallic solid. 
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TLC (hexane/ethyl acetate 3:1 + 1% Et3N): Rf = 0.40 Rf = 0.44. 
UV/Vis (CH2Cl2 + 1% Et3N): 410 (100, Soret); 508 (12); 576 (9); 583 (5). 
1H-NMR (400 MHz, CDCl3): 10.16 (s, 2H, meso-H); 7.55 (t, J = 8.2, 2H, arylH-4‘); 6.76 (m, 
4H, arylH-3‘, arylH-5‘); 4.00 (m, 8H, PyCH2); 3.63 (s, 6H, αα-OCH3); 3.55 (s, 6H, αβ-OCH3); 
3.36 (br, s, 2H, αβ-NH2); 3.23 (br, s, 2H, αα-NH2); 2.74 (s, 12H, PyCH3); 2.17 (m, 8H, 
PyCH2CH2); 1.75 (m, 8H, Py(CH2)2CH2); 1.09 (t, J = 7.3, 12H, Py(CH2)3CH3); -2.32 (br, s, 2H, 
NH pyrrole). 
MALDI-TOF-MS: 834 (100, [M+1]+). 
 
αα-10,20-Bis(6-pivaloylamino-2-methoxyphenyl)-3,7,13,17-tetrabutyl-2,8,12,18-tetra-
methylporphyrin(αα-33) and αβ-10,20-Bis(2-pivaloylamino-6-methoxyphenyl)-3,7,13,17-
tetrabutyl-2,8,12,18-tetramethylporphyrin(αβ-33) 
NH
N
HN
N
OMe
OMe
NH2
H2N
NH
N
HN
N
OMe
OMe
NH
HN
TFA
αα/αβ-32 αα/αβ-33
αα:ββ = 6:4
O
O
 
1.65 g (1 equiv., 1.98 mmol) of the atropisomeric mixture of porphyrin αα/αβ-32 was 
dissolved in 130 ml of dry CH2Cl2 and then 0.35 ml (3.3 equiv., 6.68 mmol) of dry pyridine 
and 52 mg (0.2 equiv., 0.42 mmol) of DMAP were added. At this point the drop wise addition 
of 1.46 ml (6 equiv., 11.88 mmol) of PivCl mixed with 60 ml of dry CH2Cl2 was performed 
within 30 min at room temperature. The reaction mixture was stirred at room temperature for 
18 h and quenched with ice. Subsequently, at the temperature of an ice bath, 130 ml of 
saturated aqueous NaHCO3 (till pH ~8) were poured into the reaction mixture. The layers 
were separated and the aqueous phase was extracted two times with 60 ml of CH2Cl2. The 
combined organic layers were washed with water (160 ml) and brine (120 ml), dried over 
Na2SO4 and the solvents were removed under reduced pressure. Purification of the crude 
product and separation of the two atropisomers was accomplished by repetitive flash 
chromatography (silica gel, hexane/ethyl acetate 4:1 + 1% Et3N). 872.4 g (44%) of αα-33 and 
575.0 mg (29%) of αβ-33 as purple solids were obtained 
 
Physical data of αα-33: 
TLC (hexane/ethyl acetate/ 5:1 + 01% Et3N): Rf = 0.16. 
UV/Vis (CH2Cl2 + 1% Et3N): 412 (100, Soret); 510(6); 539 (8); 577 (5) 
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1H-NMR (400 MHz, CDCl3): 10.18 (s, 2H, meso-H); 8.45 (d, J = 8.3, 2H, arylH-5‘); 7.78 (t, 
J = 8.5, 2H, arylH-4‘); 7.09 (d, J = 8.3, 2H, arylH-3‘); 7.05 (br, s, 2H ,NHPiv); 3.90 (m, 8H, 
PyCH2); 3.55 (s, 6H, OCH3); 2.59 (s, 12H, PyCH3); 2.20 (m, 8H, PyCH2CH2); 1.74 (m, 8H, 
Py(CH2)2CH2); 1.09 (t, J = 7.3, 12H, Py(CH2)3CH3); -0.05 (s, 18H, COC(CH3)3); -2.19 (br, s, 
2H, NHpyrrole). 
MALDI-TOF-MS: 1002 (100, [M+1]+); 916 (5, [M-Piv]+). 
RP-HPLC (90-100% MeOH/H2O in 30 min, then 100% MeOH for 10 min, flow 1.5 ml/min, 
λdet = 412 nm, T = 40°): Rt = 19.8 min. 
 
Physical data of αβ-33: 
TLC (hexane/ethyl acetate 5:1 + 1% Et3N): Rf = 0.23. 
UV/Vis (CH2Cl2 + 1% Et3N): 412 (100, Soret); 510(5); 539 (8); 579 (3) 
1H-NMR (400 MHz, CDCl3): 10.21 (s, 2H, meso-H); 8.46 (d, J = 8.6, 2H, arylH-5‘); 7.79 (t, 
J = 8.5, 2H, arylH-4‘); 7.13 (d, J = 8.3, 2H, arylH-3‘); 6.99 (br, s, 2H, NHPiv); 3.91 (m, 8H, 
PyCH2); 3.64 (s, 6H, OCH3); 2.59 (s, 12H, PyCH3); 2.15 (m, 8H, PyCH2CH2); 1.71 (m, 8H, 
Py(CH2)2CH2); 1.07 (t, J = 7.4, 12H, Py(CH2)3CH3); -0.11(s, 18H, COC(CH3)3); -2.21 (br, s, 
2H, NHpyrrole). 
MALDI-TOF-MS: 1002 (100, [M+1]+); 916 (5, [M-Piv]+). 
RP-HPLC (90-100% MeOH/H2O in 30 min, then 100% MeOH for 10 min, flow 1.5 ml/min, 
λdet = 412 nm, T = 40°): Rt = 24.0 min. 
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αα-10,20-Bis(6-pivaloylamino-2-hydroxyphenyl)-3,7,13,17-tetrabutyl-2,8,12,18-tetra-
methylporphyrin (αα-34) 
AlCl3
EtSH/ CH2Cl2NH
N
HN
N
OMe
OMe
NH
HN
αα-33
O
O
NH
N
HN
N
OH
OH
NH
HN
αα-34
O
O
 
 
To a solution of 513.5 mg (1 equiv., 0.51 mmol) of αα-33 in 70 ml of dry CH2Cl2, 100 ml of 
ethanethiol was added. 2.6 g (38 equiv., 19.45 mmol) of dry AlCl3 was then added in portion. 
The solution turned grass-green and it was stirred at room temperature for 48 h. The course 
of the reaction was followed by taking aliquots from the reaction mixture that were analyzed 
after a mini-work up by MALDI TOF MS (1002 ([M+H]+, educt); 988 ([M+H-CH3+H]+); 974 
([M+H-2CH3+2H]+). The reaction was stopped by cooling the mixture in an ice bath and 
adding first some pieces of ice to destroy unreacted AlCl3 and finally 100 ml of saturated 
aqueous NaHCO3. The two organic phases were then separated and washed with two 
portions of 80 ml of saturated aqueous NaHCO3, while the aqueous phases were extracted 
twice with CH2Cl2 (2×200 ml). Finally the combined organic phases were washed with water 
(200 ml) and brine (150 ml), dried over Na2SO4 followed by removal of volatiles in vacuo. The 
crude purple solid was purified by flash chromatography (silica gel, hexane/ethyl acetate 4:2 
+ 1% Et3N) which yielded 471 mg (95%) of pure purple solid αα-34.  
 
TLC (hexane/ethyl acetate 3:1 + 1% Et3N): Rf = 0.25. 
UV/Vis (CH2Cl2 + 1% Et3N): 408 (100, Soret); 510(7); 542(10); 577 (3) 
1H-NMR (400 MHz, CDCl3): 10.30 (s, 2H, meso-H); 8.43 (d, J = 8.1, 2H, arylH-5‘); 7.74 (t, 
J = 8.3, 2H, arylH-4‘); 7.17 (s, 2H, NHPiv); 7.12 (dd, J = 8.3, J = 0.8, 2H, arylH-3‘); 3.99 (m, 
8H, PyCH2); 2.69 (s, 12H, PyCH3); 2.20 (m, 8H, PyCH2CH2); 1.76 (m, 8H, Py(CH2)2CH2); 
1.12 (t, J = 7.5, 12H, Py(CH2)3CH3);0.12 (s, 18H, COC(CH3)3); -2.31 (br, s, 2H, NHpyrrole). 
MALDI-TOF-MS: 974 (100, [M+1]+); 996 (15, [M+Na]+). 
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10,20-[Di-(6-pivaloylamino)-undecamethylenedioxydi-2,1-phenylene]-3,7,13,17-
tetrabutyl-2,8,12,18-tetramethylporphyrin (35) 
NH
N
HN
N
O
O
NH
HN
O
O
α β γ
δ
ε
ζ
NH
N
HN
N
OH
OH
NH
HN
O
O
αα-34 αα-35
Br(CH2)11Br
DMF, 60°
 
A solution of 8.0 mg (1 equiv., 8.2 µmol) of bisphenol porphyrin αα-33 in 5 ml of dry DMF 
and 85.5 mg (32 equiv., 262.4 µmol) of Cs2CO3 (previously dried overnight at 100°C in high-
vacuum) was added. This suspension was heated to 60°C and stirred for 30 min. Then a 
solution of 3.1 µl (1.5 equiv., 12.3 µmol) of 1, 11 -dibromoundecane in 1 ml of dry DMF was 
added via syringe pump within 3 h at 60°C. Stirring was continued at 60°C for 1 h after which 
the reaction mixture was poured into a ice-cooled mixture of 2 ml of 1M HCl and 5 ml of 
CH2Cl2. The aqueous phase was separated from the organic layer and then extracted twice 
with CH2Cl2 (2X 5 ml). The combined organic phases were washed with saturated aqueous 
NaHCO3 (2×15 ml), water (10 ml) and brine (10 ml), dried over Na2SO4 and all volatiles were 
removed under reduced pressure. Purification by flash chromatography (silica gel, 
hexane/ethyl acetate 2:1 + 1% Et3N) yielded 9.6 mg (70%) of the “bridged” porphyrin αα-35 
as purple solid. 
TLC (hexane/ethyl acetate 1:1 + 1% Et3N): Rf = 0.53. 
UV/Vis (CH2Cl2 + 1% Et3N): 412 (100, Soret); 510(7); 542(10); 577 (3). 
1H-NMR (400 MHz, CDCl3): 10.18 (s, 2H, meso-H); 8.51 (d, J = 8.3, 2H, arylH-5‘); 7.75 (t, 
J = 8.3, 2H, arylH-4‘); 7.65 (s, 2H, NHPiv); 7.03 (dd, J = 8.3, J = 0.8, 2H, arylH-3‘);3.90 (m, 
8H, PyCH2); 3.79 (m, 4H, α-CH2); 2.61 (s, 12H, PyCH3); 2.23 (m, 8H, PyCH2CH2); 1.79 (m, 
8H, Py(CH2)2CH2); 1.13 (t, J = 7.3, 12H, Py(CH2)3CH3); 0.68 (m, 4H, β-CH2); 0.23 (s, 18H, 
COC(CH3)3);  -0.25 (m, 4H, γ-CH2); -0.52 (m, 4H, δ-CH2); -1.40 (br, s, 6H, ε-CH2, ζ-CH2); -
2.20br, s, 2H, NHpyrrole). 
ESI-MS (MeOH): Positive ion mode: 1126.2 (100, [M+H]+); 1148 (30, [M+Na]+). 
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S-[4-(tert-Butyl)-2,6-bis(3-hydroxypropyl)-1-phenyl]N,N-dimethylthiocarbamate (41) 
 
S
OHHO
O
N
S O
N
40 41
1.BH3M2S
2.NaOH/ H2O2
 
A solution of 4.0 g (1 equiv., 12.6 mmol) of S-[2,6-Diallyl-4-(tert-butyl)-1-phenyl] N,N-
dimethylthiocarbamate (40) in 100 ml of dry THF was cooled to 5°C (ice bath) and then 4.5 
ml (3.6 equiv., 45.3 mmol) of BH3•SMe2 was added dropwise via syringe within 5 min. The 
solution was then stirred at room temperature for three hours. After one hour the reaction 
became cloudy and the addition of 20 mL more of THF was necessary. The reaction mixture 
was cooled in an ice bath and 13 ml of 3M NaOH was added drop by drop carefully followed 
by 13 ml of 10% aqueous H2O2. The reaction mixture so obtained was then refluxed for 1 h 
and subsequently cooled to room temperature and poured onto ice-water 1:1. The resulting 
biphasic mixture was extracted with three portions of 330 ml of CH2Cl2, the combined organic 
phases were washed with water (250 ml) and brine (200 ml), dried over Na2SO4 and 
concentrated in vacuo. The obtained pale yellow oil was purified by flash chromatography 
(silica gel, CH2Cl2/MeOH 95:5) and gave 3.47 g (78%) of pure 41as colourless oil.  
 
TLC (CH2Cl2/MeOH 95:5): Rf   = 0.25. 
1H-NMR (400 MHz, CDCl3): 7.19 (s, 2H, arylH-3, arylH-5); 3.64 (t, J = 6.2, 4H, CH2OH); 
3.16, 3.01 (br, s, 6H, NCH3); 2.88 (t, J = 7.6, 4H, CH2(CH2)2OH); 1.88 (m, 4H, 
CH2CH2CH2OH); 1.79 (s, 2H, OH); 1.30 (s, 9H, t-Bu). 
 
S-[4-(tert-Butyl)-2,6-bis(3-methanesulfonylpropyl)-1-phenyl]-N,N-dimethylthiocarba-
mate (42) 
S
OHHO
O
N
S
OMsMsO
O
N
41 42
1.NEt3
2.MsCl
 
To a solution of 1.0 g (1 equiv, 2.82 mmol) of diol 41 in 100 ml of dry CH2Cl2 3.25 ml (8 
equiv., 22.5 mmol) of Et3N was added. This solution was cooled to 0°C (ice bath) and then a 
solution of 1.95 ml (4.7 equiv., 13.5 mmol) of methanesulfonyl chloride in 63 ml of dry CH2Cl2 
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was added dropwise within 1 h, keeping the temperature constantly around 0°. The reaction 
mixture became torpid due to the formation of Et3N•HCl. Subsequently the stirring of the 
reaction mixture was continued for 2h at room temperature. The reaction mixture was cooled 
in an ice bath and quenched with 60 ml of 1M HCl. The layers were separated and the 
aqueous phase was extracted with two portions of 100 ml of CH2Cl2. The organic phases 
were washed with saturated aqueous NaHCO3 (200 ml), water (100 ml) and brine (60 ml), 
dried over Na2SO4 and the solvent was removed in vacuo. The crude was then purified by 
flash chromatography (silica gel, hexane/ethyl acetate 1:2) and 1.34 g (95%) of titled 
compound was obtained. The product 42 was a viscous oil that solidified on storing at 4°C. 
 
TLC (CH2Cl2/MeOH 95:5): Rf = 0.70. 
1H-NMR (400 MHz, CDCl3): 7.19 (s, 2H, arylH-3, arylH-5); 4.24 (t, J = 6.4, 4H, CH2OMs); 
3.18, 3.01 (br, s, 6H, NCH3); 3.00 (s, 6H, CH3SO3); 2.90 (t, J = 7.7, 4H, CH2(CH2)2OMs); 2.05 
(m, 4H, CH2CH2CH2OMs); 1.31 (s, 9H, t-Bu). 
 
 
10,20-{{[4-(tert-Butyl)-2-(N,N-dimethylcarbamoyl)thio-1,3-phenylene]bis(trimethylene-
oxy)}-di-(6-pivaloylamino)-di-2,1-phenylene}-3,7,13,17-tetrabutyl-2,8,12,18-tetramethyl-
porphyrin (36) 
NH
N
HN
N
OH
OH
NH
HN
O
O
αα-34
Cs2CO3/ DMF
S
OMsMsO
O
N
42
+
NH
N
HN
N
O
O
S
NH
HN
O
O
O
N
36  
To a solution of 200 mg (1 equiv., 205 µmol) of bisphenol porphyrin αα-34 in 90 ml of dry 
DMF was added 2.0 g (30 equiv., 6.15 mmol) of Cs2CO3 which was previously dried at 100°C 
in high-vacuum overnight. The resulting suspension was heated to 60°C and stirred for 30 
min. Then a previously prepared solution of 156 mg (1.5 equiv., 307 µmol) of dimesylate 42 
in 30 ml of dry DMF was added via syringe pump within 4 h at 60°C. Stirring was continued 
for 40 min at 60°C.The reaction mixture was then cooled with an ice bath and the reaction 
was quenched with 60 ml of 1M HCl. The two layer were then separated the aqueous phase 
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was extracted with two portions of 100 ml of CH2Cl2. The combined organic layers were 
washed with twice with 200 ml of saturated aqueous NaHCO3, water (170 ml) and brine 
(100ml), dried over Na2SO4 and concentrated in vacuo. The DMF was removed at 60°C 
under reduced pressure. The crude product was purified by flash chromatography (silica gel, 
hexane/ethyl acetate 2:1 + 0.5% Et3N) which gave 210 mg (79%) of the bridged porphyrin as 
purple solid.  
 
TLC (hexane/ethyl acetate 2:1 + 0.5% Et3N): Rf = 0.42 
UV/Vis (CH2Cl2 + 1% Et3N): 413(100, Soret); 510 (9); 579 (3); 658 (2). 
1H-NMR (400 MHz, CDCl3): 10.10 (s, 1H, meso-H); 9.71 (s, 1H, meso-H); 8.60 (d, J = 8.3, 
2H, arylH-5‘); 8.41 (s, 2H, NHPiv); 7.77 (t, J = 8.3, 2H, arylH-4‘); 6.94(d, J = 8.3, 2H, arylH-
3‘); 6.36 (s, 2H, arylH-3‘‘, arylH-5‘‘); 4.06 (m, 2H, PyCH2); 3.93 (m, 2H, PyCH2); 3.84 (m, 4H, 
PyCH2 and α-CH2); 3.58 (m, 4H, PyCH2 and α-CH2); 2.71 (s, 6H, PyCH3); 2.54 (s, 6H, 
PyCH3); 2.23(m, 4H, PyCH2CH2); 1.98 (m, 2H, PyCH2CH2); 1.76 (m, 2H, PyCH2CH2); 1.79 
(m, 4H, Py(CH2)2CH2); 1.53(br, s, NCH3); 1.71 (m, 4H, Py(CH2)2CH2); 1.54 (s, 6H, COCH3); 
1.13 (t, J = 7.3, 6H, Py(CH2)3CH3); 1.10 (t, J = 7.3, 6H, , Py(CH2)3CH3); 1.07(s, 9H, t-Bu); 
0.65 (m, 6H, β-CH2 and γ-CH2);0.50 (s, 18H, COC(CH3)3); 0.05 (m, 2H, γ-CH2); -1.10(br, s, 
3H, NCH3); -2.06 (br, s, 2H, NHpyrrole).  
MALDI-TOF-MS: 1219 (20, [M-CONMe2]+); 1291(100, [M+1]+), 1348 (10, [M+Cs]+); 
RP-HPLC (90-100% MeOH/H2O in 10 min, then 100% MeOH for 20 min, flow 1.5 ml/min, 
λdet = 413 nm, T = 40°): Rt = 15.8 min. 
 
 
10,20-{{[4-(tert-Butyl)-2-mercapto-1,3-phenylene]bis(trimethylene-oxy)}-di-(6 
pivaloylamino)-di-2,1-phenylene}-3,7,13,17-tetrabutyl-2,8,12,18-tetramethyl-porphyrin 
(37) 
NH
N
HN
N
O
O
S
NH
HN
O
O
O
N
36
NH
N
HN
N
O
O
SH
NH
HN
O
O
37
KOMe in MeOH
 
In an oxygen-free atmosphere a solution of 132 mg (1 equiv., 102.2 µmol) of porphyrin 36 
in 80 ml of dry and degassed dioxane was heated to 80°C. To this hot solution was added 
460 µl (10 equiv., 1.02 mmol) of freshly prepared and degassed KOMe solution (2.18M in 
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MeOH) and the resulting grass-green solution was heated at reflux for 10 min.   [This solution 
was prepared following a procedure described in M. Lochner Dissertation Basel 2003]. The 
reaction mixture was cooled in an ice bath and the reaction was quenched with 50 ml of 
saturated aqueous NH4Cl. [All of the used solvents and solutions for the aqueous work up 
were quickly degassed by bubbling with argon for 15-20 min to use]. 20 ml of CH2Cl2 were 
then added, the two layers were separated and the aqueous phase was extracted with two 
portions of 2 ml of CH2Cl2 (40 X2 ml). The combined organic layers were washed with water 
(40 ml), dried over Na2SO4 and concentrated in vacuo. The obtained crude residue was 
purified by flash chromatography (silica gel, hexane/AcOEt 2:1 + 1% Et3N, under argon, 
solvents were quickly degassed by bubbling with argon for 5-10 min prior to use) which 
yielded 81 mg (65%) of pure thiophenyl porphyrin.  
 
TLC (hexane/ AcOEt 3:1 + 0.05% Et3N): Rf = 0.31. 
UV/Vis (CH2Cl2 + 1% Et3N): 413 (100, Soret); 510 (9); 542 (4); 578 (5); 630 (2); 658 (1). 
1H-NMR (400 MHz, CDCl3): 10.11(s, 2H, meso-H); 8.61 (d, J = 8.0, 2H, arylH-5‘); 8.43 (s, 
2H, NHPiv); 7.76 (t, J = 8.4, 2H, arylH-4‘); 6.92 (d, J = 7.5, 2H, arylH-3‘); 6.17 (s, 2H, arylH-
3‘‘, arylH-5‘‘); 4.02 (m, 4H, PyCH2); 3.88 (m, 4H, PyCH2); 3.61 (m, 4H, α-CH2);2.61 (s, 12H, 
PyCH3); 2.10 (m, 8H, PyCH2CH2); 1.66 (m, 8H, Py(CH2)2CH2);1.02 (t, J = 7.3, 12H, 
Py(CH2)3CH3); 0.85(s, 9H, t-Bu); 0.65 (m, 4H, β-CH2, γ-CH2); 0.53 (s, 18H, COC(CH3)3); 0.46 
(m, 4H, β-CH2, γ-CH2); -2.12(s, 2H, NHpyrrole); -3.01 (s, 1H, SH).  
MALDI-TOF-MS: 1220 (100, [M+1]+). 
ESI-MS (MeOH): Positive ion mode: 1219.7 (100, [M+H]+); 1241 (30, [M+Na]+); 1257 (17, 
[M+K]+). Negative ion mode: 1218 (100, M−). 
RP-HPLC (90-100% MeOH/H2O in 10 min, then 100% MeOH for 20 min, flow 1.5 ml/min, 
λdet = 413 nm, T = 40°): Rt = 23.9 min. 
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10,20-{{[4-(tert-Butyl)-2-sulfonate-1,3-phenylene]bis(trimethylene-oxy)}-di-(6-
pivaloylamino)-di-2,1-phenylene}-3,7,13,17-tetrabutyl-2,8,12,18-tetramethyl-porphyrin 
(37-SO3) 
NH
N
HN
N
O
O
S
NH
HN
O
O
O
N
36
KOMe in MeOH
under O2 NH
N
HN
N
O
O
SO3
NH
HN
O
O
H
37-SO3  
In an oxygen-enriched atmosphere a solution of 20 mg (1 equiv., 16.4 µmol) of porphyrin 
36 in 10 ml of dry dioxane [previously enriched in O2 by oxygen-bubbling] was heated to 80°. 
To this hot solution 57.5 mg (50 equiv., 0.82 mmol) of solid dry KOMe was added and the 
resulting grass-green solution was heated at reflux for 24 h. The completion of the 
deprotection and subsequent thiolate oxidation were followed by TLC and ESI-MS. [The 
oxidation reaction did not reach more than 40% of conversion of the thiolate into the 
sulfonate].The reaction mixture was cooled in an ice bath and the reaction was quenched 
with 10 ml of saturated aqueous NH4Cl. 20 ml of CH2Cl2 were then added, the two layers 
were separated and the aqueous phase was extracted with two portions of 2 ml of CH2Cl2 
(10 X2 ml). The combined organic layers were washed with water (10 ml), dried over Na2SO4 
and concentrated in vacuo. The obtained crude residue was purified by flash 
chromatography (silica gel, hexane/AcOEt 3:1) which yielded 7.28 mg (35%) of pure 37-SO3. 
 
TLC (Hexane/AcOEt 5:1): Rf = 0.25 
UV/Vis (CH2Cl2): 418 (100, Soret); 510 (12); 540 (3); 643 (2). 
1H-NMR (500 MHz, CDCl3): 10.34 (s, 2H, meso-H); 8.59 (d, J = 8.2, 2H, arylH-5‘); 8.12 (s, 
1H, NHPiv);  7.81 (t, J = 8.4, 2H, arylH-4‘); 7.05 (d, J = 8.1 2H, arylH-3‘); 6.06 (s, 2H, 
arylH-3‘‘, arylH-5‘‘); 4.07 (m, 4H, PyCH2); 3.83 (m, 4H, PyCH2); 3.56(m, 4H, α-CH2); 2.64 (s, 
12H, PyCH3); 2.50 (m, 8H, PyCH2CH2); 1.65 (m, 8H, Py(CH2)2CH2); 1.04 (t, J = 7.4, 12H, 
Py(CH2)3CH3); 0.82 (s, 9H, t-Bu); 0.65 (m, 4H, β-CH2); 0.57 (m, 4H, γ-CH2);;0.52 (s, 18H, 
COC(CH3)3). 
MALDI-TOF-MS: 1268(100, [M+1]+); 1290 (10, [M+1+Na]+); 
ESI-MS (MeOH): Positive ion mode: 1267 (1100, M+); 1286(60, [M+Na]+). Negative ion 
mode: 1266 (100, M−). 
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RP-HPLC (90-100% MeOH/H2O in 10 min, then 100% MeOH for 20 min, flow 1.5 ml/min, 
λdet = 414 nm, T = 40°): Rt = 9.1 min. 
 
10,20-{{[4-(tert-Butyl)-2-mercapto-1,3-phenylene]bis(trimethylene-oxy)}-di-(6-
pivaloylamino)-di-2,1-phenylene}-3,7,13,17-tetrabutyl-2,8,12,18-tetramethyl-
porphyrinato iron(III) (38) 
NH
N
HN
N
O
O
SH
NH
HN
O
O
37
FeIII
N
N
N
N
O
O
NH
HN
S
O
O
-
FeBr2, 2,6-lutidine
toluene
38  
Inside the glove box, to a solution of 20.8 mg (1 equiv., 17.13 µmol) of thiophenol porphyrin 
37 in 14 ml of dry and degassed toluene was added 100 µl (50 equiv., 856.5 µmol) of dry and 
degassed 2,6-lutidine. Subsequently the resulting solution was heated to reflux for 5 min. 
Then a suspension of 53.0 mg (20 equiv., 247 µmol) of FeBr2 in 4 ml of dry and degassed 
toluene was added. The resulting brown reaction mixture was stirred at reflux for 30 min, 
cooled to room temperature and filtered through a small pad of celite. [The completion of the 
iron insertion was checked by TLC (silica gel, hexane/ AcOEt 5:1) directly inside the glove 
box. The residue on the pad was washed with toluene portions until the filtrate was 
colourless. The combined brown filtrates were evaporated under reduced pressure and the 
crude iron porphyrin was purified by column chromatography (silica gel, hexane/ AcOEt 5:1) 
which yielded 20.7mg (95%) of iron porphyrin 38 as brown solid. 
 
TLC (hexane/AcOEt 5:1): Rf =0.28. 
UV/Vis (toluene): 404 (100, Soret); 488 (12); 510 (25); 583 (5); 658 (3); 767 (2). 
MALDI-TOF-MS: 1272 (100, [M+]). 
ESI-MS (MeOH): Positive ion mode: 1272 (30, [M+H]+); 1295 (100, [M+Na]+); 1310 (20, 
[M+K]+). Negative ion mode: 1271 (100, M−); 1303 (15, [M+CH3O-]).. 
cw-EPR (toluene, 100 K): 8.53, 5.43, 3.34, 2.67 (rhombic, high-spin). 
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10,20-{{[4-(tert-Butyl)-2-sulfonate-1,3-phenylene]bis(trimethylene-oxy)}-di-(6-
pivaloylamino)-di-2,1-phenylene}-3,7,13,17-tetrabutyl-2,8,12,18-tetramethyl-
porphyrinato iron(III) (39) 
NH
N
HN
N
O
O
SO3
-
NH
HN
O
O
FeIII
N
N
N
N
O
O
NH
HN
SO3
-
O
O
FeBr2, 2,6-lutidine
toluene
3937-SO3  
To a solution of 15 mg (1 equiv., 11.8 µmol) of sulfonate porphyrin 37-SO3 in 10 ml of dry 
toluene was added 68 µl (50 equiv., 590 µmol) of dry 2,6-lutidine. Subsequently the resulting 
solution was heated to reflux for 5 min. Then a suspension of 50.6 mg (20 equiv., 236 µmol) 
of FeBr2 in 4 ml of dry toluene was added. The resulting brown reaction mixture was stirred 
at reflux for 30 min, cooled to room temperature and filtered through a small pad of celite. 
[The completion of the iron insertion was checked by TLC (silica gel, hexane/ AcOEt 5:1) 
directly inside the glove box. The residue on the pad was washed with toluene portions until 
the filtrate was colourless. The combined brown filtrates were evaporated under reduced 
pressure and the crude iron porphyrin was purified by column chromatography (silica gel, 
hexane/ AcOEt 5:1) which yielded 14.0 mg (90%) of iron porphyrin 38 as brown solid 
TLC (hexane/AcOEt 4:1): Rf =0.32. 
UV/Vis (toluene): 389-416 (100, Soret); 483 (9); 510 (25); 587 (2); 670 (2). 
MALDI-TOF-MS: 1321 (100, [M+1]+). 
ESI-MS (MeOH): Positive ion mode: 1321 (20, [M+H]+); 1343 (100, [M+Na]+). Negative ion 
mode: 1319 (100, M−); 1350 (15, [M+CH3O-]). 
cw-EPR (toluene, 102 K): g⊥ = 5.57, gII = 2.10 (axial, high-spin). 
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7.2.3. Dichloroporphyrin  
 
2, 2'-[(2,6-dichlorophenyl)methylene]bis-1H-pyrrole (49) 
H
N
CHO
ClCl
ClCl
HNNH
+ TFA, dark
48 47
49
1'
2'
3'
4'
6'
5'
2
3
4578
9
10
 
In the dark, under argon atmosphere, at -15°C, 5 g of 2, 6-dichloro-benzaldehyde (1 equiv, 
28.57 mmol) was dissolved in 158 mL of pyrrol (80 equiv., 2.28 mol). The solution was then 
bubbled with argon for 20 minutes and finally 88 µL of TFA (0.08 equiv., 2.28 mmol) was 
added. After 5 minutes the reaction was quenched with aqueous saturated NaHCO3 (250 
mL) and extracted twice with ethyl acetate (2 X 200mL). The combined organic phase was 
washed with water (2 X 100 mL) and dried over Na2SO4 (always under argon atmosphere). 
The crude product (mixture of six different compounds) was purified by flash chromatography 
(silica gel, hexane/ethyl acetate 3:1). The collected fractions of the desired compound were 
then concentrated in vacuum and subjected to a crystallization process using hexane/ ethyl 
acetate and dried at the high vacuum pump for 24 hours. 8.32 g (26%) of white solid was 
obtained. This compound should be used immediately for the following step or stored at -
20°C, under argon and in the dark just for few days. 
TLC (hexane/ AcOEt 3:1): Rf = 0.50. 
mp : 102-103 °C 
1H-NMR (400 MHz, CDCl3) : 8.28 (br s, 2H, NH); 7.33 (d, J = 8 Hz, 2H, H-3’, H-5’); 7.13 (t, 
J = 8 Hz, 1H, H-4’); 6.73-6.71 (m, 2 H, H-2, H-10);  6.48 (s, 1H, H-6); 6.19 (q, J = 2.8 , 2H, H-
3, H-9); 6.06 (m, 2H, H-4, H-8). 
13C-NMR (100 MHz, CDCl3): 137.1(2C, C-2’,C-6’); 135.8 (1C, C-1’); 129.75 (1C, C-4’); 
129.02 ( 2C,C-3’, C-5’); 128.5 (2C, C-5, C-7); 117.3 (2C, C-2, C-10); 109.07 (2C, C-4, C-8); 
107.8 (2C, C-3, C-9); 40.4 (1C, C-6). 
EI-MS (70eV) : 290 (68, M+); 188 (29) ;145 (100). 
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5,15-bis(2,6-dichlorophenyl)-10,20-bis(2-methoxyphenyl)-porphyrin (51) 
 
HN
N
N
HN
MeO
MeO
Cl
Cl
Cl
Cl
MeO
OHC 1. TFA
2. DDQ
4649 51
ClCl
NH HN
 
 
1.2 g of 2,2' -[(2,6-dichlorophenyl)methylene]bis-1H-pyrrole   49 (1 equiv, 4.12 mmol) and 
561mg of 2-methoxy-benzaldehyde 46 (1 equiv., 4.12 mmol)were dissolved in 415 ml of 
dichloromethane and bubbled with a light flow of argon for 15 minutes in the dark. Afterwards 
561 mL of TFA (1.8 equiv., 7.42 mmol,) were added and the reaction mixture was stirred for 
15 hours at room temperature in light exclusion. For the subsequent oxidation of the formed 
porphyrinogens 1.87 g of 1, 2-dichloro-4, 5-dicyano-p-benzoquinone (DDQ) (2 equiv., 8.24 
mmol) was added and the solution was refluxed for 1 hour. As for the synthesis of the other 
porphyrin the completion of the oxidation was followed by the disappearance of the 
porphyrogen absorption at 485 nm and the appearance of the porphyrin Soret absorption at 
418 nm. All the volatiles were removed in vacuum, after a previous addition of 4.15 mL of 
triethylamine (1% in volume) to the cooled reaction mixture. The residue was re-dissolved in 
CH2CI2 + 1%NEt3, filtrated trough a silica gel pad and finally purified by flash chromatography 
(silica gel,). 784 mg (23%) of purple porphyrin 51 (mixture of two atropisomers) were 
obtained.   
 
TLC (CH2Cl2/ hexane 3:1): Rf = 0.35, Rf = 0.40 
UV/Vis (CH2Cl2 + 1% Et3N): 418 (100, Soret); 512 (8); 548(3); 637 (1). 
1H-NMR (400 MHz, CDCl3): 8.78 (d, J = 4.8, 4H, H-2, H-8, H-12, H-18); 8.61 (d, J = 4.8, 
4H, H-3, H-7, H-13, H-17); 8.02-7.99 (m, 2H, H-6’); 7.79-7.77(m, 4H, H-c,H-e); 7.76-7.73 (m, 
2H, H-4’); 7.71-7.66 (m, 2H, H-d); 7.35-7.33 (m, 2H, H-5’); 7.32-7.30 (m, 2H, H-3’);3.60 (s, 
6H, OCH3); -2.56 (br s, 2H, NH). 
ESI-MS (MeOH): Positive ion mode: 811.0(100, [M+H]+); 945 (56); 1097 (40). Negative 
ion mode: 809.3 (100, [M-H]−).  
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5,15-bis(2,6-dichlorophenyl)-10,20-bis (2-hydroxyphenyl)-porphyrin (52) 
 
HN
N
N
HN
MeO
MeO
Cl
Cl
Cl
Cl
HN
N
N
HN
HO
HO
Cl
Cl
Cl
ClBBr3, CH2Cl2
51 52  
100 mg of porphyrin 51 (123 µmol, 1 equiv.) were dissolved in 40 mL of CH2Cl2 (~ 3.1 M) and 
the solution was cooled down to -78°C (dry ice and acetone).Then 380 µL of BBr3 (3.94 
mmol, 32 equiv.) were added slowly via syringe and the reaction mixture was stirred for 12 
hours at room temperature. The completion of the double demethylation reaction was 
controlled by ESI-MS. The reaction was quenched with 30 mL of aqueous saturated NaHCO3 
and the organic layer was washed with water (2 X 20 mL). The combined organic phases 
were then dried over Na2SO4 and concentrated under reduced pressure. The residue was 
then re-dissolved in CH2Cl2 and filtered trough a silica gel pad. The purification at this stage 
was quite complex and so the 93.6 mg (97%) of crude 52 was just filtered (silica gel, CH2Cl2) 
and used for the following step without further purification.   
  
TLC (CH2Cl2): Rf = 0.13 Rf = 0.65 
UV/Vis (CH2Cl2 + 1% Et3N): 418 (100, Soret); 512 (7). 
1H-NMR (400 MHz, CDCl3):  8.88 (d, J = 4.8, 4H, H-2, H-8, H-12, H-18); 8.69 (d, J = 4.8, 
4H, H-3, H-7, H-13, H-17); 8.01-7.98 ( m, 2H, H-6’); 7.82-7.79 (m, 4H, H-c, H-e); 7.74-7.68 
(m, 4H, H-4’,  H-d); 7.35-7.31 (m, 4H, H-5’,H-3’); -2.64 (br s, 2H, NH). 
ESI-MS (CH2Cl2): Positive ion mode: 783.1 (100, [M+H]+); Negative ion mode : 781.3 ([M-
H]-). 
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5,15-{[4-(t-butyl)-2-(N,N-dimethylcarbamoyl)thio-1,3-phenylene]-bis(tri-methyleneoxy)]-
di-2,1-phenylene}-10,20-di-(2,6-dichlorophenyl)-porphyrin (53) 
 
NH
N
N
H N
O
O
S
Cl
Cl
Cl
Cl
N
O
NH
N
N
H N
OH
OH
Cl
Cl
Cl
Cl
52
S
OMsMsO
O
N
42
53
Cs2CO3/ DMF
 
 
To a solution of 93.6 mg (119.3 µmol, 1 equiv.) of crude of bisphenol porphyrin 52, in 75 ml of 
dry DMF was added 1.17 g (3.81 mmol, 32 equiv.) of Cs2CO3 which was previously dried at 
100°C in high-vacuum overnight. The resulting suspension was heated to 60°C and stirred for 
30 min. Then a solution of 86.7 mg (178 µmol, 1.5 equiv.) of dimesylate 42 in 20 ml of dry DMF 
was added via syringe pump within 4 h (velocity 0.3 mm/min) at 80°C. Stirring was continued 
for 30 min at 80°C after which the reaction mixture was cooled with an ice bath and the 
reaction was quenched with 40 ml of 1M HCl. For better phase separation 90 ml of CH2Cl2 was 
added. After phase separation the aqueous phase was extracted with two portions of 80 ml of 
CH2Cl2. The combined organic layers were washed with two portions of 150 ml of saturated 
aqueous NaHCO3, water (100 ml) and brine (100ml), dried over Na2SO4 and concentrated 
under reduced pressure (silica gel, CH2Cl2. The crude product was purified by flash 
chromatography + 1% NEt3) which gave 202 mg (0.43 mmol, 45% in the last two step) of the 
bridged porphyrin 53 as purple solid.  
TLC (CH2Cl2 + 1% NEt3): Rf = 0.34. 
UV/Vis (CH2Cl2): 423 (100, Soret); 517 (9); 543 (2); 580 (4). 
1H-NMR (400 MHz, CDCl3): 9.07 (d, J = 4.73, 2H, pyrrylH); 8.70 (d, J = 3.98, 2H, pyrrylH); 
8.68 (d, J = 4.02, 2H, pyrrylH); 8.64 ( dd, J = 7.33, 1.72, 2H, H-6’); 8.40 (d, J = 4.69, 2H, PyH); 
7.91 (m, 1H, H-d); 7.74 (td, J = 7.80, 1.75, 2H, H-4’); 7.69 (m, 1H, H-c); 7.60 (m, 1H, H-d); 7.55 
(m, 1H, H-c); 7.51 (td, J = 7.5, 0.90, 2H, H-5’); 6.55 (s, 2H, H-3’’,H-5’’); 3.85 (m, 2H, H-α); 3.74 
(m, 2H, H-α); 1.31 (m, 2H, H-γ); 1.13 (s, 9H, C(CH3)3); 0.96 (m, 2H, H-γ); 0.89 (m, 2H, H-β); 
0.66 (m, 2H, H-β); 1.66 (br s, 3H, NCH3); -1.45 (br s, 3H, NCH3); -1.97 (s, 2H, NH).  
ESI-MS (MeOH): Positive ion mode: 1139.2 ([M+K]+);1122.1 ([M+Na]+); 1101.2 ([M+H]+); 
Negative ion mode : 1098.0 ([M-H]-) 
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[5,15-{[4-(t-butyl)-2-sulfate-1,3-phenylen]-bis(tri-methylenoxy)]-diphenylen}-10,20-di-
(2,6-dichlorophenyl)-porphyrin (54))  
 
 
NH
N
N
H N
O
O
S
Cl
Cl
Cl
Cl
N
O
NH
N
HN
N
O
O
SO3
-
Cl
Cl
Cl
Cl
53
H+
54
O2, KMeO
 
 
In a oxygen-enriched atmosphere 60 mg (1 equiv., 54.45 µmol) of porphyrin 53 was 
dissolved in 20 ml of dry dioxane. Then 228 mg of KOMe (60 equiv., 3.26 mmol) were added. 
The KOMe had been previously dried at 100°C overnight at the high vacuum pump. The 
dioxane solution was then bubbled with O2 for 15 minutes and heated at 110-115°C. After 
half an hour its color turned dark green. The reaction mixture was left to reflux for 35 hours. 
Then it was cooled in an ice bath and quenched with 20 ml of saturated aqueous NH4Cl.The 
obtained suspension was diluted with 15 ml of water and 20 ml of CH2Cl2. The layers were 
separated and the aqueous phase was extracted with two portions of 25 ml of CH2Cl2. The 
combined organic phases were washed with water (2×10 ml), dried over Na2SO4 and 
evaporated under reduced pressure. The crude product was filtered through a silica gel pad 
(CH2Cl2 +MeOH 2%) and it was afterwards purified by flash chromatography (silica gel, 
hexane/ethyl acetate: from 2:1 to 1:5). 18.3 mg of pure porphyrin 54 were obtained (31%). 
 
TLC (hexane/ethyl acetate 1:5): Rf = 0.20 
UV/Vis (MeOH): 420 (100, Soret); 516 (5).  
      (CH2Cl2): 424 (100, Soret); 581 (6). 
1H-NMR (400 MHz, CDCl3): 9.07 (d, J = 4.8, 4H, pyrrylH); 8.72 (d, J = 4.8, 4H, pyrrylH); 
8.44 (dd, J = 7.32, 1.51, 2H, H-6’); 7.82-7.69 (m, 9H, arylH); 7.53-7.49 (m, 3H, arylH); 6.10 
(s, 2H, H-3’’, H-5’’); 3.69 (m, 4H, H-α); 0.90-0.83 (m, 8H, H-β, H-γ); 0.93  (s, 9H, tert-Bu).  
13C-NMR (125 MHz, CDCl3): 230.8; 186.9; 160.5; 149.1; 144.8; 140.3; 138.9; 138.4; 
137.4; 133.1; 132.3; 132.1; 131.1; 131.0; 129.9; 129.25, 128.32; 127.6; 123.5; 119.9; 113.7; 
77.27; 77.22; 77.02; 76.76; 76.30; 68.99; 38.72;31.93;30.86; 29.71; 29.37; 28.93; 28.55; 
23.14; 22.70; 14.13; 10.97; 2.03; 1.03; 0.01; -13.21. 
ESI-MS (MeOH): Positive ion mode: 1101.1 ([M+Na]+); 1123.1([M-H+2Na]+). Negative ion 
mode: 1077.3 ([M-H]-). 
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[5,15-{[4-(t-butyl)-2-sulfate-1,3-phenylen]-bis(tri-methylenoxy)]-diphenylen}-10,20-di-
(2,6-dichlorophenyl)-porphyrinate]iron(III)  (55)  
 
 
-O3S
NH
N
HN
N
O
O
SO3
-
Cl
Cl
Cl
Cl
H+
54
N
N
N
N
O
O
Cl
Cl
Cl
Cl
55
FeIIIFeBr2
2,6-lutidin / toluene
 
 
50 mg of porphyrin 54 (46.3 µmol, 1 equiv.) was dried for 24 hours at the Schlenk-line. Once 
three cycles of vacuum/argon were then completed under argon atmosphere, 25 mL of 
degassed, dry toluene were added. Subsequently an addition of 269 µL of 2,6-lutidine (2.315 
mmol, 50 equiv., 291 mg) dissolved in 10mL of toluene was done. The reaction mixture was 
refluxed for 10 minutes at 130°C and soon after  ca 200 mg of FeBr2 ( 926 µmol, 20 equiv.) 
were introduce into the flask and the solution was refluxed for an another hour. After cooling 
down to room temperature the reaction mixture was poured over a celite pad and filtrated 
trough it. The crude was purified by flash chromatography (silica gel, hexane/CH2Cl2/ethyl 
acetate 5:5:1). The porphyrin 55 was obtained in 90% yield. 
 
TLC (hexane/CH2Cl2/ethyl acetate 5:5:1) Rf = 0.35 
UV/Vis (CH3Cl): 416 (100, Soret) and 467(6), 509 (10), 582 (2), 687 (2)  
cw-EPR (toluene, 95 K): g⊥ = 5.51, gII = 2.00 (axial, high-spin). 
ESI-MS (MeOH): Positive ion mode: 1130.1 ([M+H]+); Negative ion mode: 1029.3 ([M-H]-). 
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7.3. Porphyrin catalyzed oxidations 
 
7.3.1. General procedure for catalytic oxidation of probe 45 
 
In a 1.5 mL glass vial trans-1-benzyl-2-phenyl-cyclopropane 45 (5.0 mg, 24.0 µmol >99.5% 
GC-pure, 1 equiv.) was dissolved under argon in 250 µL of previously degassed and dried 
dichloromethane. The iron (III)-porphyrin 55 (0.70 mg, 0.60 µmol, 2.5mol %) and subsequently 
PhIO (5.3 mg, 24.0 µmol, 1 equiv.) were added under Argon. The reaction mixture was then 
stirred vigorously for 10 min at room temperature. After this time an aliquot was taken and 
centrifuged in order to precipitate the undissolved PhIO. The supernatant was directly by GC-
FID. [Column Supelcowax; inlet temp. (230°C); detector temp. (265°C); constant pressure (50 
kPa); temperature gradient : 100°(2 min); 100°-200° (10°/min); 200°C (5 min); 200°C -
260°C(10°C/ min); 260°C (5 min)]. Compounds were identified by distinct retention times: 13.3 
min (45), 20.7 min (57), 22.7 min (58-dia-1), 22.9 min (58-dia-2), 23.6 (61) and by coinjection 
with the authentic material >99% GC-pure that were prepared according to slightly modified 
published procedure. The product distribution is shown in table 4 
 
Ph
Ph
Ph
Ph
OH
Ph
OH
Ph
Ph
Ph
O
2.5%mol porphyrin 55
1 eq. PhIO / CH2Cl2
45
diastereomeric mixture
5761 (R1)58
 
Table 4.  
Reaction 57* 58-dia-1* 58-dia-2* 61* 
R1 226.7 505.0 242.6 11.7 
Chemical yield % 3.12 7.56 3.64 0.15 
GC-retention time 20.7min. 22.7min. 22.9min. 23.6min. 
* 1 unit corresponds to 0.013 µmol / mL (CH2Cl2) 
 
 
Control Reaction R2 (without porphyrin 55) 
 
The reaction of 45 with the oxidant was performed in exactly the same manner as shown 
above except that the synthetic porphyrin 55 was not used. In a 1.5 mL glass vial trans-1-
benzyl-2-phenyl-cyclopropane 45 (5.0 mg, 24.0 µmol >99.5% GC-pure, 1 equiv.) was 
dissolved under argon in 250 µL of previously degassed and dried dichloromethane. 
Subsequently PhIO (5.3 mg, 24.0 µmol, 1 equiv.) was added under Argon. The reaction 
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mixture was then stirred vigorously for 10 min at room temperature. After this time an aliquot 
was taken and centrifuged in order to precipitate the undissolved PhIO. The supernatant was 
directly by GC-FID. The product distribution is shown below 
 
Ph
Ph
Ph
Ph
OH
Ph
OH
Ph
Ph
Ph
O
1 eq. PhIO / CH2Cl2
45 58 5761 (R2)
 
Table 5.  
Reaction 57* 58-dia-1* 58-dia-2* 61* 
R2 1.1 4.8 3.2 1 
GC-retention time 20.7min. 22.7min. 22.9min. 23.6min. 
* 1 unit corresponds to 0.013 µmol / mL (CH2Cl2) 
 
Control Reaction R3 
 
In a 1.5 mL glass vial a degassed dichloromethane 9.72 mM solution of 58 (> 99.5% Gc-
pure), the concentration equal to the amount of 58 produced in the reaction R1, was treated 
with iron (III)-porphyrin 55 (0.70 mg, 0.60 µmol, 2.5mol % with respect to 45 in R1) and 
subsequently PhIO (5.3 mg, 24.0 µmol, 1 equiv. with respect to 45 in R1) were added under 
Argon. The reaction mixture was then stirred vigorously for 10 min at room temperature. After 
this time an aliquot was taken and centrifuged in order to precipitate the undissolved PhIO. 
The supernatant was directly by GC-FID. The product distribution is shown in table 6: 
 
Ph
Ph
OH
Ph
OH
Ph
Ph
Ph
O
2.5% porphyrin 55
1 eq. PhIO / CH2Cl2
58 5761 (R3)
Ph
Ph
OH
58
 
 
Table 6.  
Reaction 57* 58-dia-1* 58-dia-2* 61* 
R3 186.5 488 238.9 12.4 
GC-retention time 20.7min. 22.7min. 22.9min. 23.6min. 
* 1 unit corresponds to 0.013 µmol / mL (CH2Cl2) 
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Control Reaction R4 (without porphyrin 55) 
 
In a 1.5 mL glass vial a degassed dichloromethane 9.72 mM solution of 58, the concentration 
equal to the amount of 58 produced in the reaction R1, was simply treated with PhIO (5.3 
mg, 24.0 µmol, 1 equiv. with respect to 45 in R1) were added under Argon. The reaction 
mixture was then stirred vigorously for 10 min at room temperature. After this time an aliquot 
was taken and centrifuged in order to precipitate the undissolved PhIO. The supernatant was 
directly by GC-FID. The product distribution is shown in table 7: 
 
Ph
Ph
OH
Ph
OH
Ph
Ph
Ph
O
1 eq. PhIO / CH2Cl2
58 5761 (R4)
Ph
Ph
OH
58
 
 
Table 7.  
Reaction 57* 58-dia-1* 58-dia-2* 61* 
R4 232.5 551.6 269 11.1 
GC-retention time 20.7min. 22.7min. 22.9min. 23.6min. 
* 1 unit corresponds to 0.013 µmol / mL (CH2Cl2) 
 
7.3.2 Qualitative Enzymatic Experiments with Rat Liver Microsomes, CYP 2B1 and CYP 2E1. 
 
General Incubation Conditions 
 
Rat Liver Microsome 
Ph
Ph
Ph
Ph
OH
45 58
Rat Liver Microsomes
 
10 µL of MeCN 1 mM solution of substrate 45 inside an eppendorf tube was pre-heated at 
37°C for 3 min in shaking water bath. Then the following reagents (seel list 1) were added, 
mixed and incubated at 37°C for 1 h. 
 
List 1: 
25 µL of Rat Liver Microsome (1mg/mL of protein) 
50 µL of solution R (1.3 mM NADP; 3.3 mM Glu-6-ph; 3.3 mM MgCl2* 6H2O) 
50 µL of Glu-6-ph dehydrogenase (0.4 U/mL) 
365 µL of potassium phosphate buffer (pH = 7.4). 
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The reaction was then quenched with 100 µL of dichloromethane, mixed using the vortex and 
finally was centrifugated. 80 µL of this organic phase was extracted and injected directly into 
the GC-FID. The Rat Liver Microsome resulted to be able to transform the substrate 45 into 
the alcohol 58. No rearranged alcohol 61 and ketone 57 were detected. 
 
CYP2B1  
 
Ph
Ph
Ph
Ph
OH
45 58
CYP2B1
 
10 µL of MeCN 1 mM solution of substrate 45 inside an eppendorf tube was pre-heated at 
37°C for 3 min in shaking water bath. Then the following reagents (seel list 2) were added, 
mixed and incubated at 37° for 1 h. 
 
List 2: 
50 µL of CYP2B1 (50 pmol in 0.5 mL) 
50 µL of solution R (1.3 mM NADP; 3.3 mM Glu-6-ph; 3.3 mM MgCl2* 6H2O) 
50 µL of Glu-6-ph dehydrogenase (0.4 U/mL) 
365 µL of potassium phosphate buffer (pH = 7.4). 
 
The reaction was then quenched with 100 µL of dichloromethane, mixed using the vortex and 
finally was centrifugated. 80 µL of this organic phase was extracted and injected directly into 
the GC-FID. The CYP2B1 resulted to be able to transform the substrate 45 into the alcohol 
58. No rearranged alcohol 61 and ketone 57 were detected. 
 
Experimental Part 
 
 114
 
CYP2E1 
Ph
Ph
45
CYP2E1
no metabolites
 
10 µL of MeCN 1 mM solution of substrate 45 inside an eppendorf tube was pre-heated at 
37°C for 3 min in shaking water bath. Then the following reagents (seel list 3) were added, 
mixed and incubated at 37°C for 1 h. 
 
List 3: 
50 µL of CYP 2E1 (100 pmol in 0.5 mL) + 50 µL buffer solution. 
50 µL of solution R (1.3 mM NADP; 3.3 mM Glu-6-ph; 3.3 mM MgCl2* 6H2O) 
50 µL of Glu-6-ph dehydrogenase (0.4 U/mL) 
365 µL of potassium phosphate buffer (pH = 7.4). 
 
The reaction was then quenched with 100 µL of dichloromethane, mixed using the vortex and 
finally was centrifugated. 80 µL of this organic phase was extracted and injected directly into 
the GC-FID. CYP2E1 could not metabolize the substrate 45. 
 
7.3.3. General procedure for catalytic oxidation of probe 10 
 
In a 1.5 mL glass vial trans-2-phenyl-methylcyclopropane 10 (3.3 mg, 25.0 µmol >99.5% GC-
pure, 1 equiv.) was dissolved under argon in 250 µL of previously degassed and dried 
dichloromethane. The iron (III)-porphyrin 55 (0.75 mg, 0.650 µmol, 2.5mol %) and 
subsequently PhIO (5.5 mg, 25.0 µmol, 1 equiv.) were added under Argon. The reaction 
mixture was then stirred vigorously for 10 min at room temperature. After this time an aliquot 
was taken and centrifuged in order to precipitate the undissolved PhIO. The supernatant was 
directly by GC-FID. [Column Supelcowax; inlet temp. (230°C); detector temp. (265°C); 
constant pressure (50 kPa); temperature gradient : 70°C (2 min); 70°C -200°C (10°C/ min) ; 
200°C (10 min); 200°C -250°C (10°C /min); 250°C (5 min)]. Compounds were identified by 
distinct retention times: 3.9 min (10), 10.3 min (66), 13.0 min (63), 14.9 (70) and by 
coinjection with the authentic material >99% GC-pure that were prepared according to 
slightly modified published procedure. Oxidation experiments were repeated four times and 
standard deviation of +/- 5% was determined for product ratios. The product distribution is 
shown in table 8: 
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CH3
OH
OH
10 63 66
CH3
70HO
(R5)  
Table 8. 
Reaction 66* 63* 70* 
R5 1 9 22 
Chemical yield % 0.003 0.027 0.066 
Retention time 10.37 min. 13.02 min. 14.91 min. 
* 1 unit corresponds to 0.003 µmol / mL (CH2Cl2) 
 
Ratio [70/ (66 + 63)] = 2.2 and Ratio (63/ 66) = 9 
 
Control Reaction R6 (without porphyrin 55) 
1 eq. PhIO / CH2Cl2
10
(R6)none of the three products are detected
 
The reaction of 10 with the oxidant was performed in exactly the same manner as shown 
above except that the synthetic porphyrin 55 was not used. In a 1.5 mL glass vial trans-2-
phenyl-methylcyclopropane 10 (3.3 mg, 25.0 µmol >99.5% GC-pure, 1 equiv.) was dissolved 
under argon in 250 µL of previously degassed and dried dichloromethane. PhIO (5.5 mg, 
25.0 µmol, 1 equiv.) was added under Argon. The reaction mixture was then stirred 
vigorously for 10 min at room temperature. After this time an aliquot was taken and 
centrifuged in order to precipitate the undissolved PhIO. The supernatant was directly by GC-
FID. No products were detected. 
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Control Reaction R7   
 
OH
63
2.5% porphyrin 55
1 eq. PhIO / CH2Cl2 no rearranged alcohol 66 is formed (R7)
 
In a 1.5 mL glass vial a degassed dichloromethane 0.67 mM solution of 63, the concentration 
equal to 25-fold the amount of 63 produced in the reaction R5, was treated with the iron (III)-
porphyrin 55 (0.75 mg, 0.650 µmol, 2.5mol % respect to 10 in R5) and subsequently with 
PhIO (5.5 mg, 25.0 µmol, 1 equiv. respect to 10 in R5) under Argon. The reaction mixture 
was then stirred vigorously for 10 min at room temperature. After this time an aliquot was 
taken and centrifuged in order to precipitate the undissolved PhIO. The supernatant was 
directly by GC-FID. The alcohol 63 does not rearrange to 66 in the presence of the porphyrin 
%5 together with PhIO. 
 
Control Reaction R8 (without porphyrin 55). 
 
OH
63
1 eq. PhIO / CH2Cl2 no rearranged alcohol 66 is formed (R8)
 
In a 1.5 mL glass vial a degassed dichloromethane 0.67 mM solution of 63, the concentration 
equal to 25-fold the amount of 63 produced in the reaction R5, was simply treated with PhIO 
(5.5 mg, 25.0 µmol, 1 equiv. respect to 10 in R5) under Argon. The reaction mixture was then 
stirred vigorously for 10 min at room temperature. After this time an aliquot was taken and 
centrifuged in order to precipitate the undissolved PhIO. The supernatant was directly by GC-
FID. The alcohol 63 does not rearrange to 66 in the presence of the only PhIO. 
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